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Strains from Canadian hospitals were classified as A. baumannii, A. pitti, or A. nosocomialis 
and the most commonly expressed resistance nodulation division (RND) efflux pump was 
adeFGH. A collection of A. baumannii isolates from the environment showed decreased 
susceptibility to at least three antibiotics and expression of three RND efflux pumps (adeFGH, 
adeABC, adeIJK). From the clinical collection two blood isolates, AB030 and AB031, were 
chosen to evaluate the outcomes of three virulence models. Using Caenorhabditis elegans and 
Galleria mellonella a statistically significant difference was shown in AB030 the extremely 
drug resistant strain. 
 
Investigation of the physiological role of adeFGH pump revealed its expression may be more 
important to cell metabolism and independent of factors controlling expression of the other 
pumps. This was further demonstrated through examination of local regulator knockout (adeL) 
in ATCC17978 showing expression levels of adeFGH pump increased only 2-fold. Expression 
in sub-lethal concentrations of chloramphenicol or florfenicol showed >5-fold induction of 
adeFGH expression as well as adeABC, independently of AdeL. These data show that the 
AdeFGH pump is likely regulated by AdeL, but more so by another unknown regulatory 
mechanism that responds to aberrant peptide formation and not DNA synthesis error or 
nitrosative stress. In addition strain specific differences likely also account for differences in 
phenotypic observations since nitrosative stress has improved tolerance and induced adeFGH 




Finally analysis of efflux pumps in two triclosan resistant mutants, AB042 and AB043, revealed 
overexpression of AdeIJK and mutation in the adeIJK regulator, AdeN. Complementation 
repressed adeIJK expression levels and increased susceptibility to moxifloxacin and 
ciprofloxacin. The AB043 strain did not have any mutations in adeN, promoter region or RND 
operon. Osmotic stress tolerance revealed more C16 fatty acids and less C18 compared to the 
parent strain. The more triclosan resistant strain AB043, showed biofilm formation exclusively 
at 30°C. Twitching was observed and caused by mutation in the histone-like nucleoid 
structuring (HNS) protein but did not affect biofilm formation. Using RNA-seq and proteomic 

















I would like to first express my sincere gratitude and appreciation to my supervisor Dr. Ayush 
Kumar. Your guidance, ideas, confidence, opportunities to learn and tremendous ability to 
inspire, have taught me so much more about science and research than I ever thought possible. 
Thank you for your unending support and opportunities you have given me over these five 
years. 
  
To my committee members, Dr. Julia Green-Johnson, Dr. Dinesh Christendat, Dr. Andrea 
Kirkwood and (former member) Dr. John Samis, thank you so much for your support, guidance, 
ideas and opportunities to learn. Your integral support has been pivotal in my achieving this 
body of research.  
 
Wonderful members of the Kumar lab have come and gone before me at the University of 
Ontario Institute of Technology, it was a wonderful time and I’ve made some lasting friendships 
and learned a tremendous amount from each of you. I am also happy to have met all the great 
students that have come through the APBS graduate program and happy that I was able to 
participate in talks with everyone in the group.  
 
To my good friend and former lab mate, Yasser. Your enduring creativity, your love and 
curiosity for science inspired me, and your sense of humour made coming to work a pleasure. 
It has been a rewarding experience working with, Malaka De Silva, Manu Singh, Mark Unger 
and Dr. Rakesh Patidar and I wish you all the very best in your research. 
 
I would like to express my sincere thanks to the faculty in the Department of Microbiology at 
the University of Manitoba especially, Dr. Karen Brassinga, Dr. Deb Court and Dr. Peter 
Loewen. Thank you for your support of my research while at the UofM. A special thank you to 
the graduate students in the Department of Microbiology who have been welcoming, friendly 
and supportive since I arrived in Winnipeg. Your kindness and friendship has been sincere, 
genuine and has left a lasting impression on me.  
 
The friends I have had since highschool were a refreshing source of humour and relaxation 
during my research and I thank them for their proactive approach to spending time with me even 
though I was always late.   
 
Finally to my dear family, Rohini, Shirley and brother Mallik. Without your support and love 
this would have not been achievable. Mom and dad, your enduring encouragement of my 
academics and love for me throughout my life, with inspiration and confidence leading the way, 









TABLE OF CONTENTS 
Abstract ...................................................................................................... i 
Acknowledgments ...................................................................................... iii 
List of Tables ............................................................................................. ix 
List of Figures ............................................................................................. x 
Abbreviations .......................................................................................... xiii 
INTRODUCTION ........................................................................................ 1 
MATERIALS AND METHODS .................................................................... 41 
RESULTS & DISCUSSION .......................................................................... 70 
FUTURE DIRECTIONS ............................................................................ 276  




1.0 Taxonomic analysis of Acinetobacter species ............................................................... 2 
1.0.1 Epidemiology ............................................................................................................ 4 
1.0.2 Reservoirs .................................................................................................................. 6 
1.0.3 The core and pan genome of Acinetobacter baumannii ............................................ 7 
1.2 Observations of Persistence and Virulence in Nosocomial Settings .......................... 8 
1.2.1 Biofilms and Motility in Persistence and Virulence .................................................. 9 
1.2.2 Mechanisms of Iron Acquisition ............................................................................. 13 
1.2.3 Host Interaction Virulence Factors .......................................................................... 13 
1.2.4 Virulence Models to Study Acinetobacter baumannii pathogenesis ....................... 15 
1.3 Mechanisms of Antibiotic Resistance ......................................................................... 19 
1.3.1 Enzymatic Modification .......................................................................................... 20 
1.3.2 Target Modification ................................................................................................. 22 
1.3.3 Decreased Influx ...................................................................................................... 22 
v 
 
1.3.4 Efflux Pumps In Acinetobacter baumannii ............................................................. 23 
1.3.5 Mechanism of RND Pump Action .......................................................................... 24 
1.4 The Induction of RND Efflux Pumps ......................................................................... 29 
1.4.2 RND Pump Expression and Decreased Susceptibility to Antimicrobials ............... 30 
1.5 Induction of RND Pumps by Non-antibiotic Molecules ............................................ 32 
1.5.1 Induction of Efflux Pumps by Oxidative and Nitrosative Stress............................. 34 
1.5.2 Induction of RND Efflux Pumps by Antimicrobial Compounds ............................ 35 
Hypothesis ........................................................................................................................... 40 
MATERIALS AND METHODS ......................................................... 41 
2.1 Bacterial Strains, Plasmids and Oligonucleotides ..................................................... 42 
2.2 Media and Growth Conditions .................................................................................... 42 
2.2 Genomic and Plasmid DNA Extraction ...................................................................... 42 
2.3 Gel Extraction ............................................................................................................... 52 
2.4 DNA Manipulations ...................................................................................................... 52 
2.4.1 General PCR ............................................................................................................ 52 
2.4.2 Restriction Enzyme Digest and Ligation ................................................................. 52 
2.4.3 Splice Overlap Extension PCR (SOEing - adeLGmFRT, hnsGmFRT) .................. 53 
2.5 Preparation of Competent Cells .................................................................................. 57 
2.5.1 Preparation of CaCl2 Competent Cells (DH5ɑ, SM10) ........................................... 57 
2.5.2 Preparation of Electrocompetent Cells (A. baumannii Strains) ............................... 57 
2.6 Transformation of Bacterial Cells .............................................................................. 57 
2.6.1 Electroporation ........................................................................................................ 57 
2.6.2 Chemical Transformation ........................................................................................ 58 
2.7 Clean Knockout of Genes in A. baumannii ................................................................ 58 
2.7.1 Conjugation ............................................................................................................. 58 
2.7.2 Homologous Recombination ................................................................................... 58 
vi 
 
2.7.3 Excision of Gm Marker ........................................................................................... 59 
2.8 Quantitative-Reverse transcriptase polymerase chain reaction (qRT-PCR) ......... 60 
2.8.1 RNA Extraction and cDNA synthesis ..................................................................... 60 
2.8.2 Real-Time PCR ....................................................................................................... 60 
2.9 Minimum inhibitory concentrations ........................................................................... 61 
2.9.1 Two-fold Broth Dilution .......................................................................................... 62 
2.9.2 Etest ......................................................................................................................... 62 
2.10 Growth Curves ............................................................................................................ 63 
2.11 Biofilm Assay .............................................................................................................. 63 
2.12 Virulence Models ........................................................................................................ 64 
2.12.2 Candida albicans Co-culture Survival Assay ....................................................... 64 
2.12.1 Caenorhabditis elegans ......................................................................................... 65 
2.12.3 Galleria Mellonella Infection ................................................................................ 65 
2.13 Genome Sequencing ................................................................................................... 66 
2.14 RNA-seq Preparation and Data Analysis ................................................................. 67 
2.15 Sample Preparation for Proteomics and Analysis ................................................... 67 
2.16 Fatty acid extraction ................................................................................................... 68 
RESULTS & DISCUSSION.............................................................. 70 
3.1 Role of efflux pumps and porins in clinical and environmental isolates of 
Acinetobacter spp. ............................................................................................................... 71 
3.1.1 Analysis of Canada wide collection of A. baumannii clinical isolates for multidrug 
resistance, efflux pump and porin expression .................................................................. 71 
3.1.2 MIC and qRT-PCR reveal strains with multidrug resistance and expression of   
three characterized efflux pumps. ..................................................................................... 75 
3.1.3 Analysis of Acinetobacter environmental isolates from Canadian agricultural  
niches for multidrug resistance and efflux pump expression. .......................................... 81 
Discussion ......................................................................................................................... 89 
vii 
 
3.2 Assessment of three virulence models, Candida albicans, Caenorhabditis elegans, 
Galleria mellonella against two A. baumannii blood isolates AB030 and AB031. ......... 95 
3.2.1 The use of non-mammalian models to study nosocomial pathogens ...................... 95 
3.2.2 Candida albicans as a model organism to test virulence in AB030 and AB031  
show clearing of fungal filaments but not wildtype cells. ................................................ 95 
3.2.3 Caenorhabditis elegans as a model organism to test virulence in AB030 and  
AB031 reveal differences in virulence, enhanced in presence of ethanol. ..................... 100 
3.2.4 Galleria mellonella as a model organism to test virulence in AB030 and AB031 
reveal significant differences between each strain. ........................................................ 106 
3.2.5 Comparison of AB030 and AB031 Genome Sequence Indicate Additional 
Virulence Genes in AB030. ............................................................................................ 109 
Discussion ....................................................................................................................... 116 
3.3 Regulation of Resistance Nodulation Division Efflux Pumps in Acinetobacter 
baumannii. ......................................................................................................................... 123 
3.3.1 Growth Phase Dependant Expression of Efflux Pumps ........................................ 123 
3.4 Characterization of AdeFGH natural function as a response to antibiotic and 
nitrosative stress ............................................................................................................... 131 
3.4.1 Characterization of the AdeFGH efflux pump and the related improved tolerance  
of A. baumannii strains in presence of nitrosative stress. ............................................... 131 
3.4.1 Sub-lethal combinations of TMP and CHL improve tolerance compared to TMP 
alone. .............................................................................................................................. 138 
3.4.2 Gene expression analysis shows adeG responds to nitrosative stress in AB031     
and ATCC17978. ............................................................................................................ 144 
3.4.3 Characterization of nitrosative stress effect on tolerance and RND pump                   
expression in ATCC17978 and isogenic knockout of gene encoding adeFGH     
regulator, AdeL. .............................................................................................................. 150 
Discussion ....................................................................................................................... 166 
 
3.5 Study of Triclosan Resistant Acinetobacter baumannii ATCC17978 reveals a 
unique composition of phenotypes and RND efflux regulation. ................................... 174 
3.5.1 Triclosan mutants are resistant to multiple antibiotics .......................................... 175 
3.5.2 Triclosan mutants have repressor dependant and independent mutations    
controlling adeJ expression. ........................................................................................... 184 
viii 
 
3.5.3 Triclosan strains contain modified fatty acid composition and osmotic stress 
tolerance.......................................................................................................................... 194 
3.5.4 Triclosan strain shows attenuated virulence, motility and temperature        
dependant biofilm formation. ......................................................................................... 200 
3.5.5 Identification and characterization of mutant global regulator HNS .................... 206 
3.6.1 Genome sequencing of strains show large deletions in more resistant AB043 ..... 215 
3.6.2 RNA-sequencing data reveal uncharacterized transcriptional regulation in      
AB042 and downregulated SOS transcriptional repressors in AB043. .......................... 228 
3.6.3 Proteome of AB042 and AB043 show trend with RNA-seq data and overall      
show fewer changes in expression compared to wildtype .............................................. 246 
3.6.4 The role of mutant HNS in AB043 and its role in motility ................................... 258 
Discussion ....................................................................................................................... 260 
 
FUTURE DIRECTIONS ................................................................. 276 
APPENDIX ....................................................................................... 280 
I Appendix - Construction of A. baumannii Overexpression Vectors ......................... 281 
II Appendix - Confirmation of adeL and hns knockout in ATCC17978 ..................... 284 
III Appendix - Table of ΔadeL Minimum Inhibitory Concentration of Antibiotics . 2863 
    IVa Appendix - Table of ΔadeL Minimum Inhibitory Concentration of Antibiotics.284 
    IVb Appendix - ΔadeL Role in Biofilm Reduction………………………………….....284 
 
   V Appendix - CFU in Sublethal Concentrations of ½ TMP, ½ TMP+ 5mM GSNO            
    and ½ TMP+ 1/10 CHL…….……………………………………………….….…….….285 
 
    VI Appendix - Scanning electron microscopy of triclosan resistant mutants……….286 
 





List of Tables 
Table 1 – Bacterial strains and plasmids used in this study. .............................................. 43 
Table 2 – List of oligonucleotides used in this study. .......................................................... 48 
Table 3 – Antibiotic susceptibilities of Acinetobacter clinical isolates. .............................. 77 
Table 4 – Antibiotic susceptibilities of Acinetobacter environmental isolates from. ........ 82 
Table 5 – Annotated ORF’s found in AB030 but absent from AB031 and ATCC17978 
that have a reported role in virulence. ................................................................................ 113 
Table 6 – Antibiotic drug structures and MIC’s against ATCC17978, ATCC17978, 
AB030 and AB031. ................................................................................................................ 136 
Table 7 – MIC of ATCC17978, AB042 and AB043 against a panel of twenty antibiotics 
show decrease susceptibility after exposure to triclosan. .................................................. 176 
Table 8 ................................................................................................................................... 217 
Table 9 – Genes missing from AB042 (5 genes) genome compared to the parent strain 
ATCC17978. .......................................................................................................................... 221 
Table 10 – Genes missing from the AB043 (33 genes) genome compared to the parent 
strain ATCC17978 ................................................................................................................ 223 
Table 11 - Genes in AB042 showing at least 2-fold change by RNA-seq, in at least one 
biological replicate. ............................................................................................................... 233 
Table 12 - Genes in AB043 showing at least 2-fold change by RNA-seq, in at least one 
biological replicate. ............................................................................................................... 240 
Table 13 – Similar trends between transcriptomics and proteomic data for AB042. .... 249 
Table 14 – Similar trends between transcriptomic and proteomic data for AB043. ..... 251 
Table 15 – Global protein expression of AB043 before and after HNS compliment     








List of Figures 
Figure 1 – Antibiotic targets in gram negative bacteria and their resistance   
mechanisms. ............................................................................................................................ 26 
Figure 2 – Schematic of splice overlap extension PCR. ...................................................... 55 
Figure 3 – Multiplex PCR against the gyrB gene identifying clinical isolates as A. 
baumannii, A. nosocomialis, A. pitti. ...................................................................................... 73 
Figure 4 – Expression of resistance nodulation division pump (adeB, adeG, adeJ) and 
outer membrane porin encoding genes (carO, oprD, 33-kDa) in clinical isolates of 
Acinetobacter species. ............................................................................................................. 79 
Figure 5 – Characterization of Acinetobacter environmental strains by (A) multiplex 
PCR and (B) efflux pump expression by qRT-PCR. ........................................................... 84 
Figure 6 - Survival of wildtype (Wt) and constitutively filamentous (Δtup1) C. albicans 
following co-incubation with A. baumannii strains. ............................................................ 97 
Figure 7 – Nematode infection assays measuring survival differences between AB031, 
AB030 and ATCC17978. ...................................................................................................... 101 
Figure 8 – Nematode killing following infection with A. baumannii clinical isolates. 
Arrows indicate areas where nematodes seemed to burst when dying. .......................... 103 
Figure 9 – Galleria mellonella larvae infection assay measuring survival after infection 
with AB030, AB031 or ATCC17978 at 1.5x108 CFU/mL. ................................................ 107 
Figure 10 – Comparison of genomes ATCC17978 (blue), AB030 (green), AB031 (red)    
in CGView. ............................................................................................................................ 110 
Figure 11 – Growth curve of ATCC19606 showing O.D.600 values over 16 hour time 
course. .................................................................................................................................... 126 
Figure 12 – Relative expression of RND efflux pumps in A. baumannii ATCC19606    
with increasing cell density over 16 hour time course. ...................................................... 129 
Figure 13 – Multiple amino acid alignment of RND efflux pump components from P. 
aeruginosa (MexB, MexD, MexY, MexF), E. coli (AcrB) and A. baumannii (AdeG)    
show greatest homology between AdeG and MexF. .......................................................... 132 
Figure 14 – Improved tolerance of (A) ATCC17978, (C) AB031 compared to (B) AB030 
exposed to 1/2 MIC TMP with 1/10 or 1/100 MIC CHL compared to 1/2 TMP alone over 
24 hours. Significant difference between 1/2 TMP and combinations of CHL are shown 
by markers filled in black. ................................................................................................... 139 
Figure 15 – Tolerance of both (A) ATCC19606 and (B) AB031 grown in 1/2 TMP is 
improved with addition of 1/10 FLO or 10 mM GSNO. ................................................... 142 
xi 
 
Figure 16 – Expression of adeG increases after exposure to TMP and CHL.................. 146 
Figure 17 – Expression of adeG in AB031 increases sequentially when exposed to 1/5 
TMP, CHL and 10mM GSNO, respectively. ..................................................................... 148 
Figure 18 – Sub-lethal TMP, CHL, GSNO, FLO effect tolerance in ATCC17978 and 
ΔadeL, reveal an adeL dependent tolerance. ...................................................................... 152 
Figure 19 – Expression of RND pumps in ATCC17978 in adeL knockout strains indicate 
overexpression of adeG and adeB. ....................................................................................... 154 
Figure 20 – Expression of RND efflux pumps in ATCC17978 and ΔadeL after sub-lethal 
exposure to drugs reveal expression of adeB and adeG is independent of adeL. All 
expression is calculated relative to ATCC17978 LB control. ........................................... 156 
Figure 21– Alignments of AdeL amino acid sequence and intergenic region from 
ATCC17978, ATCC19606 and AB031. .............................................................................. 163 
Figure 22 – Sequencing and gene expression profile of fabI in AB043, AB042 and 
ATCC17978. .......................................................................................................................... 180 
Figure 23 – Expression analysis of RND and MATE family pumps reveal overexpression 
of adeJ in AB042 and AB043. .............................................................................................. 182 
Figure 24 – adeN gene alignment from ATCC17978, AB042, AB043 show a 73 b.p. 
deletion in the adeN gene from AB042 leading to a premature stop codon and truncated 
protein. ................................................................................................................................... 187 
Figure 25 – Overexpression of adeN in AB042 restores (A) adeJ expression levels to 
ATCC17978 levels by qRT-PCR, and (B) MIC of moxifloxacin and ciprofloxacin. ...... 189 
Figure 26 – Overexpression of adeN in AB043 does not restore adeIJK expression levels 
to ATCC17978 level. ............................................................................................................. 192 
Figure 27 – Tolerance defect in AB042 and AB043 with increasing sucrose 
concentration. ........................................................................................................................ 195 
Figure 28 – Fatty acid analysis of triclosan resistant mutants show major changes in 
C16:1 and C18:1. .................................................................................................................. 198 
Figure 29 – A G. mellonella infection model reveal attenuated virulence in AB043, 
compared to AB042 and ATCC17978. ............................................................................... 201 
Figure 30 – Triclosan strain AB043 shows biofilm formation at 30°C but not 37°C and is 
motile on semi-solid agar. .................................................................................................... 204 
Figure 31 – The HNS gene in AB043 contains an 88 b.p. insertion element with inverted 
repeats flanking its ends. ...................................................................................................... 207 
Figure 32 – Motility in AB043 is repressed by the HNS regulator but has no role in 
regulation of biofilm. ............................................................................................................ 210 
xii 
 
Figure 33 – Expression analysis of adeJ reveal an hns independent expression in both 
ATCC17978 and AB043. ...................................................................................................... 212 
Figure 34 – Transcriptome of AB042 and AB043 grouped according to clusters of 
orthologous group (COG) show differences relative to ATCC17978. Accession numbers 
indicate at least 2-fold change in expression relative to ATCC17978. ............................. 231 
Figure 35 – The proteome of (A) AB042 and (B) AB043 reveal clusters of genes that have 
















aacC1 Acetyltransferase 3-1 encoding gene (Gm resistance) 





adeA, adeB, adeC 
adeI, adeJ, adeK 
adeF, adeG, adeH 
Acyl homoserine lactone 
AI Autoinducer 
Ampr Ampicillin resistance 
BAP Biofilm Associated Protein 





Canadian Antimicrobial Resistance Alliance 
Carbenicilin resistance 
cDNA Complimentary DNA 
CF Cystic Fibrosis 
CHL Chloramphenicol 
CSU Cu sensor  
Ct Cycle Threshold 
dhfr Dihydrofolate Reductase 
DNA Deoxyribonucleic Acid 
EPI efflux pump inhibitor 
ESBL extended spectrum β-lactamase 
FLO florfenicol 
FRT Flp Recombinase Target 
Gm gentamicin  
GSNO S-Nitrosoglutathione 
HNS Histone-like nucleoid structuring 
ICL 
ICU 
International Clonal Lineage 
Intensive care Unit 
IS Insertion Sequence 
Kanr 
LB 
Kanamycin resistance (apha) 
Luria-Bertani Lennox, Lysogeny Broth 
MDR Multidrug Resistance 
MIC Minimum Inhibitory Concentration 
OXA Oxacillinase 
NTC No Template Control 
OMP Outer Membrane Protein 
ori Origin of Replication 
PCR Polymerase Chain Reaction 
xiv 
 
RND Resistance Nodulation Division Efflux 
RNS Reactive Nitrogen Species 
ROS Reactive Oxygen Species 
sacB Levansucrase 
SMRT Single Molecule Real Time 
TMP Trimethoprim 
VAP Ventilator Associated Pneumonia 
v/v Volume/Volume  
w/v Weight/Volume  
g Gravitational Force 
mL millilitre 
mM millimolar 











































1.0 Taxonomic analysis of Acinetobacter species 
The Acinetobacter genus is within the Moraxellaceae family of Pseudomonadacae which are 
composed of Acinetobacter, Moraxella, Psychrobacter, Alkanindiges, Paraperlucidibaca and 
Perlucidibaca. These genus come from a wide variety of environments and have various roles 
in ecological and clinical environments. Apart from Acinetobacter the Moraxella, genus also 
have species that contribute to respiratory tract infections (Janiero, 2014). One unifying 
characteristic of these bacteria is their inability to metabolize carbohydrates through a 
fermentive pathway and are usually catalase positive while fatty acids are primarily composed 
of unbranched, saturated and mono or di-unsaturated constituents dominated by 16 and 18 
length carbon chains (Janiero, 2014). The taxonomy of Acinetobacter has changed since it was 
first identified by Beijerink in 1911 as Micrococcus calcoaceticus (Baumann 1968) and then 
was later named Acinetobacter, proposed by Brisou and Prévot in 1954. The subcommittee on 
the Taxonomy of Moraxella and Allied Bacteria subsequently proposed that the genus 
Acinetobacter should include only the oxidase-negative strains (Lessel 1971) and today 
Acinetobacter taxonomy is supported by its ability to transform readily, a prerequisite for 
inclusion into the Acinetobacter genus (Peleg, 2008). As with other genus it is difficult to 
distinguish through biochemical methods different species, but through molecular methods 
genomic groups or genospecies have been identified. The Acinetobacter genus is comprised of 
34 genomic groups primarily identified through DNA-DNA hybridization; 23 of these have 
been named (Di Nocera et al., 2011). These genomic groups have derived from a phylogenetic 
bottleneck of evolution followed by population expansion (Diancourt et al., 2010) that has seen 
the rise of closely related phylogenetic groups (Nemec et al., 2011). Included in this are the 
closely related Acinetobacter baumannii, calcoaceticus, pitti (formerly genospecies 3) and 
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nosocomialis (formerly genospecies 13TU) groups or Acb-complex (Gerner-Smidt et al., 1991; 
Nemec et al., 2011) due to their inability to be identified using older biochemical methods such 
as those detailed in Bouvet & Grimont (1987). Due to more advanced molecular methods such 
as DNA-DNA hybridization, the closely related members of the Acb-complex were first 
grouped (Tjernberg and Ursing 1989). The members of the Acb complex although 
phylogenetically grouped come from distinct niches ranging from soils and water to hospital 
and intensive care units. The A. calcoaceticus strains are usually found in soil and water with 
two reports identifying the presence of the NDM-1 containing plasmids in soil isolates (Wang 
and Sun, 2015; Li et al., 2015) but no reports of human infection. The A. baumannii species is 
the most clinically relevant because it is the most frequently identified MDR isolate, followed 
by A. pittii and A. nosocomialis that are also clinically relevant but to a lesser extent compared 
to A. baumannii (Dijkshoorn et al., 2007). More recent genome-wide analysis has showed A. 
baumannii is well separated from the other members of the Acb-complex and those of the 
complex from the remainder of species in the genus (Chan et al., 2012). Multiplex PCR for the 
delineation of species have become increasingly popular due to its ease of use, fast analysis and 
flexibility. Most recently a simple multiplex PCR technique was developed using the gyrB gene 
variation among species to delineate Acb complex species (Higgins et al., 2010) and newer 
multiplex techniques take advantage of differences in 16S-23S rRNA, gyrB and recA genes in 






Members of A. baumannii, A. pittii and A. nosocomialis are not ubiquitous in nature and are 
commonly isolated from colonized or infected individuals in hospital and from the local 
environment during hospital outbreaks (Towner, 2009). However A. baumannii has been the 
most frequently isolated species and presents the greatest resistance to conventional antibiotic 
treatment. The prominence of Acinetobacter baumannii infections has rapidly taken over as a 
primary infection type in nosocomial settings. The distribution of Acinetobacter isolates from 
around the world is classified into six international clonal lineages (ICL) using multilocus 
sequence typing to characterize strains (Diancourt et al., 2010). Of these, A. baumannii core 
genomes were highly conserved and also the most prevalent in nosocomial settings, likely due 
to a rapid expansion from a few multi-drug resistant clones (Diancourt et al., 2010). The 
pathogen is notorious for causing varied health care associated infections that are multidrug 
resistant (MDR), with multiple persistent outbreaks (Halachev et al., 2014; McGrath et al., 
2011; Pagano et al., 2015; Umezawa et al., 2015)  from around the world, including Europe, 
North America, Argentina, Brazil, China, Japan, Korea (Perez et al., 2007) and Madagascar, 
where patients were found with isolates of carbapenem resistant A. baumannii despite the 
country never having used this class of drug before (Andriamanantena et al., 2010).  
 
In hospital settings the pathogen will primarily colonize and cause infection of critically ill and 
immunocompromised patients in ICU (Liu et al., 2014; Ñamendys-Silva et al., 2015; Nunley et 
al., 2010)  with likelihood of mortality ranging from 10-43% in ICU and 7.8-23% in hospitals 
(Falagas et al., 2006). The pathogen A. baumannii is recognized as causing a broad range of 
severe nosocomial infections in the ICU including urinary tract infections, ventilator associated 
pneumonia (VAP), bacteremia, secondary meningitis, soft tissue and wound infections with 
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severity of outcome primarily determined by underlying disease (Peleg et al., 2008; Paolo Visca 
et al., 2011). The most frequent source of A. baumannii infections is VAP with 5-10% of ICU 
cases in the USA attributed to the pathogen (Gaynes & Edwards, 2005) and bacteremia 
associated infections caused by VAP having poor outcomes (Lee et al., 2014). Acinetobacter is 
the 10th most commonly reported organism causing bacteremia and mortality is reported as high 
as 58% (Chuang et al., 2010), this number is exacerbated when patients are treated with a broad 
spectrum antibiotic such as imipenem, 70% (Lee et al., 2014). Bacterial meningitis case studies 
of hospital acquired bacterial meningitis have shown 3.6% of patient meningitis was caused by 
A. baumannii in adults while another study showed it was responsible for 11.2% of the cases in 
children (Kim et al., 2009). Large studies in the USA and Taiwan suggest Acinetobacter as the 
5th most common genus associated with meningitis while more recent studies from Turkey have 
shown Acinetobacter as the leading cause of gram-negative post-surgical meningitis (Kim et 
al., 2009). The A. baumannii organism has been shown to colonize the skin of healthy 
individuals and not cause disease (Peleg et al., et al., 2008) however nosocomial A. baumannii 
skin and soft tissue infections are also a major source of morbidity and mortality (Guerrero et 
al., 2010). These types of A. baumannii infections are notoriously associated with natural 
disasters (Oncül et al., 2002; Uçkay et al., 2008; Wang et al., 2010) and war afflicted countries; 
namely Afghanistan and Iraq where Canadian and American soldiers wounded in conflicts 
suffered from severe skin and soft tissue infections (Members, 2004; Tien et al., 2007), in some 
cases progressing towards a necrotizing infection (Sebeny et al., 2008). In a case study of 18 
soldiers infected with A. baumannii osteomyelitis, treatment options were surgical debridement 
of necrotic bone where three of the cases were associated with bacteremia (Davis et al., 2005). 
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While no mortality was reported in these cases the median age of patients was 26 possibly 
contributing to the low mortality (Davis et al., 2005). 
 
1.0.2 Reservoirs 
Although the natural reservoir of A. baumannii is still not clear a study has shown the organism 
along with various other Acinetobacter spp. was able to colonize 75% of patients and 42.5% of 
healthy individuals while colonization rates increased during their hospital stay (Seifert et al., 
1997). In another study using 192 healthy volunteers over 40% were found to carry some species 
of Acinetobacter spp. mostly on the forearm and forehead with A. baumannii only being isolated 
in one patient (Berlau, et al., 1999). In a more advanced study examining the effect of skin 
colonizing Acinetobacter it was found patients with colonized forearms had an attenuated 
cytokine response against Candida albicans and Staphylococcus aureus, while corynebacteria 
did not suppress cytokine production (Smeekens et al., 2014). More specifically A. baumannii  
infection can be exacerbated due to internal transmission of the pathogen through physical 
contact between health care provider and patient (Weber et al., 2010) as well as through medical 
equipment and hospital beds. Strains of A. baumannii have been found to survive under diverse 
conditions and have been isolated from innate surfaces such as bed curtains, air condition vents, 
furniture and hospital equipment (Dijkshoorn et al., 2007). In addition the pathogen has been 
shown to survive in dry conditions for up to four months (Jawad et al., 1998). A basis for 
survival under desiccating conditions has also recently been reported through proteomic 
analysis of strains (Gayoso et al., 2014). In hospital environments there is constant exposure to 
antimicrobials therefore enhancing the persistence of bacterial species and  their  acquisition  of  
multidrug  resistance  determinants  from  mixed  bacterial  populations (Hornsey et al., 2011; 
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Smith et al., 2007). The exact mechanism of acquisition of foreign DNA in A. baumannii is 
currently unknown however it is plausible that foreign plasmids could enter the cell where it is 
incorporated into the genome or through viral DNA transduction.  
 
1.0.3 The core and pan genome of Acinetobacter baumannii 
Comparative genomics has allowed for the identification of the core-genome in A. baumannii 
ranging from 1455 to 2688 coding sequences; the functions coding mostly for metabolic and 
general processes (65%) as well as a large number of hypothetical proteins (22%). This is in 
contrast to the pan-genome coding for over 8800 proteins and increasing with each additional 
genome added to the collection (Antunes et al., 2014). Part of the pan genome is the accessory 
genome which contributes the greatest variability among A. baumannii isolates coding for 25-
46% unique proteins in each strain. The accessory genome is enriched by transport and 
transcription regulation genes while variation in strain specific genes is mostly in hypothetical 
proteins (39%), transposases (36%) and insertion sequences (16%). Analysis of 116 strains of 
Acinetobacter identified the a majority of strains contain CRISPR-Cas systems which could 
facilitate the genetic diversity in the genus and could contribute to multidrug resistance and 
virulence by acquisition of foreign DNA (Touchon et al., 2014). The organism also has a 
remarkable propensity to mutate under stressful conditions and encodes stress inducible error-
prone polymerases that could contribute to multidrug resistance (Norton et al., 2013). This was 
demonstrated through genome sequencing of a clinical isolate before and 1-week after 
tigecycline therapy. During the course of 1-week tigecycline therapy resistance rose from 
0.5μg/mL to 16μg/mL. It was later proposed that a single SNP in the adeS gene regulating 
adeABC efflux pump expression was likely the cause of tigecycline resistance (Hornsey et al., 
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2011). Another case of rapid evolution was observed during treatment for A. baumannii 
infection in a single patient where 13 consecutive clonal isolates were obtained from the patient 
with increasing and multi drug resistance profiles. These isolates were found in the respiratory 
tract and later from blood cultures and was found to contain mutations in key drug resistance 
genes including efflux pumps (Higgins et al., 2010).   
 
1.2 Observations of Persistence and Virulence in Nosocomial Settings 
Despite these well documented cases the routes and sources of infection remain elusive due to 
the absence of a well-defined natural source of A. baumannii and also to its non-specific but 
persistent identification in nosocomial settings. It may be that individuals carrying the bacterium 
can colonize and infect biotic and abiotic surfaces in hospitals (Dijkshoorn 2008) where 
immunocompromised individuals are more susceptible to infection. The hospital environment 
acts as a reservoir, increasing the likelihood of patient transmission and infection. The primary 
mode of transmission through hospital staff coming in contact with patients and hospital 
equipment (Dijkshoorn et al., 2007). An extreme example of this was reported (Bernards et al., 
2004) when  outbreak  strains  of  A. baumannii were  traced  back  to  dust  filters  found  on 
respiratory ventilators and hemofiltration devices. Once the filters were replaced the outbreaks 
ended. The ability of A. baumannii to survive under such conditions may foster emergence with 
novel resistance and virulence characteristics (Dijkshoorn 2008) which has allowed it to quickly 
advance as a nosocomial pathogen. Recent molecular studies have identified key factors in 
virulence that play roles in the organism’s persistence, invasiveness and ability to evade immune 
responses. Using tools recently developed to study A. baumannii the virulence of this pathogen 
has been shown and where possible animal studies have been used to confirm these findings. 
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The majority of identified virulence factors in A. baumannii have been identified in its core 
genome (Antunes et al., 2014) suggesting that many strains possess the full complement of 
virulence factors required for infection. It is thus hypothesized that the species possesses 
differential gene regulation in order to regulate the expression of virulence factors. Evidence of 
this is suggested by comparison of A. baumannii which has two times the number of 
transcriptional regulators compared to A. baylyi (Adams et al., 2008). 
 
1.2.1 Biofilms and Motility in Persistence and Virulence 
Biofilms are an important aspect of A. baumannii growth and colonization, and are hypothesized 
to be a fundamental aspect of persistence in nosocomial settings, resistance to antimicrobials 
and cause of disease. It has a remarkable ability to survive on diverse surfaces as well as 
indwelling devices such as catheters, and respiratory equipment and biotic surfaces such as 
A549 human alveolar epithelial cells which may be a target during respiratory infection (Gaddy 
et al., 2009; Carlos Rumbo et al., 2014). It has also been shown to survive on the fungal 
filaments of Candida albicans which could represent its ability to interact and control other host 
flora during infection (Gaddy et al., 2009). The biofilm consists of a complex multicellular 
matrix that is made up of carbohydrates, nucleic acids, proteins and other macromolecules and 
where stratification within the layers of biofilm exist (Costerton et al., 1999).  
 
Through combinatorial studies specific genes have been identified as encoding virulence 
factors. The outer membrane protein A (OmpA) when disrupted in A. baumannii type strain, 
ATCC19606 shows a loss of abiotic biofilm formation and loss of adherence to A549 human 
alveolar epithelial cells and decreased killing of fungal C. albicans cells (Gaddy et al., 2009). 
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The significance of binding to abiotic surfaces is relevant to various medical devices that come 
into contact with patients such as catheters, ventilator equipment, indwelling intravenous lines 
and various other non-invasive but close contact devices (Antunes et al., 2014). Later studies 
confirmed the adhesion phenotype of OmpA as well as the TonB copper receptor and the 34 
kDa outer membrane protein to A549 human alveolar epithelial cells through specific binding 
to fibronectin in eukaryotic cells (Smani et al., 2012). Multiple players involved in different 
aspects of biofilm development have been identified. The formation of biofilms on abiotic 
surfaces requires the expression of the CsuA/BABCDE chaperone-usher pili assembly system 
but is not required for biotic adherence (de Breij et al., 2009; Tomaras et al., 2003). This operon 
has been shown to be regulated by the BfmSR two component system; loss of the bfmR gene 
causes loss of csu expression while the bfmS only causes partial loss of abiotic biofilm formation 
(Tomaras et al., 2008). Another two component system GacSA was also shown to act as a 
regulator of biofilm formation after knockout of the gacS gene showed loss of csu expression, 
motility and overall virulence suggesting its role as a global virulence factor (Cerqueira et al., 
2014). An extracellular matrix is produced to establish biofilm formation and is dependent on 
production of poly-β-(1-6)-N-acetylglucosamine (PNAG) encoded by the pgaABCD gene locus 
(Choi et al., 2009). The biofilm-associated protein (Bap) is expressed in A. baumannii cells and 
is required for the adherence to eukaryotic cells (Brossard & Campagnari, 2011) and maturation 
of biofilm by intercellular adhesion (Loehfelm et al., 2008). Apart from biofilm formation, 
disruptions to the BfmSR, GacSA, OmpA and N-acyl-homo-serine lactone (AHL) encoding 
genes have shown loss of motility in A. baumannii (Clemmer et al., 2011) and more recently 
deletion of the acidic transcription factor A (AtfA) was shown to severely affect cell tolerance 
and reduce biofilm and twitching phenotypes (Withers et al., 2014). The role of motility in 
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pathogenesis is not yet clear. Many clinical isolates when tested for motility show variable 
phenotypes and also vary depending on media used. It is currently unknown if motility depends 
on the variability in different strains capacity to respond to environmental cues or if there exist 
different types of motility systems (McConnell et al., 2013). Virulence models have not been 
able to accurately predict the purpose, if any, of motility in the context of virulence in A. 
baumannii. The exact form of motility displayed by A. baumannii is still under consideration 
but current evidence suggests it moves on semi-solid surfaces by  twitching motility rather than 
swimming or swarming motility (Eijkelkamp et al., 2011) and evidence of this was shown by 
loss of motility on iron deficient media and expression of the pil-com genes in ATCC 17978 
(Eijkelkamp et al., 2011) which are involved in assembly and function of type IV pili known to 
be involved in twitching motility (Mattick, 2002). However pilT independent motility has also 
been reported by disruptions in BfmS, OmpA, synthesis of O-antigen and peptidoglycan 
synthesis, with no known role in type IV expression (Clemmer et al., 2011). In addition the roles 
of cell density dependant quorum sensing (Clemmer et al., 2011) as well as free iron 
(Eijkelkamp et al., 2011) are currently unexplained factors that affect motility.  
 
Efflux pumps, specifically Resistance Nodulation Efflux (RND) pumps have also been shown 
to play a role in biofilm formation.  Extensive studies have been carried out using the organism 
P. aeruginosa primarily because it tends to cause infection in the lungs of patients diagnosed 
with cystic fibrosis (Costerton et al., 1999). Infectious agents predominantly form biofilms 
making them very difficult to treat (Drenkard & Ausubel, 2002). When bacterial cells are 
forming biofilms a key aspect in their coordinated activities relies on quorum sensing, an 
important density dependant signalling system. This cell density is proportional to the 
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accumulation of autoinducer molecule (AI) which triggers coordinated gene expression in the 
population once a threshold concentration has been reached. The MexAB-OprM and MexEF-
OprN efflux pumps have both been shown to efflux AI molecules (Evans et al., 1998; Köhler 
et al., 2001) and most recently the MexAB-OprM was shown to efflux non-native AI (Moore et 
al., 2014). This in turn will reduce the amount of AI accumulation in the cell and the expression 
of AI genes and other virulence factors, causing decreases in biofilm. This seemingly counter 
active strategy used by P. aeruginosa to establish biofilms may be explained by recent studies 
showing that in dividing cells, uneven amounts of c-di-GMP are generated by a biofilm 
dispersal gene PA5017 (Kulasekara et al., 2013) which act as signalling molecules for biofilm 
formation, overlapping many of the quorum sensing targets (Srivastava & Waters, 2012). This 
in turn could influence heterogeneous biofilm populations. The role of MexAB-OprM and 
MexCD-OprJ are also expressed during azithromycin-resistant biofilm formation (Gillis et al., 
2005). The function of RND pumps in AI efflux has also been shown in B. cenocepacia where 
knockout of two efflux pumps, BCAL1675 and BCAL2821 showed a 30% reduction in 
extracellular AI (Buroni et al., 2009). In A. baumannii a collection of isolates obtained from 
burn would patients in China were shown to have a correlation of increased biofilm formation 
and adeFGH expression (He et al., 2015) while a systematic knockout and overexpression study 
of each of the three characterized RND pumps, AdeABC, AdeIJK and AdeFGH  showed that 





1.2.2 Mechanisms of Iron Acquisition 
Iron is an essential co-factor utilized by many enzymes in all domains of life. Bacterial 
pathogens have devised multiple mechanisms of iron acquisition from vertebrates who store 
iron in the form of the heme co-factor, or the iron binding proteins lactoferrin and transferrin. 
Pathogens that invade the host often express and secrete Fe3+ chelators or siderophores since 
iron is complexed as heme or in binding proteins. While A. baumannii is not known to express 
any transferrin or lactoferrin binding siderophores, ATCC 17978 contains genes coding for 
heme transport into the cytoplasm. The ATCC 19606 strain has been shown to use heme as an 
iron source as well as the recently characterized acinetobactin gene cluster coding for all genes 
required for siderophore synthesis and expression (Dorsey et al., 2004). Recently the role of a 
defective acinetobactin gene cluster with mutations in biosynthesis and export, showed no loss 
in adherence to A549 human alveolar epithelial cells but attenuated killing in a Galleria 
mellonella (Gaddy et al., 2012).  
 
1.2.3 Host Interaction Virulence Factors 
Using comparative genomics and advances in in vitro and in vivo models of infection, the 
virulence factors associated with the interaction between host and Acinetobacter are being 
studied. Animal models and cell culture have provided new insights into the innate immune 
response to A. baumannii infection. 
 
Generally Acinetobacter contain lipopolysaccharide (LPS) that elicit a strong immune response. 
LPS is composed of the lipid A molecule (endotoxin) that makes up the outer leaflet of the outer 
membrane, the core oligosaccharides that makes up the chain or length of the LPS, and the O-
antigen which is a polysaccharide having variable chain lengths (Raetz & Whitfield, 2002). LPS 
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has been shown to contribute to inflammatory response contributing to morbidity and mortality 
in infected patients (Pier, 2007). 
 
A characteristic of A. baumannii LPS is that it elicits an innate immune response and subsequent 
neutrophil recruitment (Erridge et al., 2007). There have been reports of colistin-resistant 
mutants of A. baumannii with mutations in lipid A biosynthesis genes that have complete loss 
of LPS without loss of viability in the host (Moffatt et al., 2010). A mutant strain of A. 
baumannii generating truncated LPS molecules showed increased susceptibility to human 
serum, and decreased survival in rat soft tissue infection models (Luke et al., 2010) indicating 
its necessity for blood stream infections. The phospholipase C and D encoding genes as well as 
the K1 capsular polysaccharide of A. baumannii were also shown to be required for survival in 
human serum (Camarena et al., 2010; Jacobs et al., 2010; Russo et al., 2010) and in the case of 
the capsule, plays a role in immune evasion (Russo et al., 2010). Loss of the phospholipase 
genes reduced bacterial burden in animal models (Jacobs et al., 2010) and the protein has also 
been shown to be excreted from the cell and cause loss of epithelial cell apoptosis (Antunes et 
al., 2011; Camarena et al., 2010). Virulence in a G. mellonella model was also attenuated (Stahl 
et al., 2015). Finally, the role of penicillin-binding-proteins are normally associated with the 
hydrolysis of β-lactam antibiotics but have also been shown to act in the final steps of 
peptidoglycan synthesis and contribute to bacterial membrane stability and was shown to be 
required for rat soft tissue infection and pneumonia models (Roca et al., 2012). 
 
The two outer membrane proteins, OmpA and the 33-36 kDa protein (modulating autophagy 
protein from Acinetobacter, MapA) have both been identified as virulence factors that directly 
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interact with eukaryotic cells through outer membrane vesicles inducing apoptosis  (Jin et al., 
2011; Rumbo et al., 2014). OmpA is known to localize in the mitochondria and move to the 
nucleus where it induces cell death and contains a nuclear localization signal (Choi et al., 2005) 
and in human laryngeal cells upregulates expression of nitric oxide synthase (Kim et al., 2008). 
Initially MapA was characterized by its ability to reduce carbapenem susceptibility in A. 
baumannii (del Mar Tomás et al., 2005). This is in contrast to a more recent paper by the same 
group showing that MapC induces apoptosis through mitochondrial release of cytochrome c, 
and allows A. baumannii to replicate intracellularly in macrophages by inducing autophagy and 
preventing cell death (Rumbo et al., 2014). It is suggested that these two porins together with 
phospholipase D are necessary for host invasion that allows for their evasion of immune 
recognition (Doi et al., 2015). Once inside the host acinetobactin genes are expressed that allow 
the organism to persist (Gaddy et al., 2012).  
 
1.2.4 Virulence Models to Study Acinetobacter baumannii pathogenesis 
The virulence characteristics of A. baumannii have recently begun to be studied in detail. The 
most common A. baumannii associated infections include pneumonia, bacteremia, endocarditis, 
skin and soft tissue infection, urinary tract infection and meningitis. Models to study the 
pathogenicity of A. baumannii include the use of mice, rats and rabbits. Generally they have 
been used to generate pneumonia, soft and soft tissue and animal sepsis models of infection. 
Models of pneumonia infection primarily utilize mice and are infection occurs through injection 
of bacteria into the trachea or by intranasal inoculation using a blunt-tip syringe (Rodriguez-
Hernandez et al., 2000). Both modes of infection have resulted in acute pneumonia that have 
resulted in inflammatory cytokine levels in the lung (Knapp et al., 2006; Eveillard et al., 2010) 
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and also cause mortality (Eveillard et al., 2010). The pneumonia model has also been employed 
for characterizing host factors in respiratory infections showing that LPS detection by CD14 
and Toll-like receptor 4 (Knapp et al., 2006). The use of rats to study pneumonia more closely 
mimics that of humans in that they allow bacterial growth in the lung, react with decreased 
arterial oxygenation, increased cytokine levels in bronchoalveolar lavage, neutrophil infiltration 
and mortality. They can also be infected by direct injection into the trachea which improves 
reproducibility of infection by ensuring all of the inoculum reaches the airways (McConnell et 
al., 2013). In skin and soft tissue infection models burn wounds have been the most studied 
where tissue burns are administered through hot water or a heated metal block while the animal 
is anesthetized followed by topical application or subcutaneous injection of A. baumannii under 
the skin. This model has primarily been used to evaluate the efficacy of unique treatment options 
for infection such as the gallium maltolate (DeLeon et al., 2009) for P. aeruginosa infection, 
antimicrobial conjugation treatment (Shankar et al., 2007) and photodynamic therapies (Dai et 
al., 2009). Other uses have included the study of bacterial dissemination after injection resulting 
in dissemination of the infection into organs causing mortality in untreated mice (Pantopoulou 
et al., 2007) and measures of bacterial load after injection into the thigh muscle (Dijkshoorn et 
al., 2004). Sepsis is another infection model developed to study virulence of A. baumannii in 
the host. This model of infection primarily involving mice results in the most mortality when 
using inoculums on average of 2.0 x 107 causing 87.5 – 100% (Ko et al., 2004) and has been 
used to study the efficacy of vaccines (McConnell and Pachón, 2010) and the role of antibiotic 
resistance on virulence and fitness (López-Rojas et al., 2011). Studies using ATCC 19606 have 
shown 100% mortality in as little as 24 hours after 5 x 104 CFU infection (McConnell et al., 
2011) Intraperitoneal injections are made with variable LD50 values suggesting its value for 
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measuring virulence (Gaddy et al., 2012). Bacterial induced host responses such as IL-6, IL-1β 
and TNF-ɑ are shown to be induced during septic shock and disseminate rapidly to other organs 
(McConnell et al., 2011).  
 
Other non-mammalian models such as C. albicans (Gaddy et al., 2009), G. mellonella (Peleg et 
al., 2009), and Caenorhabditis elegans (McConnell et al., 2013) are also being used. The co-
incubation assay with C. albicans fungal species in a mixed environment with bacteria allows 
the study of two major factors. Incubation with C. albicans provides a method in which to study 
A. baumannii interaction with eukaryotic cells, and it also generates complex bacterial-fungal 
interactions that may reflect environments during colonization of human hosts. It was shown 
that ATCC19606 with a deletion in outer membrane protein C (ΔompC) was less lethal against 
a filamentous or fungal form (Δtup1) of C. albicans (Gaddy et al., 2009). Previous studies have 
shown that bacteria were able to adhere to the filamentous yeast and cause apoptosis whereas 
adhesion and subsequent apoptosis was not observed in the wildtype (Gaddy et al., 2009). In a 
mixed colonization model it was shown that C. albicans and A. baumannii caused enhanced 
lethality against the C. elegans host. Subsequently, due to C. albicans ethanol production which 
induced enhanced virulence in A. baumannii (Smith et al., 2004).  
 
The nematode C. elegans exists as a free-living organism commonly found in soil and compost 
heaps. It provides a basic comparison of host infection when examining A. baumannii virulence 
factors and interactions with eukaryotic cells (McConnell et al., 2013). Although not possessing 
an adaptive immune response, the C. elegans organism has systemic innate immune responses 
comprising of physical aversion, a cuticle and the action of antimicrobial molecules (Irazoqui 
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et al., 2010; Marsh & May, 2012a). C. elegans have been used to study various pathogenic 
infections caused by gram negative P. aeruginosa, (Olivares et al., 2012; Tan et al., 1999) 
Serratia marcescens (Chauvet et al., 2003) and A. baumannii (Eijkelkamp et al., 2013; Smith et 
al., 2004, 2007). When infected with P. aeruginosa a bi-functional mode of killing has been 
observed depending on the media. The pathogen will show fast (Mahajan-Miklos et al., 1999) 
or slow (Tan et al.,  1999) killing, dependent on production of phenazine in the former, produced 
in rich media. The C. elegans model has been shown as a virulence model in studying various 
virulence factors in A. baumannii (Eijkelkamp et al., 2013) as well as its role in co-infections 
with fungi (Peleg, Tampakakis, et al., 2008). The model was used to discern the differences 
between isogenic disruptions of a global regulator, the histone like nucleoid structuring protein 
(HNS). 
 
Another model organism that has recently been used in testing virulence is G. mellonella or the 
greater wax moth. The larvae have the advantage of not requiring a food source since they are 
last instar larvae and can withstand temperature ranges from 16°C - 37°C which is more 
conducive to mimicking a mammalian host. Because of their larger size (1-1.5cm) they can be 
easily injected with pathogens and live/dead scoring is made by observing non-movement and 
increased pigmentation. The G. mellonella immune system is more advanced than that of C. 
elegans in that they possess haemocytes capable of phagocytosing and encapsulating pathogens 
as well as a humoral response with the secretion of antimicrobial peptides, reactive oxygen 
intermediate, melanisation and coagulation of the haemolymph (the equivalent of the circulatory 
system in mammals) (Kavanagh & Reeves, 2004). Using this particular organism comparative 
studies between clinical and non-clinical isolates have shown greater lethality of clinical isolates 
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at 37°C compared to 30°C (Peleg et al., 2009). In a more recent study, G. mellonella was used 
to assay the virulence of acyltransferases in A. baumannii LPS modification, with respect to 
cyclic antimicrobial peptides (CAMP’s). It was found that strains with knockout of the LpxM 
and LpxL acyltransferases had attenuated virulence phenotypes (Boll et al., 2015).  
 
One of the more universally attractive factors for use of non-mammalian models is the better 
cost-effective outcomes in maintaining and purchasing the animals as well as circumvention of 
ethical issues (Marsh & May, 2012). In addition due to their smaller size larger groups can be 
utilized for high throughput screening of novel drugs or clinical isolates.  
 
1.3 Mechanisms of Antibiotic Resistance 
There is accumulating evidence that A. baumannii has emerged as a MDR pathogen due to its 
abundant array of resistance mechanisms. Some of these mechanisms are intrinsic such as low 
membrane permeability and constitutively expressed efflux pumps. In addition there are 
various acquired mechanisms of MDR which have propelled issues of how to treat A. 
baumannii into the worldwide forum (Figure 1A). Another mechanism of resistance that has 
recently gained attention in A. baumannii is the role of error-prone polymerases or mutagenesis. 
This has been observed in E. coli as a global change brought on by DNA damage caused by 
antibiotics or another stress responses causing oxidative stress and ultimately helps cells 
survive poor environmental conditions. This form of stress induces DNA damage by way of 
error prone polymerases that are well conserved in A. baumannii that induce SOS response 
genes. One of the genes initially involved in this process is RecA, it coats single stranded DNA 
that accumulates at stalled replication forks and is necessary for homologous recombination 
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(Friedberg et al., 2006). When recA is knocked out strains are sensitized to DNA damage 
(Aranda et al., 2011). Along with this various DNA polymerases are upregulated and play a 
role in interaction with RecA to form trans-lesion synthesis complexes (Tang et al., 1998). In 
an A. baumannii study DNA damage was observed to induce multiple error-prone DNA 
polymerase genes in a RecA mediated fashion generating rifampicin resistance (Norton et al., 
2014). It was also found that these polymerases may also contribute to desiccation-induced 
mutagenesis (Norton et al., 2014).  
1.3.1 Enzymatic Modification 
The current ambler classification of β-lactamase enzymes are divided in four categories, 
A,B,C,D. These are based on their target in the beta-lactam ring where A,C and D classes are 
serine hydrolases while in group B, the metallo-β-lactamases require a zinc metal cofactor. 
Resistance genes coding for enzymes in all four classes of β-lactamase are present in A. 
baumannii. Within the A classification there are enzymes with resistance to extended spectrum 
β-lactamases (ESBL’s) namely, cephalosporin and its derivatives. These enzymes are capable 
of hydrolyzing these antibiotics. In A. baumannii there are six known ESBL’s with CTX-M 
being identified as the first integron or plasmid based ESBL (Nagano et al., 2004). The class C 
β-lactamases are comprised of a single enzyme, ampicillin C type β-lactamases (AmpC) whose 
sequence is highly conserved in A. baumannii strains. This enzyme also acts on the same range 
of targets as ESBL’s but are chromosomally encoded. In strains possessing an insertion element 
(IS), ISAb-1, the expression of AmpC is increased, causing resistance to ceftazidime (Corvec 
et al., 2003). The class D β-lactamases in A. baumannii are also termed the OXAs (blaoxa) with 
some being capable of hydrolyzing extended spectrum cephalosporin’s (Hsueh et al., 2002). 
There are at least 121 different variants of the class D β-lactamases with 45 of those exhibiting 
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carbapenem hydrolyzing activity (Lin & Lan, 2014). The groupings of these enzymes can be 
based on plasmid encoded (OXA-23, OXA-40, OXA-58) and those that are intrinsic (OXA-
51-like) (Evans & Amyes, 2014) whose expression was found to be upregulated again by the 
presence of an insertion element upstream of the gene (Lopes et al., 2012). Finally the Class B 
β-lactams (metallo-β-lactamases) confer resistance to the greatest number of β-lactams due to 
their broad range, resistance to β-lactamase inhibitors and carbapenemase activity (Cornaglia 
et al., 2011). They are categorized mostly by presence on integrons which are on transposons 
indicative of a rapid dissemination and are often on resistance cassettes encoding genes with 
resistance to aminoglycosides (Walsh et al, 2005). In A. baumannii 17 different metallo- β-
lactamases have been identified including the notorious new Delhi metallo- β-lactamase 
(NDM)-1 (Pfeifer et al., 2011) and NDM-2 (Espinal et al., et al., 2011) conferring resistance to 
last line antibiotics meropenem and imipenem. 
 
Another class of antibiotic that is effectively modified by the A. baumannii arsenal is the 
aminoglycoside class of antibiotics. The genes encoding resistance to aminoglycosides are often 
encoded on plasmids, transposons and integrases and disseminated by natural transformation or 
transduction. Phenotypic studies for aminoglycoside resistance have found that strains can 
express more than one aminoglycoside modifying enzyme and in various surveillance studies 
have shown the majority of strains in collections to possess at least one aminoglycoside 
modifying enzyme (Lin & Lan, 2014). There are three major types that have been identified in 





1.3.2 Target Modification 
Resistance to aminoglycosides, quinolones, trimethoprim and tetracycline have been 
attributed to this mechanism. The 16S rRNA methyltransferase, ArmA is well conserved in 
A. baumannii and across gram negative bacteria as it is plasmid borne and within a 
transposon. Plasmids have also been found to contain alternative forms of the dihydrofolate 
reductase (Dhfr) gene and mutations in gyrA and parC have been well described for A. 
baumannii where they interfere with trimethoprim and quinolone binding respectively (Lin 
& Lan, 2014). 
 
1.3.3 Decreased Influx 
The decreased expression of outer membrane proteins has been discussed for their role in 
virulence but specific porins have also been identified as having a role in specific drug 
resistance. These transporters will decrease in expression thus preventing influx of drug 
molecules as a mechanism of resistance (del Mar Tomás et al., 2005; Limansky et al., 2002). It 
is primarily the carbapenem family of drugs that have been targeted by the OMP proteins in A. 
baumannii. Studies from Spain and the USA have shown decreased expression of eight different 
porins with carbapenem resistance, while specific molecular studies have shown the CarO porin 
to be involved in imipenem resistance (Lin & Lan, 2014). More recent studies have identified 
the ISAba10 element within ISAba1, upstream of blaoxa-23 disrupting the carO sequence (Lee et 
al., 2011) and through gene disruption ompA was shown to increase MIC’s of aztreonam, 




1.3.4 Efflux Pumps In Acinetobacter baumannii 
The mechanisms above account for the majority of specific resistance mechanisms that are 
present in the A. baumannii armamentarium. The characteristic broad spectrum resistance that 
has come to be a mainstay of A. baumannii infections are inherent to the organism as it exists 
today. Examining its ancient past it is understood that the dual membrane possessed by all gram-
negative pathogens coupled with the expression of efflux pumps predates the use of antibiotics. 
Unlike any other resistance mechanism that has been characterized the efflux pumps are able to 
physically remove antibiotic molecules from the cell cytoplasm into the periplasm, or into the 
extracellular space and thereby decrease the intracellular concentration. There exist nine 
chromosomally encoded efflux pumps along with three acquired pumps that have been 
identified in A. baumannii with roles in antibiotic resistance. Of the seven chromosomally 
encoded pumps, five pumps come from different families. The major facilitator superfamily 
pump (AmvA) pumps out dyes, disinfectants, detergents and erythromycin (Rajamohan et al, 
2010a), the CraA pump (chloramphenicol resistance Acinetobacter) only extrudes 
chloramphenicol (Roca et al., 2009), the multidrug and toxic compound extrusion family pump, 
(AbeM), pumps out fluoroquinolones, chloramphenicol, trimethoprim, ethidium bromide and 
dyes (Su et al., 2005a). The small multidrug resistant pump (AbeS) shows low level resistance 
to chloramphenicol, fluoroquinolones, erythromycin, novobiocin, dyes and detergents (Vijaya 
et al., 2009). The fifth family of multidrug transporters, the proteobacterial antimicrobial 
compound efflux family (PACE) were found to extrude the biocide chlorhexidine (Hassan et 
al., 2013). The remaining three encode RND efflux pumps (AdeABC, AdeFGH, AdeIJK) which 
are proton antiporters, characterized by their broad substrate profiles (Cortez-Cordova & 
Kumar, 2011; Coyne et al., 2010; Damier-Piolle et al., 2008; Magnet et al., 2001) and ability to 
synergize with other resistance mechanisms (K Poole, 2004; Sugawara & Nikaido, 2014). First 
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identified in E. coli and termed Resistance Nodulation Division efflux pumps. This convention 
came about due homology the RND complex EmrB has to multidrug resistance protein QacA 
from Staphylococcus aureus (Lomovskaya and Lewis, 1992). The adaptor protein that stabilizes 
the RND and outer membrane pumps in the periplasmic space has homology to the NolF protein 
involved in root nodulation of alfalfa roots in Rhizobium meliloti and the EnvC protein from E. 
coli (Baev et al., 1991). The outer membrane component shows homology to a protein involved 
in cell division, EnvD by an unknown mechanism (Klein et al., 1991). Based on characterization 
studies the pumps possess an overlapping substrate profile where all three are able to extrude 
fluoroquinolones, chloramphenicol, tigecycline and trimethoprim while AdeABC and AdeIJK 
are both able to efflux tetracycline and β-lactam drugs (Coyne et al., 2011). Furthermore the 
pumps have been identified in other studies with other reported substrates. The AdeABC pump 
was shown to act on aminoglycosides, β-lactams and macrolides (Damier-Piolle et al., 2008); 
AdeFGH on clindamycin, sulfamethoxazole (Coyne, et al., 2010); and AdeIJK on ticarcillin, 
cephalosporins, aztreonam, lincosamides, rifampin, cotrioxazole, novobiocin and fusidic acid 
(Damier-Piolle et al., 2008) where aminoglycosides are not substrates and AdeIJK (Coyne et 
al., 2010). A fourth RND efflux pump, MacAB-TolC has been identified to play a role in 
response to loss of LPS in an ATCC19606 strain and in tigecycline resistance (Henry et al., 
2011).  
 
1.3.5 Mechanism of RND Pump Action 
Apart from its broader substrate profile compared to other single substrate efflux proteins 
present in A. baumannii, RND pumps physically extrude substrates directly into the 
extracellular space. The RND pump is composed of a pump component embedded in the inner 
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membrane and an outer membrane component in the outer membrane joined together by an 
adaptor in the periplasm (Figure 1B). These genes are usually encoded on a single operon 
regulated by an upstream local regulator (except in the case of adeIJK) and the proteins are 
assembled into a 3:6:3 ratio (Du et al., 2014). Together they span the inner and outer membranes 
and extrude substrates into the extracellular milieu. The mechanism of the RND pump is 
proposed for E. coli homologue AcrB to work on a functional rotation mechanism where each 
of the three monomers of RND pump conform to one of three conformations (access, binding, 
extrusion) depending on the position of substrate (Murakami et al., 2006). The mechanism 
begins with one monomer in an access state (L) that is unoccupied, once substrate is bound the 
conformation changes to the binding mode (T) where substrate is moved into the vestibule of 
the RND pump, the other two monomers may conform to the other two conformations at this 
point. After binding the substrate is moved into the central cavity of the RND pump while the 
entry vestibule is closed, as the substrate is moving into the top funnel of the pump the substrate 



































Figure 1 – Antibiotic targets in gram negative bacteria and their resistance mechanisms. 
(A) The A. baumannii bacterium contains a number of antimicrobial resistance mechanisms 
against specific classes of drugs. (B) The structure of the cross section of RND efflux pump is 
composed of three components, the RND pump (AcrB), the periplasmic anchor protein (AcrA) 
and the outer membrane protein (TolC). The RND protein complex is composed of a functional 
rotation mechanism where each monomer occupies each of (L) loose where substrate is free to 
bind, binding of substrate causes (T) tight conformation and opening of substrate binding 
pocket. This is followed by loss of proton from the monomer and conformational change in the 
substrate binding pocket to (O) open, pushing the substrate towards the exit channel by 






























Figure -1  
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The regulation of efflux pumps has classically been attributed to two main regulatory levels. 
Gene expression has been controlled by genes adjacently found or local to the efflux pump 
operon such as the lysR regulator, AdeL that controls adeFGH (Coyne, Rosenfeld, et al., 2010) 
or the AdeRS system that regulates adeABC gene expression (Higgins, Schneiders, et al., 2010; 
Marchand et al, 2004). The second level of gene regulation comes by regulators that are 
physically located elsewhere in the genome away from the efflux pump operon such as the AraC 
family, multiple antibiotic resistance A (MarA), superoxide response regulator sensor kinase 
(SoxS) and right angle binding protein (Rob) in E. coli. Generally the role of these regulators 
has been found to control expression of not only efflux pumps but other genes also found in the 
cell. In a study of MarA regulatory functions, over 60 genes were identified to be controlled by 
this global regulator (Barbosa & Levy, 2000) and in MDR apart from acrAB-tolC 
overexpression, MarA decreases the expression of the porin ompF through activation of an 
antisense RNA, micF (Alekshun & Levy, 1999). The gene soxS encodes the effector and is part 
of the soxRS operon that effectively responds to oxidative stress in the cell by upregulation of 
the acrAB-tolC pump as well. It does this primarily by detecting oxidative changes such as the 
reduction of the SoxR iron-sulphur clusters (Singh et al, 2013) which activates transcription of 
soxS that then de-represses marA expression (Alekshun & Levy, 1997) and also activate many 
of the same targets as MarA (Duval & Lister, 2013). The Rob protein unlike the previous two 
regulators is constitutively expressed albeit in an inactive state that is regulated by external 
stimuli such as bile salts and fatty acids (Rosenberg et al., 2003) but also activates expression 
of the acrAB-tolC operon (Rosenberg et al., 2003) and binds to the micF promoter (Kwon et al, 
2000). Another global regulator, the Histone-like Nucleoid Structuring protein (H-NS) is a 
repressor of acrAB, acrEF and MdtEF efflux genes (Kunihiko et al., 2004) and in P. aeruginosa 
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one of the H-NS homologues, MvaT is known to repress expression of mexEF-oprN (Westfall 
et al., 2006) but is also a repressor of biofilm formation (Vallet et al., 2004) and cell lysis by 
Pf4 superinfection (Castang & Dove, 2012). Examination of a motile strain of A. baumannii 
revealed an insertion element disrupting the expression of hns which showed overexpression of 
type IV secretion, Csu operon and adherence genes but no changes to efflux (Eijkelkamp et al., 
2013). Although located ~800kbp from its only known operon of regulation, adeIJK, the tetR-
family regulator has not been shown to act on other genes (Rosenfeld et al., 2012). In addition 
there have been no global regulators identified in A. baumannii that control the expression of 
RND pumps except for the BaeSR system. It has been shown to regulate expression of adeABC 
(Lin et al., 2014) and possibly adeIJK and macAB-tolC efflux systems through an indirect 
regulatory pathway (Lin et al., 2015). 
 
1.4 The Induction of RND Efflux Pumps  
The induction of efflux pumps are often observed by in vivo or in vitro mutations in regulatory 
regions or in proteins responsible for co-ordinating or carrying out cellular stress responses. 
Fewer studies have looked at how pumps may be temporarily induced using sublethal 
concentrations of antimicrobials or natural compounds. Examples of this are studies in P. 
aeruginosa, a notorious nosocomial pathogen that has a total of twelve RND pumps with roles 
in drug resistance. Studying how RND efflux pump regulation is modulated in response to low 
antimicrobial stress may help uncover how these mechanisms play a dangerously under 




1.4.2 RND Pump Expression and Decreased Susceptibility to Antimicrobials 
The expression of RND efflux pump AdeABC after in vitro exposure to tigecycline showed a 
10-fold increased tigecycline MIC in non-susceptible strains overexpressing AdeABC, 
compared to the parental strain (Peleg et al., 2007). Numerous international studies have linked 
decreased tigecycline susceptibility with AdeABC overexpression (Lin & Lan, 2014), this has 
also been linked to mutations in the adjacently located, AdeRS two component system (Sun et 
al., 2012; E.-J. Yoon et al., 2013) and molecular characterization of the BaeRS two component 
system (Lin et al., 2014). The second pump to be identified in A. baumannii was the AdeIJK 
pump through degenerate primer amplification. Subsequent analysis revealed the pump to be 
highly ubiquitous in strains of A. baumannii. This pump is likely involved in intrinsic resistance 
since its disruption in a clinical isolate led to ≥4-fold increased susceptibility to more than three 
classes of antibiotics (β-lactams, chloramphenicol, fluoroquinolones and tetracycline) (Damier-
Piolle et al., 2008). Recently it was shown that the newly identified BaeSR two component 
system has a regulatory role in expression of adeIJK and subsequent resistance to tannic acid 
and tigecycline but not through direct interaction with the regulatory region of the pump (Lin et 
al., 2015). It should be noted that this pump has been shown to have the most diverse range of 
substrates and also synergizes with the AdeABC pump for resistance against fluoroquinolones, 
chloramphenicol, tigecycline and tetracycline (Coyne et al., 2011). Clean knockout of the 
adeIJK repressor, adeN revealed decreased susceptibility to erythromycin, chloramphenicol, 
tetracycline, minocycline, tigecycline, rifampin, ciprofloxacin, norfloxacin, trimethoprim, 
sulfamethoxazole, aztreonam, cefepime, ceftazidime, ertapenem and meropenem (Rosenfeld et 
al., 2012).  The third RND pump was identified through an in vitro method of selecting for 
chloramphenicol resistant mutants and subsequent microarray analysis in an ΔadeABC, 
ΔadeIJK background. This yielded adeFGH and its local regulator adeL (Coyne et al., 2010). 
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In strains overexpressing adeFGH mutations were found in adeL as the suggestive reason for 
adeFGH overexpression (Coyne et al., 2010). While it has shown a capability to export a 
number of antimicrobials including fluoroquinolones and tigecycline (Coyne, Rosenfeld, et al., 
2010) it is not commonly expressed in clinical isolates and showed no effect on MIC in an 
isogenic knockout strain (Amin et al., 2013). This was shown again by the same group who 
identified the pump but used a different clinical isolate (Yoon et al., et al., 2015). This 
observation highlights the effect strain background may have on interpretation of results. It also 
highlights the need to exhaustively characterize the regulators involved in not only efflux pump 
expression but MDR as a system. Due to reasons such as strain dynamics, the role of RND 
efflux pumps is difficult to ascertain unless a predefined strain is used that does not contribute 
to resistance by other compensatory pumps. The AdeIJK and AdeABC efflux pumps were 
expressed in a surrogate strain of ΔacrAB E. coli, with very low expression of β-lactamase to 
show that AdeABC or AdeIJK was capable of extruding multiple β-lactamase drugs, a finding 
that was not shown before due to the large number of β-lactamase modifying enzymes present 
in A. baumannii. Another study examining the efficacy of the efflux pump inhibitor 
phenylalanine-arginine β-naphthylamide (PaβN) against the AdeFGH pump utilized a strain of 
P.aeruginosa with six of its efflux pumps knocked out to express the A. baumannii pump in 
single copy expression (Cortez-Cordova & Kumar, 2011). The results revealed that when 
examined in an efflux deficient strain the potentiation of PaβN was significantly higher than in 
the parent strain, ATCC19606. This result showed that despite all efflux in the parent strain 
being blocked, the efficacy of the EPI was not accurately described. Its role in an efflux pump 
deficient strain examining a single pump from the parent strain showed much greater 
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potentiation and more quantitatively, the substrates of the AdeFGH pump (Cortez-Cordova & 
Kumar, 2011). 
 
1.5 Induction of RND Pumps by Non-antibiotic Molecules 
The major MDR pathogens that exist in hospital environments are far outnumbered by the 
number of species found in natural environments. Despite this fact, efflux pumps are commonly 
conserved across MDR and non-MDR strains. In Acinetobacter the three RND efflux pumps 
AdeABC, AdeIJK and AdeFGH seem to be conserved among the genomes of non A. baumannii 
strains (Espinal et al., 2011). Expanding to other organisms some of the most resistant 
organisms found in hospitals had origins in the environment where antibiotic pressure is 
considerably lower. Examination of agricultural, urban and pristine soils identified 412 
antibiotic resistant bacteria of which >80% were resistant to 16-23 antibiotics tested (Walsh & 
Duffy, 2013). Multi-drug resistance conferred by efflux was identified in 83% of the soil isolates 
where 410 of 412 isolates conferred resistance to at least one class of antibiotic by efflux (Walsh 
& Duffy, 2013). These results suggest that RND efflux pumps are not nosocomial resistance 
mechanisms but rather serve a more ancient role. Indeed the fact these pumps have been 
expressed across different domains of life, long before the use of antibiotics to treat human 
infections is evidence of this (Tseng et al., 1999). Considering the large number of conserved 
MDR pumps across gram negative bacteria and the overlap of toxic substrates they extrude, the 
sole function of MDR pumps cannot be limited to detoxification otherwise there would be no 
need for a diversity of pumps within a species (Poole 2008).  
33 
 
An informative approach to studying the natural function of efflux pumps is through 
characterization of the effector molecules that module gene expression of bacterial pumps. In 
clinical strains of bacteria the role of RND pump regulation is commonly through a multilayer 
approach using global regulators as well as locally transcribed genes acting as local regulators. 
In a similar way, the expression of RND pumps in environmental strains of gram-negative 
bacteria can be finely tuned for expression. Non-clinical environmental strains often encounter 
toxic compounds produced by plants and by heavy metals found in soil. Some metals are 
required as co-factors in small amounts and therefore their concentrations likely need to be 
tightly regulated to prevent toxicity, such as efflux pumps for maintenance of chaperones 
utilizing copper (Becker & Skaar, 2014). In some cases the metal effector molecule acts as an 
environmental cue signalling the organism what ecosystem it is in. Two examples of this are 
the mtrCDE pump encoded by Neisseria gonorrhoeae and the CzcABC pump in P. aeruginosa. 
The MtrCDE pump is induced by iron limiting conditions, often encountered during infection, 
causing its local repressor, MpeR to be downregulated (Mercante et al., 2012). In P. aeruginosa 
the CzcABC efflux system confers increased tolerance to zinc, cadmium and cobalt and is 
activated by the metal inducible two component system CzcRS (Caille et al., 2007). This system 
also regulates expression of OprD, part of the MexEF-OprD pump (Dieppois et al., 2012). The 
role of RND pumps in relation to bacterial colonization of plants is another area of study as well 
as ties to detoxification during plant-bacterial interaction. The species P. putida changes the 
regulation of its genes emphasizing efflux pump expression during root colonization suggesting 
a role for efflux pumps during plant-bacterial interactions (Matilla et al., 2007). The expression 
of acrAB increases in the presence of plantlet toxic metabolites naringenin and phloretin. Loss 
of this pump from Erwinia amylovora makes them less virulent and may have a role in 
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attenuation of plant root colonization (Burse et al., 2004). The siderophore salicylate is 
considered a major signalling molecule in the human pathogen Burkholderia cenocepacia 
(Visca et al., 1993) but is also produced by plants as a signalling molecule during infection 
(Loake & Grant, 2007). The ceoA efflux operon and regulator ceoR were found to be 
upregulated when exposed to either salicylate or the antibiotic chloramphenicol, showing a link 
between natural function and clinical relevance (Nair et al., 2004). The study suggests that the 
natural substrates of pumps are not only for antibiotic resistance but intercellular signalling and 
response to plant secondary metabolites secreted during colonization. 
 
1.5.1 Induction of Efflux Pumps by Oxidative and Nitrosative Stress 
Multiple studies examining the generation of cross resistance to antibiotics generated by nutrient 
starvation or metabolic stress highlight the links between adaptive stress responses and 
antibiotic resistance (Poole 2012).Various forms of stress that are under the scope of oxidative 
and nitrosative stress including membrane stresses have also been linked to the expression of 
RND efflux pumps. The SoxRS system is the primary target in E. coli responsible for detection 
of oxidative (ROS) and nitrosative stress (RNS). SoxR sensing of stress triggers modulation of 
SoxS repression of acrAB and other genes that code for cell protection mechanisms 
(Koutsolioutsou 2005). Mutations in the soxR gene from Salmonella Typhimurium have shown 
the same MDR phenotype (Koutsolioutsou et al., 2001) and SoxRS regulated expression of 
acrAB has been shown in Klebsiella pneumonia (Bratu et al., 2009) and Enterobacter cloacae 
(Pérez et al., 2012). Studies using hydrogen peroxide to elicit oxidative stress in A. baumannii 
have shown upregulation of adeABC RND pump but to date there have been no SoxRS 
homologues identified and its regulatory activation is currently unknown (Andrei Bazyleu and 
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Ayush Kumar, unpublished data). The expression of MexXY in P. aeruginosa has also been 
shown to be induced by oxidative stress and generating cross resistance to aminoglycosides 
(Fraud & Poole, 2011). Infections by P. aeruginosa often occur in the cystic fibrosis lung, an 
environment highly rich in free radical moieties and also nitrogen stress (Folkerts et al., 2001).  
 
Bacteria commonly encounter nitrosative stress in the form of RNS in their environments 
through host innate immune responses and also through denitrification of nitrogenous 
compounds. RNS go on to damage DNA and proteins triggering an adaptive response that 
serves to detoxify the cell of RNS constituents (Fang 2004). It has been shown that RND efflux 
pumps, such as MdtEF in E. coli and MexEF in P. aeruginosa are upregulated in presence of 
nitrosative stress suggesting they may have a role in expelling toxic or damaged molecules from 
the cell (Fetar et al., 2011; Zhang et al., 2011). The role of the MexT activator was shown to be 
required during exposure to nitrosative stress in the form of S-nitrosoglutathione (GSNO) or the 
antibiotic chloramphenicol, to induce the expression of mexEF-oprN (Fetar et al., 2011) .  
 
1.5.2 Induction of RND Efflux Pumps by Antimicrobial Compounds 
Finally RND efflux pumps may also have a role in response to fatty acids and antimicrobials 
such as triclosan. Fatty acids make up a primary constituent of the two bacterial membranes in 
gram negative bacterial. Their diversity comes from chain length and double bond formation 
that characterizes saturated and unsaturated (double bond) varieties. Generally the length of the 
fatty acid chain influences fluidity in an indirect relationship where increased chain length will 
increase melting temperature and therefore fluidity decreases over a range of temperatures. 
Antibacterial factors such as bile salts and fatty acids carry detergent like properties that can 
36 
 
interfere with cell structures and proteins. The link between RND efflux pumps and free fatty 
acids has been to decrease susceptibility of bile and fatty acids as a method to evade the host 
response. A knockout of the acrAB pump revealed an increase in susceptibility to fatty acids 
and bile salts (Ma et al., 1995) while  later studies have shown the Rob regulator as the trigger 
of acrAB expression (Rosenberg et al., 2003). More recently examining whole genome 
transcriptomics have revealed that E. coli sensing bile salts will activate iron siderophore genes 
along with efflux pump expression to prepare for iron limiting environments (Hamner et al., 
2013). The role of efflux pumps in resistance to fatty acid and bile efflux in other species has 
also been shown. Inactivation of the oxidative stress regulator OxyR caused a decreased 
expression of acrB and increased susceptibility to bile, hyperosmotic, oxidative and nitrosative 
stress (Srinivasan et al., 2013). The colonization of mammalian intestines by Vibrio cholera 
was attenuated in a knockout strain of three of its RND pumps (vexB, vexD, vexK) along with 
an increase in susceptibility to fatty acids and bile salts (Bina et al., 2008). Despite the role of 
efflux pump activation in response to membrane stresses their exact substrates are unclear. Since 
free fatty acids and bile salts are likely to perturb membrane structure and function (Desbois & 
Smith, 2010) they may act as substrates of the RND pumps where substrate capture occurs in 
the periplasm and outer leaflet of the inner membrane (Aires & Nikaido, 2005). Indeed the Rob 
protein has been shown to be constitutively expressed but only causing induction of acrAB in 
presence of bile salts and free fatty acids (Rosenberg et al., 2003). Free fatty acids have been 
shown to be definitively extruded from the cell by the activity of AcrAB-TolC (Lennen et al., 
2013). The role of efflux pumps in this regard may be to facilitate the ongoing remodelling of 
the lipid bilayer in order to compensate for membrane stress. The use of sodium dodecyl sulfate 
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(SDS), which has a similar structure to free fatty acids, has also shown similar effects on 
susceptibility in absence of the acrAB (Nishino & Yamaguchi, 2001).  
 
In an alternative approach using the biocide triclosan, the effect of membrane stress has also 
been studied. Triclosan is a synthetic bisphenol compound that has specific activity against 
organisms that carry out type II fatty acid biosynthesis thus targeting prokaryotes. Because of 
its high specificity against the bacterial pathway of fatty acid synthesis the use of triclosan as a 
common biocide has exploded since its first use in 1972 to the point that 75% of soap brands 
contain triclosan, and across the United States 75% of adults and children are reported to excrete 
triclosan in their urine, (Bergstrom 2014) where it may accumulate in the environment. Many 
brands of personal hygiene products, cleaning products, clothing and office stationary contain 
triclosan and are available in Canada. This widespread use of triclosan has raised concern that 
bacterial pathogens could develop resistance to this biocide with cross resistance to other 
medically relevant antibiotics (Curiao et al., 2015; Lavilla et al., 2015; Schweizer 2001; Yu et 
al., 2012). Studies examining in vitro generated resistant mutants to triclosan have primarily 
identified a single base pair mutation causing a change from glycine to valine in enoyl-[acyl-
carrier protein] reductase (fabI) (Heath 1999) in S. enterica Typhimurium (Webber et al., 2008) 
and S. aureus (Heath 2000). While studies have not looked at in vitro generation of triclosan 
mutants of A. baumannii, in a collection of 40 clinical isolates of A. baumannii from China, 12 
were classified as high level resistant due to 95GlySer in fabI (Chen et al., 2009). In P. 
aeruginosa two reductase enzymes, FabI and FabV were found to be responsible for triclosan 
resistance. While knockout of the fabI gene did confer some sensitivity to triclosan, the major 
factor was found to be caused by fabV which upon disruption was shown to cause >2000-fold 
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increased susceptibility to the biocide (Zhu et al., 2010). The FabI enzyme is responsible for 
NADH-dependant reduction of the double bond generated during the last step of fatty acid 
biosynthesis and elongation (Heath & Rock, 1995). Although it is unclear if the sole mutation 
in FabI is responsible, membrane defects have been found in triclosan-exposed strains with fabI 
mutations (Pycke et al., 2010) and in strains exposed to the triclosan homologue, diazaoborine 
(Turnowsky et al., 1989). Efflux pumps have also been implicated in triclosan resistance in E. 
coli through mutations in marA,soxS and acrR regulators (McMurry et al., 1998a). The P. 
aeruginosa efflux pumps MexCD-OprJ, MexEF-OprN and MexJK-OpmH have all been shown 
to efflux triclosan by mutations in their regulators NfxB, NfxC (Chuanchuen et al., 2001) and 
MexL (Chuanchuen 2002), respectively. In the same studies, these were shown to also exhibit 
cross resistance to multiple antibiotics. P. aeruginosa also encodes the TriABC-OpmH efflux 
pump through a promoter point mutation conferring >100-fold decreased susceptibility to 
triclosan (Mima et al., 2007). In A. baumannii a MATE family efflux pump AbeM, triclosan 
was identified as a substrate of the pump in an E. coli surrogate strain (Su et al., 2005b). 
 
The role of A. baumannii as a global pathogen is made evident by the numerous observational 
studies that have been carried out across different parts of the world. The organism’s dynamic 
genome has allowed for its survival and persistence in various nosocomial environments where 
disinfectants are used. In conjunction with its various virulence factors that allow for its 
persistence, MDR within strains add another level of complexity to treating these infections. 
Clinical isolates that have been isolated contain intrinsic resistance to multiple classes of 
antibiotics. The RND efflux pumps play a major role in generating this resistance and generate 




This study will examine the roles of RND efflux in these aspects of A. baumannii and how 
efflux regulation influences the outcomes of MDR and virulence. The need to examine the 
regulatory pathways that influence virulence and MDR in A. baumannii are essential to 
understanding how new antimicrobials can be developed. These studies will help future work 
to circumvent MDR infections and help gain insight into how these mechanisms have become 














Resistance nodulation division efflux pumps in Acinetobacter baumannii express in response 
to antimicrobial and non-antimicrobial stressors with the purpose of removing toxic compounds 
and metabolites, assisting the A. baumannii cell to survive. 
 
Therefore the objectives of this thesis were: 
 1. Characterization of RND efflux pump expression in clinical and environmental 
isolates of Acinetobacter. 
 
 2. Assessing the role of three virulence models to test for differences in outcomes 
between a multidrug resistant and susceptible strain. 
 
 3.  Determining the natural function of RND efflux pump AdeFGH through exposure to 
nitrosative stress and deletion of local regulator gene AdeL. 
 
 4. Identifying the molecular mechanisms regulating over expression of AdeIJK genes in 





























2.1 Bacterial Strains, Plasmids and Oligonucleotides 
Various bacterial strains and plasmids used in this study are listed in Table 1, oligonucleotides 
used are listed in Table 2. Clinical isolates of Acinetobacter baumannii were obtained from the 
CARA surveillance program (Canadian Antimicrobial Resistance Alliance), Dr. George 
Zhanel, University of Manitoba, Canada. The type strains ATCC19606 and ATCC17978 were 
used as reference strains obtained from ATCC unless otherwise stated.  
 
2.2 Media and Growth Conditions 
Bacterial strains were routinely grown at 37°C in Luria-Bertani Lennox (LB) medium (Becton, 
Dickinson and Company, Mississauga, Canada) and incubated at 37°C unless otherwise stated. 
Concentrations of antibiotics to maintain plasmids for recombination or overexpression in A. 
baumannii were as follows: 50 μg/L Gentamicin, 50 μg/L Kanamycin, 100 μg/L Trimethoprim, 
10 μg/L Tetracycline, 200 μg/mL Carbenicilin (instead of ampicillin). 
 
2.2 Genomic and Plasmid DNA Extraction 
Genomic DNA (gDNA) was extracted from 1.5mL of overnight cultures using the Biobasic 
genomic DNA extraction kit (Biobasic Inc., Markham, Canada). Briefly cells were spun down 
and resuspended in supplied lysis buffer and proteinase K at 56°C for 10 min. Buffer containing 
ethanol was added to the sample and vortexed. Sample was added to silica column and washed 
with ethanol solution followed by elution with Tris-Cl pH 8.4. Plasmids were extracted using 
the Biobasic Plasmid Miniprep Kit from Biobasic (Biobasic Inc., Markham, Canada) by 











Table 1 – Bacterial strains and plasmids used in this study. Clinical isolates obtained from 










Wildtype Dr. Robert 
Hancock Lab 
AB004 
Acinetobacter 63169 Clinical Isolate 
(isolated from respiratory system of a 75 
years old patient from Winnipeg) 
This study 
AB005 
Acinetobacter 58352 Clinical isolate 
(isolated from respiratory system of a 1 
year old patient from Winnipeg) 
This study 
AB006 
Acinetobacter 59960 Clinical isolate 
(isolated from respiratory system of a 64 
year old patient from Vancouver) 
This study 
AB007 
Acinetobacter 59973 Clinical isolate 
(isolated from respiratory system of a 33 
year old patient from Vancouver) 
This study 
AB008 
Acinetobacter 64130 Clinical isolate 
(isolated from blood of a 30 year old 
patient from Hamilton) 
This study 
AB009 
Acinetobacter 64153 Clinical isolate 
(isolated from respiratory system of a 26 
year old patient from Hamilton) 
This study 
AB010 
Acinetobacter 64797 Clinical isolate 
(isolated from respiratory system of a 75 
year old patient from Vancouver) 
This study 
AB011 
Acinetobacter 63487 Clinical isolate 
(isolated from respiratory system of a 54 
year old patient from Winnipeg) 
This study 
AB012 
Acinetobacter 65239 Clinical isolate 
(isolated from respiratory system of a 4 
year old patient from Victoria) 
This study 
AB013 
Acinetobacter 66310 Clinical isolate 
(isolated from respiratory system of a 20 
year old patient from Vancouver) 
This study 
AB014 
Acinetobacter 66985 Clinical isolate 
(isolated from blood of a 25 year old 
patient from Montreal) 
This study 
AB027 
Acinetobacter 73858 Clinical isolate 
(isolated from blood of a 72 year old 
patient from Montreal) 
This study 




Acinetobacter 77763 Clinical isolate 
(isolated from blood of a 63 year old 
patient from Winnipeg) 
This study 
AB029 
Acinetobacter 84376 Clinical isolate 
(isolated from blood of a 51 year old 
patient from Winnipeg) 
This study 
AB030 
Acinetobacter 88145 Clinical isolate 
(isolated from blood of a 29 year old 
patient from Winnipeg) 
This study 
AB031 
Acinetobacter 88727 Clinical isolate 
(isolated from blood of a 55 year old 













































(manure cow tank #4) 
This study 
AB054 
Acinetobacter CF0141 Environmental isolate 







A. baumannii CF0140 
Environmental isolate 
(manure cow tank #4) 
This study 
AB042 












AB062 ΔadeL, ATCC 17978 This study 
DH5ɑ 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZΔM15 Δ(lacZYA-










Candida albicans (wildtype) Dr. Roberto Kolter 
Lab 
Y002 
Candida albicans (Δtup1), ura3∆::lambda 
imm434 
 




Cloning vector ampr, PCR Promega 
pMO130 
Suicide plasmid, aph(3'), sacB (Amin et al., 2013) 
pPS856 
aacC1 FRT fragment (GmFRT) (Hoang, T.T. et al., 
1998) 
pUCP26 
TetAr (West, S.E. et al., 
1994) 
pUCP28T 
Tmpr (Dhfr) (Schweizer, H.P. et 
al., 1996) 
pPLS097 Ampr, A. baumannii shuttle vector This study 
pPLS088 pGEM®-T-Easy-adeN from ATCC17978 This study 
pPLS145 Ampr, pPLS097-adeN This study 
pWH1266 A. baumannii origin of replication (ori1266) Dr. Louis Actis Lab 
pPLS092 Tmpr, pUCP28T-ori1266 (pSR1266TMP) This study 
pPLS114 TetAr, pUCP26-ori1266 (pSR1266TET) This study 
pPLS135 pGEM®-T-Easy ΔadeL::Gm-FRT  
pPLS140 pGEM®-T-Easy-hns from ATCC17978 This study 
pPLS142 Ampr, pPLS097-hns This study 
pPLS147 pGEM®-T-Easy-fabI This study 
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pPLS148 Ampr, pGEM®-T-Easy-fabI116GV This study 
pPLS150 Ampr, pPLS097-fabI116GV This study 
pPLS151 Ampr, pPLS097-fabI This study 
pPLS152 pGEM®-T-Easy Δhns::Gm-FRT  
pPLS157 pMO130 Δhns::Gm-FRT This study 
pPLS161 pMO130 ΔadeL::Gm-FRT This study 
pPS911 























Table 2 – List of oligonucleotides used in this study. Oligonucleotides used for qRT-
PCR, cloning and gene expression, gene knockout and plasmid construction. 
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adeN Full length, 
cloning and 
complementation 
adeN_ FL_F GATAAGCAGTGTTAGCCGTCG 
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2.3 Gel Extraction 
Extraction of DNA fragments from 0.8% agarose gels was carried out using the GeneJet Gel 
extraction kit (Thermo Fisher Scientific., Mississauga, Canada) following manufacturer’s 
instructions. Briefly, gel excised DNA fragments were dissolved in binding buffer at 56°C and 
added to a silica column filter and washed with ethanol solution followed by an additional spin 
to remove excess ethanol then eluted with 30µL of Tris-Cl pH 8.4. DNA concentration was 
measured by a NanoDrop Lite Spectrophotometer (Thermo Scientific, Mississauga, Canada). 
2.4 DNA Manipulations 
2.4.1 General PCR 
Extracted plasmids and gDNA were utilized as templates for PCR amplification. For all TA 
cloning into pGEM®-T-Easy, Taq DNA polymerase New England Biolabs (NEB, Pickering, 
Canada) was used. Any confirmation of clones by PCR was made using Taq DNA polymerase 
(FroggaBio, North York, Canada). All PCR reaction concentrations and cycling steps were 
followed using manufacturer’s instructions.  
2.4.2 Restriction Enzyme Digest and Ligation 
DNA digestion was carried out using NEB (Pickering, Canada) enzymes following 
manufacture’s protocols. Cloning steps were carried out using the pGEM®-T-Easy system 
following manufacturer’s guidelines. Blue white selection was utilized by supplementing LB 
agar plates with 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) 80 µg/mL and AMP 100 
µg/mL. Other cloning was carried out using Invitrogen ligase (1U/µL) and varying molar ratios 
of insert to 50ng of vector following manufacture’s protocols. Sticky end ligations were carried 




2.4.3 Splice Overlap Extension PCR (SOEing - adeLGmFRT, hnsGmFRT) 
Splice overlap extension polymerase chain reaction was utilized to generate knockout cassettes 
for targeted deletion of genes from the A. baumannii genome (Figure 2). The method used to 
generate the cassettes was from a published method (Choi & Schweizer, 2005) as follows with 
slight modifications. Forward primer was designed to generate ~1kbp fragments when used with 
inner primer corresponding to the first 5-15 nucleotides of the gene of interest (GOI) in the 3’ 
end of the primer and flip recombinase sites (FRT) in the 5’ end. The reverse primer was 
designed with FRT sites and GOI homologous region located in the 5’ end and 3’ end of the 
primer respectively. The aacC1 (GmR) gene was amplified with primers containing identical 
flanking FRT sites for later overlap with 1kbp amplified fragments containing FRT sites. The 
third ~1kbp fragment was amplified using a GOI specific primer with 5’ region homologous to 
FRT sites in GmFRT and 5-15 nucleotides of the GOI in the 3’ end with the outer primer ~1000 
kbp downstream. The three fragments were amplified using Q5 DNA polymerase using 
manufacture’s protocols (NEB, Pickering, Canada) and gel purified (Thermo Fisher Scientific, 
Mississauga, Canada) .  
 
The cassette was generated by following previously published protocol (Choi & Schweizer, 
2005) mixed in equal 50ng amounts in a PCR reaction lacking primers and allowed to cycle 5 
times (annealing temperature, 55°C). Thermocycling was then paused and outer flanking 
primers for the GOI was added to the reaction tube 0.2μM each, the PCR then proceeded for 30 
cycles. The resulting ~3000kbp product was isolated by gel extracted as described above. 
Knockout cassettes were ligated to cloning vector pGEM®-T-easy following addition of 3’ A 
overhangs to PCR products. To the knockout cassette, A overhangs were added using the 
following method. Final concentrations of dATP 0.2mM, PCR buffer with 1.5mM MgCl2 (1X), 
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PCR product up to 3000ng, Taq DNA polymerase 1U (NEB, Pickering, Canada) and MilliQ 
water added to a final volume of 50µL. Reaction was incubated at 72°C for 20 min cooled to 
room temperature and used in ligation reaction to pGEM®-T-easy.  
 
Ligations were set up following manufacture’s protocol (Promega, Madison, USA) in 3:1 and 
5:1 ratios of insert to vector and incubated at 12°C overnight. Half of the ligation mix was used 
in transformation of DH5ɑ and selected on Gm 15 plates. Colonies were picked and confirmed 
by restriction enzyme digest and PCR (Appendix 2 Figure 1). 
 
Once the pGEM®-T-easy clones were confirmed the resulting construct was plasmid extracted 
and digested using appropriate enzymes and ligated into the A. baumannii suicide vector 
pMO130 containing the aphA kanamycin resistance marker, (kanR). Ligations were carried out 
as described above for sticky cloning using NotI and BglI (NEB, Pickering, Canada) (Appendix 
2 Figure 1) and constructs transformed into DH5ɑ. Growth on Gm 15, Kan 20 and restriction 
digest was each used to confirm newly made clones. The conjugating E. coli strain SM10 was 




























Figure 2 – Schematic of splice overlap extension PCR. Fragments for adeLGmFRT were 
individually amplified generating 1kbp fragments up and down stream of target gene along 
with GmFRT fragment. Fragments were mixed in equal amounts and each gene specific 
fragment was annealed to either end of the GmFRT fragment followed by PCR of the ~3kbp 






















PCR amplify and gel extract three fragments  
Combine equal amounts  
Annealing cycle 5 times for SOEing 
                  
Add outer primers and amplify 
fragment 






Figure -2  
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2.5 Preparation of Competent Cells 
2.5.1 Preparation of CaCl2 Competent Cells (DH5ɑ, SM10) 
Chemically competent cells were prepared according to outlined protocols (M. R. Green & 
Sambrook, 2012). Overnight cultures were inoculated 1% in LB media and grown to mid-log 
phase, culture was spun down at 2000 g for 15 minutes. Pellets were re-suspended in 100mM 
CaCl2 and kept on ice for 15 minutes. Cells were re-spun at 2000 g for 10 minutes at 4°C and 
re-suspended in 100mM CaCl2, 15% glycerol at 1/20 the original volume. A volume of 300µL 
was aliquoted and snap frozen at -80°C. 
2.5.2 Preparation of Electrocompetent Cells (A. baumannii Strains) 
Cells are grown to an O.D.600 0.5 and incubated on ice for 15 minutes. Cells were spun down at 
6500 g for 10 minutes and supernatant decanted. Pellets were re-suspended in 1/6 volume in ice 
cold sterile Millipore water. Cells were spun at 8000 g for 10 minutes and resuspended with ice 
cold Millipore water and this step was repeated 4-5 more times. The pellet was then re-
suspended in 1/6 original volume of Millipore water, 10% glycerol and spun down at 8000g for 
10 minutes. Pellet was re-suspended in 2mL, 10% glycerol and snap frozen at -80°C or used 
immediately for electroporation into A. baumannii strains. 
2.6 Transformation of Bacterial Cells 
2.6.1 Electroporation 
100µL of cells pipetted into a 2 mm electroporation cuvettes with 50-250ng of DNA were 
incubated on ice for 15 minutes. Cells were electroporated at 1.5kV and 900µL of LB added 
immediately to the electroporation cuvette. The time constant was measured and values above 
5ms were considered excellent efficiency. The culture was transferred to a 1.5mL tube and  
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incubated with shaking at 37°C for 1 hour in 1mL of LB. Cells were then spun down at 10,000g 
for 2 minutes and resuspended in 100µL of LB and plated on appropriate media.  
2.6.2 Chemical Transformation 
100µL of cells were incubated on ice with 50-250ng of DNA for 10 minutes. Cells were placed 
into 42°C dry bath for 70 seconds and immediately placed on ice for 1 minute. Cells were then 
incubated with shaking for 1 hour at 37°C in 1mL of LB. Cells were then spun down at 10,000g 
for 2 minutes and resuspended in 100µL of LB and plated on appropriate media.  
2.7 Clean Knockout of Genes in A. baumannii 
2.7.1 Conjugation 
The insertion, disruption and subsequent knockout of genes in A. baumannii was carried out by 
bi-parental conjugation using the SM10 cells, carrying the suicide vector pMO130 ligated to 
the appropriate knockout cassette, into A. baumannii cells. Conjugation was carried out as 
described by Amin et al., 2013 with modifications. 200µL of SM10 and A. baumannii ATCC 
17978 or AB043 were washed together with 1100µL of LB. Cells were spun down at 10,000g 
for 2 minutes and wash process repeated. Pellet was then re-suspended in 30µL of LB and 
spotted onto 1cm x 1cm nitrocellulose filter (NCF) on a pre-warmed LB agar plate. The plate 
was incubated at 30°C for 16-18 hours.  
2.7.2 Homologous Recombination 
Cells were washed off NCF with 0.9% NaCl and spread plated onto Simmons citrate agar 
(Becton, Dickinson and Company, Mississauga, Canada) supplemented with Kan50 and 
incubated at 37°C for 48 hours. The Simmons citrate agar acts as a selection agent for A. 
baumannii which utilizes citrate it as a carbon source. Media was also supplemented with Kan50 
to select for A. baumannii that had recombination of the pMO130 construct. Colonies appeared 
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after 48 hours and were patched onto Kan50 and Gm50 LB plates and incubated for 16-18 hours 
to phenotypically verify single insertion. Following conjugation and growth of patched colonies 
on both plates, patches were selected for second recombination utilizing the sacB gene present 
on the backbone of pMO130. The gene encodes for the levansucrase enzyme from B. subtilis 
that converts sucrose into levans which are lethal to bacteria (Gay et al., 1985). A volume of 
4mL LB with sucrose 15% was inoculated with Gm50 patches and passaged every 24 hours for 
3 days. The culture was then pelleted and re-suspended in 100µL of LB and spread plated on 
Gm50 and incubated at 37°C for 16-18 hours. Colonies were patched onto Gm50 and Kan50 to 
observe for survival and susceptibility, respectively. This indicated that the plasmid backbone 
containing kanamycin had been excised and the second recombination had taken place 
successfully disrupting the target gene. Gene disruptions were confirmed by PCR using the 
target gene flanking primers, producing a ~3kbp band relative to the wildtype. 
2.7.3 Excision of Gm Marker 
A. baumannii strains containing the Gmr marker disruption were made electrocompetent using 
the quick method as described above. The pFLP2 plasmid (Hoang et al., 1998) was 
electroporated into ATCC17978 and AB043 strains containing Gmr marker flanked by flip 
recombinase recognition sites (FRT). Colonies harboring the pFLP2 plasmid were selected on 
carbenicilin 200μg/mL plates. Colonies were selected and passaged for 72 hours in 4mL of LB 
media supplemented with Cb200. This was followed by plating dilutions of the culture on LB 
agar with 15% sucrose and incubating for 16-18 hours at 37°C to cure the pFLP2 plasmid from 
strains. Colonies were patched onto LB agar, Gm50 and Cb200. Colonies that only grew on LB 
agar meant the Gm marker was excised resulting in the clean knockout of target gene. The 
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deletion of the gene was confirmed by PCR using gene flanking primers and a combination of 
Gmr forward and GOI reverse primers.  
2.8 Quantitative-Reverse transcriptase polymerase chain reaction (qRT-PCR) 
2.8.1 RNA Extraction and cDNA synthesis 
Strains were streaked out onto media appropriate plates and incubated for 12-16 hours then 
single colonies were used to inoculate 3mL of LB media. Cultures were grown to an O.D. of 
0.6-0.8 at which time 1mL of culture was spun down and frozen at -80°C for 18-24 hours. RNA 
was extracted using the RNAEasy kit (Qiagen, Mississauga, Canada) following manufacture’s 
protocol. A total amount of 1µg RNA was treated to remove genomic DNA carryover using 
DNAse I (Qiagen, Mississauga, Canada) following the manufacture’s protocol. Synthesis of 
complimentary DNA (cDNA) was carried out using the GoScript Reverse Transcriptase kit 
(Promega, Madison, USA) using 1µg of RNA in a 20µL reaction volume. To confirm the 
absence of genomic DNA carryover a no reverse transcriptase reaction (-RT) was included in 
the quantitative real time PCR (qRT-PCR) assay.  
2.8.2 Real-Time PCR 
Expression of genes were quantified using the SsoFast Evagreen Supermix (Biorad, 
Mississauga, Canada) following manufacturer’s protocols. Primers were designed using the 
oligoperfect primer design tool (Invitrogen). Amplicons of 100b.p. were generated using the 
cycling program as follows: Initial denaturation 95°C for 3 minutes, 95°C for 10 seconds, 
annealing and extension 60°C for 30 seconds (cycled 40 times). Product specificity was 
analyzed after PCR cycling by melt curve analysis as follows: 65°C to 95°C, ramping conditions 
0.5°C/ .05 seconds. Primer efficiency was determined by pooling cDNA from strains to be 
tested and diluting out 10-fold generating a standard curve. Reactions were performed using 
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300nm of each primer and 5µL of template diluted as per optimized assay conditions in a 15µL 
reaction volume, unless otherwise stated. In most cases control strains used were ATCC 19606 
or ATCC 17978 as specified and reference gene was 16S rRNA. Control reactions with no 
template were also performed and 16S rRNA used as amplicon for –RT reactions. For gene 
expression in environmental isolates of A. baumannii the Applied Biosystems StepOne Plus™ 
(Thermo Fisher Scientific, Mississauga, Canada) qRT-PCR machine was used and data analysis 
was carried out using Pfaffl method for relative expression (Pfaffl, 2001). For qRT-PCR data 
analysis the t-test was also used to calculate statistically significant difference between 
conditions or strains 
2.9 Isolation of Acinetobacter Strains from Various Sources 
Clinical isolates of A. baumannii were obtained from hospitals across Canada as part of the 
Canadian antimicrobial resistance alliance (CANWARD) study and isolation techniques were 
carried out by staff at hospital locations. For isolation of Acinetobacter species from 
environmental sources, Agriculture and Agri-foods Canada collected strains of Acinetobacter 
from agricultural sources around western and central Canada. A total of eleven isolates were 
obtained initially during a screen for Campylobacter spp. from surface water at 1) South Nation 
River basin near Ottawa, ON, Canada and dairy cattle manure samples from a 2) cattle manure 
storage tank in Victoria, BC, Canada. Samples were initially isolated by culturing on rich media 
and shown to survive on polymyxin B, rifampicin, trimethoprim and amphotericin B incubated 
at 42°C under microaerophilic conditions. The strains were later further purified by isolating 
colonies on media containing vancomycin, amphotericin B and incubation at 42°C 




2.10 Minimum inhibitory concentrations 
2.10.1 Two-fold Broth Dilution 
Minimum inhibitory concentrations were carried out as described according to the microbroth 
dilution method in the Clinical and Laboratory Standards Institute (CLSI, 2010). Briefly, 3mL 
of LB broth was inoculated using a single colony for each strain and incubated at 37 oC for 16-
18 hours with shaking. Cultures were standardized using the 0.5 McFarland standard in saline 
(0.85% NaCl) using the DensiCHEKTM Plus (Biomérieux, Montréal, Canada). To 5mL of 
Mueller Hinton Broth (MHB), (Becton, Dickinson and Company, Mississauga, Canada), 60μL 
of standardized cells were added and aliquoted into each well at 50μL each. Drug concentrations 
were prepared as follows: In a 96-well format each concentration was tested in triplicate in a 
100μL volume per well. Each concentration of drug made up in MHB, were added to the first 
well starting at 2-fold higher than the desired concentration in triplicate. To remaining 50μL of 
MHB was added to each of the remaining wells. Then, to the wells containing antibiotic, 50μL 
of MHB containing antibiotic in the first well was diluted in the adjacent well creating a 2-fold 
dilution. In this way each subsequent set of wells had antibiotic distributed by 2-fold dilution.  
2.10.2 Etest 
Minimum inhibitory concentrations (MIC) for all antibiotics were carried out using Etest® 
strips according to manufacturer’s protocols (Biomérieux, Montréal, QC). Briefly, 3mL of LB 
broth was inoculated using a single colony for each strain and incubated at 37 oC for 16-18 
hours with shaking.  Cultures were standardized using the 0.5 McFarland standard in saline 
(0.85% NaCl) and spread on LB agar (BD – Canada, Mississauga, ON, Canada) plates using 
sterile cotton swabs. Two E-test strips were then placed in opposite orientation onto the 
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inoculated plates and incubated at 37 °C for 18 hours. The MIC was recorded as the 
concentration of antibiotic at which the zone of inhibition intersected the E-test strip.  
2.11 Growth Curves 
Overnight cultures were standardized to O.D.600 0.1 in LB in total well volume of 150µL in a 
96-well plate. A 1mL master mix of media, antibiotic(s) (if required) and culture was made 
before pipetting into triplicate wells. Plates were placed into a Flex Station 3 micro plate reader 
(Molecular Devices, Sunnyvale, USA) for automated plate reading over a 24 hour time course. 
Data was collected and analyzed using Excel Microsoft Office 2010 (Microsoft, Redmond, 
USA). Analysis of growth curves were calculated by comparing specific time points, statistical 
difference at respective time points was calculated using t-test and three technical replicates. 
2.12 Biofilm Assay 
Quantification of biofilm was carried out as described (Iwashkiw et al., 2012) with some 
modifications. Overnight cultures were sub-cultured to O.D.600 0.05 in MHB and 100µL of each 
strain to be tested were aliquoted in triplicate into a 96-well plate and incubated at 30°C. Strains 
requiring antibiotics for plasmid maintenance had MHB supplemented with appropriate 
concentrations. After 48 hours incubation cultures were washed out from wells by submerging 
in MilliQ water 3-4 times. 120µL of 1% (wt/vol) crystal violet/ethanol (Thermo Fisher 
Scientific, Mississauga, USA) was added to wells and incubated at room temp for 30’ with 
gentle agitation. Plates were then washed with MilliQ to rinse out any unbound stain. Biofilms 
were solubilized with addition of 100µL of 2% (wt/vol) SDS/ethanol (Biobasic Inc., Markham, 
Canada) and incubated for 30 minutes at room temperature with gentle agitation. 100µL of 
biofilm sample was transferred into sterile 96-well plate and quantified at O.D.580 using Flex 
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Station 3 micro plate reader. Error was calculated using standard deviation and statistical 
significance using t-test.  
2.13 Virulence Models 
Bacterial strains used for virulence assays were A. baumannii ATCC17978, AB030 and AB031 
(Table 1). 
2.13.2 Candida albicans Co-culture Survival Assay 
The interaction between yeast and A. baumannii was utilized to show the virulence 
characteristic of the clinical isolates AB030 and AB031 relative to ATCC17978. The assay was 
previously utilized to characterize the role of A. baumannii in virulence (Gaddy et al., 2009). 
The Candida albicans yeast strains, wildtype and Δtup1 were grown overnight in yeast (10g/L) 
peptone (20g/L) dextrose (20g/L) media (YPD), with 60μg/mL tetracycline, 30μg/mL 
chloramphenicol and 30μg/mL gentamicin at 30°C. When growing the Δtup1 strain media was 
supplemented with 80μg/mL uridine, a conditional growth marker. Bacterial strains of interest 
were grown overnight in LB media. Next day yeast and bacterial strains were mixed in equal 
number (1.0x105) determined by hemocytometer (yeast) and 0.5 McFarland standard (bacteria) 
in YPD media in a total volume of 1mL, and incubated at 37°C in a 15mL tube for 24 hours. 
To determine C. albicans survival, 10μL aliquots were taken from each co-culture condition 
and serially diluted in YPD+ uridine media without antibiotics. Three YPD agar plates 
supplemented with antibiotics and uridine was used to plate 100μL for three dilutions each. 
Plates were incubated at 30°C for 48 hours or until colonies were visible. Colonies were 
corrected for dilutions, averaged and standard deviation calculated for each condition. Statistical 
significance was calculated using t-test where the average of three technical replicates from 
each condition were compared. 
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2.13.1 Caenorhabditis elegans 
The use of the free living nematode C. elegans as a model for virulence was tested using the 
following equipment, conditions and assay methods provided and optimized by the laboratory 
of Dr. Karen Brassinga, Department of Microbiology, University of Manitoba. Bacterial strains 
were grown in 3mL of LB broth overnight at 37°C with shaking. The next day, each culture was 
standardized to O.D.600 0.3 and 10μL spotted on nematode growth media (3g/L NaCl, 17g/L 
agar, 2.5g/L peptone, 1mM CaCl2, 1mM MgSO4, 25mM KPO4, 5μg/mL cholesterol, 15μg/mL 
ampicillin) in 30mm petri plates. The CaCl2, cholesterol, MgSO4, KPO4 were added following 
autoclaving and cooling of media to 55°C. Modified media to enhance differences between A. 
baumannii strains were similarly prepared with the addition of 1.1% ethanol after autoclaving. 
All chemicals were purchased from Sigma Aldrich (St. Louis, USA). Plates with bacteria 
spotted were placed at 37°C for 24 hours followed by additional 24 hours at room temperature. 
Wild-type laboratory C. elegans, N2 were transferred from feeding plates containing E. coli 
OP50 strains to A. baumannii plates containing ampicillin to prevent growth of the OP50 strain. 
Approximately 30 nematodes were transferred per plate in triplicate using platinum pick onto 
appropriate A. baumannii plate. Plates were incubated at 15°C and scored live/dead based on 
movement and response to touch every 18-24 hours for ~350 hours (2 weeks). Survival curves 
and statistical significance tests (Kaplan-Meier and log-rank test) were generated using 
GraphPad Prism (San Diego, USA).  
2.13.3 Galleria mellonella Infection 
Bacterial overnight cultures were standardized in 0.85% saline to a cell density of 1.5 x 108 
CFU/mL using a 0.5 McFarland standard. At least 15 larvae were used per condition and 
injected with 10µL of standardized bacterial cells into the lower abdominal proleg. The larvae 
were held down with abdominal side facing upwards on top of a frozen ice pack to reduce larvae 
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movement before injection. Larvae were placed in petri plates and placed at 37°C. Live/dead 
counts made every hour for 20 hours. Survival curves and statistical significance tests (Kaplan-
Meier and log-rank test) were generated using GraphPad Prism (San Diego, USA).  
2.14 Genome Sequencing 
Extraction of gDNA for AB030, AB031 and ATCC 17978 were carried out previously (Al 
Saadi, 2014) using the MoBio® UltraClean® Microbial DNA Isolation Kit (MoBio 
Laboratories, Carlsbad, USA) following manufacturers protocol. The integrity of gDNA was 
verified by agarose gel electrophoresis and final concentration and purity of DNA were 
determined using NanoDrop Lite Spectrophotometer (Thermo Fisher Scientific, Mississauga, 
Canada). The gDNA of AB042 and AB043 were extracted in an identical method by Ayush 
Kumar Lab members. 
 
Genome sequencing and assembly of AB030, AB031, AB042 and AB043 was carried out at 
the Génome Québec Innovation Centre at McGill University using the PacBio (Pacific 
Biosciences) sequencing platform utilizing three SMRTcells (Single Molecule Real Time). 
Assembly was carried out at the facility using the Celera Assembler (Myers, 2000). The AB030 
and AB031 genomes were previously reported with coverage of 92-fold for AB030 and 89-fold 
for AB031 (Al Saadi, 2014). Annotation was performed on the NCBI annotation pipeline and 
can be accessed here: AB030 (CP009257) and AB031 (CP009256). Coverage of the AB042 
and AB043 genomes were 201-fold and 104-fold respectively and genome annotation was made 
using the Rapid Annotation using Subsystem Technology (RAST) pipeline (Overbeek et al., 
2014). The ATCC17978 genome was sequenced using the Illumina MiSeq pipeline at the 
Manitoba Institute for Child Health (MICH) and coverage from this sequencing platform 
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estimated ~320-fold coverage, the assembled reads from the MiSeq pipeline were also 
annotated using the RAST annotation server. 
2.15 RNA-seq Preparation and Data Analysis 
Extraction of RNA for RNA-sequencing of AB042, AB043 and ATCC 17978 was carried out 
as described above for qRT-PCR. Two biological replicates were prepared and shipped to 
Manitoba Institute for Child Health (MICH) for enrichment and sequencing using the Illumina 
MiSeq Platform. The overall run for all strains had a QScore of 30 or higher (Q30=<) for 94.4% 
of total reads indicating a 1/1000 probability of error in base calling. Annotation of the aligned 
reads and fold change relative to parent strain (ATCC17978) was created using the UNITY 
multi-omics platform developed in the Department of Physics and Astronomy, University of 
Manitoba (Munir et al., 2015). Each fold change was calculated by normalizing reads to mean 
of 0 and standard deviation of 1. The fold change was then calculated based on ratio of mean 
values in test and control strains. Average was calculated for biological replicates and standard 
deviation calculated for each target. Annotation files were generated using genome sequencing 
data uploaded to the IMG-ER (Export Gene Information) database (Markowitz et al., 2009) for 
use with the UNITY platform.  
2.16 Sample Preparation for Proteomics and Analysis 
From a single colony inoculation strains were grown overnight in 5mL of LB at 37°C with 
shaking. Next day 5mL was used as starter culture to grow strains in 500mL of LB to O.D.600 
~0.8. Cells were then pelleted at 6000g for 15 minutes at 4°C and pellet stored at -80°C until 
used. All strains were tested in three biological replicates. Further processing and mass 
spectroscopy was carried out at the National Microbiology Laboratory in Winnipeg, Canada. 
Data analysis was carried out using ratios of strain of interest against the reference strain 
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(ATCC17978), statistically significant difference was calculated using t-test, and variance (sum 
of squared error) was calculated for each biological triplicate variance.  
2.17 Fatty acid extraction 
The extraction of fatty acids was carried out to measure changes in fatty acid make up of A. 
baumannii triclosan mutants. The protocol for extraction of fatty acids has been described 
(Sestric et al., 2014) and is given below with slight modifications. Strains of interest were grown 
in three biological replicates, overnight from a single colony in 100mL of LB media for 16-18 
hours at 37°C with shaking. Strains O.D.600 were equalized to 1.0 or lowest O.D.600 among the 
strains then were pelleted at 3500g for 15 minutes and washed with PBS once. Pellets were then 
resuspended in 1mL of PBS and transferred to a pre-weighed 1.5mL tube, spun down at 6000g 
and supernatant removed. Pellets were re-spun to remove any excess PBS and placed in a dry 
bath at 42°C overnight to remove moisture for dry weight measurement. The following day 
tubes were weighed and at least 20mg was used for methylation of fatty acid esters. Cells were 
resuspended in 15% H2SO4/Methanol at 10mg/L (Thermo Fischer Scientific, Mississauga, 
Canada) and transferred to a glass tube with cap. To this 1.8mL of chloroform was added and 
200μL of (5% C17/chloroform) as an internal standard. The mixture was boiled at 70°C for 3-5 
hours followed by addition of 1mL MilliQ. Samples were left to equilibrate into organic and 
aqueous phases overnight and the next day, the lower organic phase was transferred to gas 
chromatography vials for GC analysis in Department of Human Nutritional Sciences, Analytical 
Laboratory, University of Manitoba. The percentage of fatty acids were determined by 
extrapolating the total peak area correlated to the amount of C17 added to each sample. Analysis 
was carried out in biological triplicates and t-test used to calculate significant difference 
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between strains. Standard deviation between each biological replicate was calculated using sum 


































3.1 Role of efflux pumps and porins in clinical and environmental isolates of 
Acinetobacter spp.  
Parts of section 3.1 have been published elsewhere:  
Fernando, D. et al., (2013). The Canadian journal of infectious diseases & medical 
microbiology / Journal canadien des maladies infectieuses et de la microbiologie 
médicale / AMMI Canada, 24(1), 17-21.  
Fernando, D.M. et al., (2015). FEMS Microbiology Ecology. Submitted (FEMSEC-15-09-
0471). 
 
In a previous study of 12 unrelated strains of A. baumannii it was estimated that 8% of the core 
genome had roles in adhesion and motility, cell-cell and environmental sensing, iron 
metabolism and drug resistance while the remainder had roles in metabolism and general cell 
function (>65%) or unknown function (22%) (Imperi et al., 2011). Efflux pumps make up a 
significant number of genes encoding proteins involved in drug resistance mechanisms 
primarily because they are intrinsically found in A. baumannii. In a study of A. baumannii 
strains a consensus 32 of 46 ORF’s encoding efflux pumps were identified (Fournier et al., 
2006). In a study of 90 multidrug resistance A. baumannii strains the role of porins was not 
associated with multidrug resistance (Rumbo et al., 2013) but analyses of other pathogenic 
species have revealed a significant role for porins in drug resistance (Fernandez & Hancock, 
2012). 
 
3.1.1 Analysis of a Canada wide collection of A. baumannii clinical isolates for 
multidrug resistance, efflux pump and porin expression 
Collections of Acinetobacter isolates obtained from across Canada by the Canadian Antibiotic 
Resistance Alliance (CARA) were first characterized by genotyping using a multiplex PCR 
assay (Higgins et al., 2010) to differentiate members of Acinetobacter-calcoaceticus-baumannii 
complex (Acb-complex).  The collection of sixteen isolates and one type strain were subjected 
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to multiplex PCR for the gyrB gene to differentiate strains. The resulting products were analyzed 
by agarose gel electrophoresis (Figure 3). In the collection, 13% were identified as A. pitti (band 
at 193 bp, AB006 and AB007), 25% were identified as A. nosocomialis (band at 294 bp, AB004, 
AB005, AB011, AB013) and 56% were identified as A. baumannii (bands at 294 bp and 490 
bp, AB008, AB009, AB010, AB014, AB027, AB028, AB029, AB030, AB031). One isolate 
(AB012) could not be clearly identified using this method because PCR results indicated both 
A. baumannii and A. nosocomialis. Multiple single colonies of AB012 were tested to rule out a 
mixed species sample and subsequent PCR analysis consistently showed mutations in primer 




























Figure 3 – Multiplex PCR against the gyrB gene identifying clinical isolates as A. 
baumannii, A. nosocomialis, A. pitti. Amplification of 193b.p. D16 to D8 identifies A. pitti 
(AB006, AB007), 294b.p. is A. nosocomialis (AB004,AB005, AB011, AB013) 490b.p. and 
294b.p. Sp2F to Sp4R indicates A. baumannii (AB008, AB009, AB010, AB014, AB027, 
AB028, AB029, AB030, AB031). All isolates except AB006 and ATCC19606 present a band 
at 1194b.p. that indicates amplification from D16 to Sp4R. AB012 present bands from all 3 





























3.1.2 MIC and qRT-PCR reveal strains with multidrug resistance and expression 
of three characterized efflux pumps. 
A panel of clinically relevant antibiotics were tested against each clinical isolate to develop a 
resistance profile for each strain. The results shown in Table 3 reveal a wide range from 
extensively susceptible to multidrug resistant (MDR). The most resistant strains in the collection 
were shown to be AB027, AB028 and AB030 with resistance to all drugs tested except for 
clindamycin (AB027, AB028, AB030) and amikacin, imipenem, meropenem and tigecycline 
(AB028) (Table 3). Among the A. nosocomialis isolates AB004 and AB011 were also 
categorized as MDR due to resistance to cefepime, gentamicin and tigecycline, while AB013 
showed resistance to gentamicin, tigecycline and intermediate resistance to cefepime. Strain 
AB005 and A. pitti strains AB006 and AB007 were susceptible to all drugs except AB006 had 
intermediate resistance to ceftriaxone.  
 
In order to characterize potential molecular mechanisms of intrinsic MDR quantitative real-time 
PCR (qRT-PCR) was carried out measuring expression levels of the five known RND efflux 
pumps and three porins (Figure 3). Expression of the porin genes carO, oprD and 33-kDa porin 
was 1) less than 2) ~2-fold greater than or 3) >5-fold of the type strain ATCC19606. The 
expression of carO was lowest in strain AB027 (A. baumannii), with majority of strains showing 
less expression than ATCC19606. Strains exhibiting higher expression than ATCC19606 
included A. baumannii AB009, AB014, AB028 and AB030. Expression of oprD was less than 




Efflux pump overexpression was ubiquitous for adeG with the highest in A. baumannii AB014 
and lowest in A. baumannii AB027. Expression levels of the adeG pump were also the highest 
observed for all three pumps suggesting it may play an important role in the organism not just 
in drug resistance (Figure 4). Overexpression of adeB was only observed in A. baumannii 
AB030 and AB031, two blood isolates with contrasting resistance profiles (Table 3). Expression 
of this gene was observed to be similar to control strain ATCC19606 in AB004, AB011, AB013 
and AB027 while the remaining genes showed less than 0.5-fold or no expression of adeB.  The 
adeJ gene was the next most commonly expressed gene in the collection with highest expression 
in AB028, AB030, AB031 followed by AB009, AB012, AB014, AB027 with AB029 having 
similar expression to the control strain. The remaining strains had less expression than the 
control strain ATCC19606. Although its substrate profile is unknown the efflux pump 
AciBau_2746 was also expressed in MDR isolates from the collection, AB027, AB030 and 
AB031. Highest expression was observed in susceptible strains AB008 and AB014 which could 
suggest a nonspecific role. The uncharacterized RND efflux pump AciBau_2436 had the least 

















Table 3 – Antibiotic susceptibilities of Acinetobacter clinical isolates. Data expressed in 
µg/mL and I: intermediate, R: resistant, S: susceptible. AMK Amikacin; CFZ Cefazolin; CIP 
Ciprofloxacin; CLI Colistin; CRO Ceftriaxone; FEP Cefepime; GEN Gentamicin; IPM 
Imipenem; LVX Levofloxacin; MEM Meropenem; MXF Moxifloxacin; SXT 
trimethoprim/sulfamethoxazole; TGC Tigecycline; TZP Piperacillin-tazobactam. Clinical 




Strain AMK GEN CFZ FEP CRO CIP LVX MXF CLI IPM MEM TZP TGC SXT 
AB004 32 (I) 32 (R) >128 128 (R) 32 (I) 2 (I) 1 (S) 0.5 (S) 2 (S) 0.25 (S) 2 (I) 64 (I) 2 (R) 0.12 (S) 
AB005 <1 (S) <0.5 (S) 128 <1 (S) <1 (S) <0.06 (S) 0.12 (S) <0.06 (S) 1 (S) 0.25 (S) 0.25 (S) <1 (S) 0.5 (S) <0.12 (S) 
AB006 2 (S) 2 (S) >128 4 (S) 16 (I) 0.5 (S) 0.25 (S) 0.25 (S) 2 (S) 0.25 (S) 1 (S) 8 (S) 1 (S) <0.12 (S) 
AB007 2 ((S)) 1 (S) >128 8 (S) 8 (S) 1 (S) 0.25 (S) 0.12 (S) 1 (S) 0.25 (S) 0.5 (S) 16 (S) 0.5 (S) 0.5 (S) 
AB008 2 (S) 0.5 (S) >128 2 (S) 4 (S) 0.12 (S) <0.06 (S) < 0.06 (S) 1 (S) 0.25 (S) 0.5 (S) <1 (S) 0.5 (S) 0.25 (S) 
AB009 2 (S) 0.5 (S) >128 2 (S) 8 (S) 0.5 (S) 0.12 (S) 0.12 (S) 0.5 (S) 0.25 (S) 0.5 (S) <1 (S) 0.5 (S) 0.25 (S) 
AB010 2 (S) 1 (S) >128 4 (S) 16 (S) 0.5 (S) 0.25 (S) 0.12 (S) 1 (S) 0.25 (S) 1 (S) 8 (S) 0.5 (S) >8 (R) 
AB011 32 (I) 32 (R) >128 64 (R) 16 (S) 2 (I) 0.5 (S) 0.5 (S) 2 (S) 0.5 (S) 2 (S) 32 (I) 2 (R) <0.12 (S) 
AB012 2 (S) 0.5 (S) >128 2 (S) 16 (S) 0.12 (S) 0.12 (S) <0.06 (S) 1 (S) 0.12 (S) 0.5 (S) 4 (S) 0.25 (S) <0.12 (S) 
AB013 16 (S) 32 (R) 128 16 (I) 16 (S) 1 (S) 0.5 (S) 0.5 (S) 1 (S) 0.25 (S) 1 (S) <1 (S) 2 (R) <0.12 (S) 
AB014 2 (S) <0.2 5 (S) >128 8 (S) 16 (S) 0.5 (S) 0.25 (S) 0.12 (S) 0.25 (S) 0.25 (S) 1 (S) 16 (S) 0.5 (S) 0.25 (S) 
AB027 >64 (R) 32 (R) >128 >128 (R) >256 (R) >16 (R) 16 (R) 8 (R) 1 (S) 32 (R) 16 (R) >512 (R) 4 (R) >8 (R) 
AB028 2 (S) >32 (R) >128 32 (R) 64 (R) >16 (R) 16 (R) 8 (R) 0.5 (S) 0.25 (S) 2 (S) 128 (R) 0.5 (S) 8 (R) 
AB029 <1 (S) <0.5 (S) 128 16 (I) 2 (S) 2 (I) 1 (S) 0.5 (S) 0.5 (S) 0.25 (S) 0.5 (S) ≤1 (S) 2 (R) ≤0.12 (S) 
AB030 64 (R) >32 (R) >128 >64 (R) >64 (R) >16 (R) 16 (R) >16 (R) 0.5 (S) >32 (R) >32 (R) >512 (R) >16 (R) >8 (R) 
AB031 2 (S) <0.5 (S) >128 4 (S) 16 (I) 0.25 (S) 0.25 (S) 0.12 (S) 0.5 (S) 0.25 (S) 1 (S) 4 (S) 8 (R) 4 (R) 

















Figure 4 – Expression of resistance nodulation division pump (adeB, adeG, adeJ) and outer 
membrane porin encoding genes (carO, oprD, 33-kDa) in clinical isolates of Acinetobacter 
species. Expression was measured in each clinical isolate relative to the control strain ATCC19606 
and genes were measured in each strain relative to the reference gene 16S with constant expression. 




















3.1.3 Analysis of Acinetobacter environmental isolates from Canadian agricultural 
niches for multidrug resistance and efflux pump expression. 
The study of Acinetobacter as an environmental isolate has been primarily devoted to two 
species, A. calcoaceticus because of its consistently being found in water treatment plants and 
soil and A. baylyi for its metabolic diversity lending to industrial applications. The identification 
of A. baumannii isolates although reported has not been studied for drug resistance mechanisms 
and therefore this study was aimed at uncovering efflux pump expression profiles and 
determining susceptibility to medically useful antibiotics. 
3.1.3 A Etest of Acinetobacter Environmental isolates reveals strains with decreased 
susceptibility to antibiotics and greater efflux pump expression compared to 
ATCC17978 
Of the collection five strains (AB045, AB046, AB047, AB048, and AB053) exhibited resistance 
to at least three classes of antibiotics (Table 4) with MIC’s greater than type strain ATCC17978. 
Strains AB047 and AB053 showed reduced susceptibility to six (tigecycline, 
amoxicillin/clavulanic acid, chloramphenicol, ceftaroline fosamil, moxifloxacin, doxycycline) 
of the twelve antibiotics tested. AB047 had additional resistance to doripenem and  
 
Piperacillin/Tazobactam and AB053 had additional resistance to cefepime and imipenem. 
Strains AB045, AB046 and AB048 were resistant to seven (tigecycline, chloramphenicol, 
ceftaroline, fosamil, cefepime, moxifloxacin, doxycycline, Piperacillin/Tazobactam), four 
(tigecycline, imipenem, doripenem, doxycycline) and five (tigecycline, ceftaroline fosamil, 
moxifloxacin, doxycycline) antibiotics respectively. The AB049, AB050, AB052 and AB055 
strains had decreased susceptibility against two antibiotics, tigecycline and doxycycline. AB054 
showed decreased susceptibility to moxifloxacin and doxycycline while AB051 showed 















Table 4 – Antibiotic susceptibilities of Acinetobacter environmental isolates from. Data expressed 
in µg/mL. TGC Tigecycline; AMC Amoxicillin/clavulanic acid; CHL chloramphenicol; CPT 
ceftaroline fosamil; FEP cefepime; IPM imipenem; DOR doripenem; MXF moxifloxacin; DOX 
doxycycline; SXT trimethoprim/sulfamethoxazole; CLI colistin; TZP Piperacillin/Tazobactam. 
Clinical breakpoints were obtained from CLSI (CLSI) and EUCAST (EUCAST 2015). I: 





Site TGC AMC CHL CPT FEP IPM DOR MXF DOX SXT CLI TZP 
AB045 SNR 1 (S) 2 0.25 1.5 3 (S) 0.125 (S) 0.019 (S) 0.094(S) 3(S) 0.19(S) 0.15 (S) 12 (S) 
AB046 SNR 0.25 (S) 6 0.125 0.75 2 (S) 0.38 (S) 0.25 (S) 0.047(S) 0.5 (S) 0.38(S) 0.125 (S) 0.032 (S) 
AB047 SNR 0.25 (S) 16 0.25 1.5 2 (S) 0.25 (S) 0.25 (S) 0.064(S) 1 (S) 0.19(S) 0.125 (S) 8 (S) 
AB048 SNR 0.38 (S) 0.5 0.125 2 2(S) 0.25 (S) 0.125 (S) 0.064(S) 1 (S) 0.25(S) 0.38 (S) 8 (S) 
AB049 SNR 0.25 (S) 1.5 0.125 0.75 1.5 (S) 0.125(S) 0.19 (S) 0.023(S) 1 (S) 0.125 (S) 0.25 (S) 0.023 (S) 
AB050 SNR 0.25 (S) 0.5 0.125 0.75 1.5 (S) 0.125(S) 0.064 (S) 0.032(S) 1.5 (S) 0.125 (S) 0.125 (S) <0.016 (S) 
AB051 SNR 0.19 (S) 0.125 0.064 0.38 0.5 (S) 0.125(S) 0.047 (S) 0.023(S) 1 (S) 0.094 (S) 0.19 (S) <0.016 (S) 
AB052 CMT 0.25 (S) 4 0.125 0.75 1.5 (S) 0.25 (S) 0.125 (S) 0.032(S) 0.5 (S) 0.19(S) 0.125 (S) <0.016 (S) 
AB053 CMT 0.38 (S) 16 0.19 2 3 (S) 0.38 (S) 0.19 (S) 
0.064 
(S) 
0.75 (S) 0.19(S) 0.38 (S) 0.094 (S) 
AB054 CMT 0.19 (S) 0.094 0.125 0.75 0.5 (S) 0.094(S) 0.032 (S) 0.064(S) 2 (S) 0.125 (S) 0.016 (S) <0.016 (S) 
AB055 CMT 0.5 (S) 0.25 0.094 0.38 1 (S) 0.19 (S) 0.064 (S) 0.032(S) 4 (S) 0.125 (S) 0.19 (S) <0.016 (S) 




















Figure 5 – Characterization of Acinetobacter environmental strains by (A) multiplex 
PCR and (B) efflux pump expression by qRT-PCR. Strain delineation was carried out 
by multiplex PCR against the gyrB gene. Amplification of bands at 294 b.p. and 490 b.p. 
indicate A. baumannii. Additional band at 1194 b.p. occurs as a result of flanking primers 
amplifying full length band. Expression of RND genes in environmental isolates of 
Acinetobacter species. Values are expressed relative to type strain ATCC17978 and are 














































3.1.3B Multiplex PCR Identifies A. baumannii strains in collection and show trend with 
efflux pump expression. 
Multiplex PCR was used to delineate strains of the Acb-complex (A. baumannii, A. pitti, A. 
nosocomialis) by selectively amplifying regions of the gyrB gene identified five strains (AB046, 
AB047, AB048, AB052 and AB053) as A. baumannii (Figure 5A). This assay was not able to 
identify other isolates in the collection. 
 
The expression of RND efflux pumps was tested in this collection of isolates using quantitative 
real-time PCR. The control strain used in this study was ATCC17978 since a markerless 
knockout system was developed for this strain, therefore future studies could be carried out with 
knockout strains in ATCC17978 to study particular genes. Three characterized RND efflux 
pumps, adeJ, adeG and adeB were tested along with two uncharacterized putative metal efflux 
pumps, AciBau_2436 and AciBau_2746 (Figure 5B). The results show adeB was expressed in 
all strains, ranging from AB049, lowest expression to AB046 with highest expression. The adeG 
pump expressed the least among all genes tested (Figure 5B). Expression of efflux pumps was 
most numerous and abundant in AB046 (A. baumannii). Expression was not detected for the 
following genes in the following strains; adeG (AB045, AB055); adeJ (AB054); A1S_3219 
(AB045, AB049, AB050, AB051, AB054, AB055; A1S_2818, AB045, AB047, AB049, 
AB050, AB051, AB054, AB055) (Figure 5B).  
 
The AB046 (A. baumannii) isolate showed the highest expression of AciBau_2436 and adeB 
with associated decreased susceptibility to the following adeB substrates, tigecycline and 
imipenem (Table 4). The AB046 strain also showed a moderate overexpression of the adeJ 
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efflux pump and this was associated with decreased susceptibility to the following adeJ 
substrates tigecycline, doxycycline. Apart from these known substrates AB046 also showed 
reduced susceptibility to doripenem and piperacillin/tazobactam (Table 4). It is interesting to 
note that expression of the AciBau_2436 pump was highest in this strain (AB046) however the 
substrates of this pump have not yet been identified. 
 
Strains AB052 (A. baumannii) and AB053 (A. baumannii) show with greater decreased 
susceptibility (Table 4) and overall efflux pump expression (Figure 5B), where AciBau_2436 
and adeB levels corresponded to decreased susceptibility to tigecycline and doxycycline. In 
addition, AB053 had decreased susceptibility to ceftaroline fosamil, cefepime, imipenem, and 
moxifloxacin (Table 4) but lower RND efflux pump expression (Figure 5B) compared to 
AB052. While no genes were overexpressed in AB053 the strain still exhibited decreased 
susceptibility to a greater number of antibiotics compared to AB052. None of the genes in this 
study were significantly expressed in AB053 compared to the control strain, ATCC17978.  
 
A range of expression for efflux pumps in AB045 (Acinetobacter) and AB055 (Acinetobacter) 
was not observed but these strains do show MIC values that are higher than the control strain 
for some antibiotics. AB045 showed decreased susceptibility against tigecycline, 
chloramphenicol, ceftaroline fossamil, cefepime, moxifloxacin, doxycycline and 
piperacillin/tazobactam but expression of only two pumps, adeB, adeJ. AB055 showed greater 
decreased susceptibility against, tigecycline and doxycycline but so too did most strains 
regardless of efflux pump expression. AB045 (Acinetobacter) was isolated from a watering 
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tank, AB055 (Acinetobacter) from dairy cattle and AB045 presents overexpression of adeJ 
while AB055 shows overexpression of adeB. Considering that AdeJ is known to have broader 
substrate specificity than AdeB and contribute more to drug resistance (Coyne et al., 2011) this 
could be a possible reason why MIC’s could be greater in AB045.  
 
Strain AB047 shows the expression of pumps, adeB, AciBau_2746 and decreased susceptibility 
to seven antibiotics. This is in contrast with the AB046 strain that shows greater expression of 
pumps but decreased susceptibility to only four antibiotics. In addition, AB048 shows 
expression of pumps, adeB, adeG, adeJ, AciBau_2436, AciBau_2746, but decreased 
susceptibility to five antibiotics. The strains AB049, AB050 and AB051 are the most susceptible 













Antibiotic efflux overexpression and porin downregulation are thought to be the major intrinsic 
mechanisms of drug resistance in A. baumannii. Expression of RND efflux pumps, AdeABC, 
AdeFGH and AdeIJK are known to be major mechanisms of drug resistance from clinical 
isolates around the world (Coyne et al., 2011; Damier-Piolle et al., 2008; Gaddy et al., 2009; 
Lin et al., 2009; Roca et al., 2011). The AdeABC pump has been reported as the most ubiquitous 
pump among Acinetobacter isolates with a substrate profile that includes amikacin, 
chloramphenicol, cefotaxime, erythromycin, gentamicin, kanamycin, norfloxacin, netilmicin, 
ofloxacin, pefloxacin, sparfloxacin, tetracycline, tobramycin, trimethoprim (Magnet et al., 
2001). In the collection of Canadian isolates the expression of adeABC was not as high as 
expression of adeFGH in all strains. Strain AB030 which is one of the most drug resistant strains 
in the collection had the only comparable expression of adeABC (5.67) to adeFGH (6.77). There 
was a trend between strains showing tigecycline resistance (AB030, AB031, Table 3) and 
expression of the adeABC efflux pump (Table 2) which compliments findings that AdeABC 
expression is a major mechanisms of resistance to tigecycline in clinical isolates (Rumbo et al., 
2013). The adeFGH pump demonstrated the highest expression in the collection followed by 
adeIJK. While the adeFGH pump is known to efflux chloramphenicol, trimethoprim, 
ciprofloxacin and clindamycin (Coyne, Rosenfeld, et al., 2010; Gaddy et al., 2009) the AdeIJK 
pump has been shown to efflux β-lactams, chloramphenicol, tetracycline, erythromycin, 
lincosamides, fluoroquinolones, fusidic acid, novobiocin, rifampin, trimethoprim, acridine, 
pyronine, safranin, triclosan and sodium dodecyl sulfate (Damier-Piolle et al., (2008). The 
expression of all three clinically relevant RND pumps was observed in the XDR isolate AB030 
but also in the susceptible AB031. In addition expression of at least three pumps in a strain did 
not correlate with decreased susceptibility, AB008 (adeG, AciBau_2436, AciBau_2746), 
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AB014 (adeG, adeJ AciBau_2746) and AB028 (adeG, adeJ and AciBau_2746). Conversely 
AB027, an MDR isolates in the collection showed expression of only two pumps (Figure 4). 
This finding may suggest that alternative resistance mechanisms may be active in these strains 
providing additional drug specific resistance. Two additional uncharacterized efflux pumps that 
may play a role in metal efflux based on sequence homology were also tested but did not have 
a observable link to drug resistant phenotypes.  
 
Also tested were the expression levels of the porin genes in A. baumannii of which there are 
three reported with carbapenem resistance, CarO (Mussi et al., 2005), OprD (Siroy et al., 2005) 
and the 33-36kDa (del Mar Tomás et al., 2005). It has been recently reported that the OprD 
protein is part of a P. aeruginosa subgroup with homology to OprQ involved in magnesium 
tolerance and functionality in low iron environments and has no role in carbapenem resistance 
(Catel-Ferreira et al., 2012). Similarly the role of the 33-36kDa porin among clinical isolates 
may not be highly influential on carbapenem resistance (Zander et al., 2013) and new data is 
suggesting a more prominent role as a virulence factor (Rumbo et al., 2014). The expression 
data did not show a statistically significant downregulation of carO that could be used to explain 
carbapenem resistance, the majority of strains had low levels of expression compared to 
ATCC17978. Similarly, oprD nor the 33-36kDa porin expression could be tied to carbapenems 
resistance. Overall no statistically significant correlations could be made between RND pump 
and porin expression with drug resistance, most likely due to the presence of alternative 
mechanisms. In previous studies the correlation between decreased porin expression and MDR 
has been observed (del Mar Tomás et al., 2005; Limansky et al., 2002; Rumbo et al., 2013). In 
a collection of 90 isolates overall porin expression was downregulated in strains that were MDR 
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but not carbapenem resistant (Rumbo et al., 2013). CarO as well as the 33-36kDa porin were 
observed to have lesser expression in carbapenem resistant isolates (Clark, 1996; Limansky et 
al., 2002). The overexpression of RND efflux pumps and downregulation of porins is a 
commonly associated phenotype in MDR isolates such as A. baumannii, P. aeruginosa and E. 
coli. Therefore these proteins remain a significant intrinsic mechanism of drug resistance. 
 
The isolation of Acinetobacter spp. from environmental sources from two agricultural sites 
revealed strains that had decreased susceptibility to medically relevant antibiotics relative to a 
control clinical isolate, ATCC17978. Using a multiplex PCR assay against the gyrB gene, 5/11 
isolates were confirmed as A. baumannii (AB046, AB047, AB048, AB052, and AB053) while 
the remainder were not identified using this technique. All A. baumannii strains were isolated 
from fresh water at the SNR basin in Ontario, Canada or cow manure tanks in British Columbia, 
Canada. 
 
The broad susceptibility profile dictated by E-test does show a relationship with RND efflux 
pump expression for strains identified as A. baumannii in the strain collection. AB047 and 
AB048 show greater resistance to tigecycline, ceftaroline fosamil, moxifloxacin, doxycycline 
and piperacillin/tazobactam compared to type strain ATCC17978. These drugs apart from 
piperacillin/tazobactam, have been shown as possible substrates of AdeG, AdeJ and AdeB 
(Coyne et al., 2011) and these genes were shown to be expressed in strains AB047 and AB048 
to a greater extent than in ATCC17978 by qRT-PCR. In addition, AB047 showed decreased 
susceptibility to chloramphenicol, a substrate of AdeG (Cortez-Cordova & Kumar, 2011; 
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Coyne, Rosenfeld, et al., 2010) and doripenem which is not known to be extruded by any RND 
pump. However, it is interesting to note that AB047 had the highest expression of AciBau_2746 
and further studies will be carried out to determine if expression of this pump is related to 
doripenem resistance.   
 
Interestingly strain AB049 (Acinetobacter) is more susceptible to a greater number of drugs 
tested than AB047 (A. baumannii) and AB048 (A. baumannii) and this correlates with AB047 
and AB048 showing higher efflux pump expression compared to AB049. Similarly, AB050 
(Acinetobacter), AB051 (Acinetobacter) and AB054 (Acinetobacter) showed the most 
susceptibility across the panel of antibiotics tested and the smallest levels of RND pump 
expression, with similar adeB expression to ATCC17978. Because AB052 has a greater 
susceptibility but higher expression of efflux pumps compared to AB053 this may suggest 
alternative mechanisms of drug resistance. Interestingly, the adeIJK pump which has the 
broadest substrate profile of the three characterized efflux pumps (Coyne et al., 2011) had a 
higher expression in AB053 than in AB052 but this difference was not statistically relevant. 
Overall there is no direct relationship with expression of efflux pumps and resistance to specific 
types or classes of antibiotics, an overarching trend that suggests strains expressing more efflux 
pumps have a decreased susceptibility to a greater number of antibiotics. Future studies will 





Another important finding was that piperacillin/tazobactam susceptibility was observed for 
some strains but not Acinetobacter isolates AB045 (Acinetobacter, 12μg/mL), AB046 (A. 
baumannii, 0.032μg/mL), AB047 (A. baumannii, 8μg/mL), AB048 (A. baumannii, 8μg/mL), 
AB049 (A. baumannii, 0.023μg/mL) and AB053 (A. baumannii, 0.094μg/mL). Treating MDR 
Acinetobacter infections with piperacillin/tazobactam has shown little success as resistance 
rates are reported to be 36-75%, (Vikas et al., 2010), and the fact these have now been isolated 
from environmental sources is highly alarming.  
 
Considering the danger to human health posed by MDR A. baumannii (Peleg et al., et al., 2008), 
coupled with the lack of new antibiotics against gram negative pathogens (Kinch et al., 2014) 
isolation of Acinetobacter baumannii species from the environment with decreased 
susceptibility to medically relevant antibiotics is of great concern. Although the resistance 
values are not comparable to major resistance reported for clinical isolates of A. baumannii 
(Morfin-Otero & Dowzicky, 2012) these strains did show decreased susceptibility compared to 
the type strain ATCC17978.  A strain of A. baumannii was isolated from  paleosol soil in an 
abandoned quarry used as an illegal dumping ground in Croatia (Hrenovic et al., 2014). The 
isolate was shown to be resistant to gentamycin, trimethoprim-sulfamethoxazole, ciprofloxacin 
and levofloxacin suggesting that clinically relevant A. baumannii strains can survive in 
relatively harsh environmental conditions (Hrenovic et al., 2014).  
 
The results from this observational study indicate the propensity for environmental isolates to 
have drug resistance characteristics of clinical isolates, specifically the expression of RND 
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efflux pumps, and decreased susceptibility to multiple antibiotics. The isolation of these 
Acinetobacter strains from environmental sources raises concern over the spread of MDR into 
non clinical reservoirs and shows that A. baumannii, a species notorious for causing major 













3.2 Assessment of three virulence models, Candida albicans, Caenorhabditis 
elegans, Galleria mellonella against two A. baumannii blood isolates AB030 and 
AB031.  
3.2.1 The use of non-mammalian models to study nosocomial pathogens 
In a preliminary assessment of virulence, the Canadian collection of strains was tested for 
biofilm formation, and two blood stream isolates were found to have contrasting ability to form 
biofilms. AB031 produced more biofilm than AB030 and both strains were non-motile 
(unpublished observations). Considering both isolates were found in the bloodstream, they may 
possess similar virulence characteristics. Virulence models using C. albicans, C. elegans and 
G. mellonella were developed to study AB030 and AB031 to see if there were differences in 
severity of infection. Finally to provide some genetic basis to differences observed in virulence, 
genomes of these two strains were sequenced using Single Molecule Real Time Sequencing 
(SMRT®) (Loewen et al., 2014a; Loewen et al., 2014b). 
 
 
3.2.2 Candida albicans as a model organism to test virulence in AB030 and AB031 
show clearing of fungal filaments but not wildtype cells. 
Cells from C. albicans Δtup1 or wildtype were mixed at 1.0X106 cells/mL with respective 
bacterial strains and incubated in co-culture. One day post incubation samples were taken and 
counts of C. albicans survival were made of the wildtype and fungal forms (Figure 6). Analysis 
of the C. albicans co-culture with A. baumannii strains revealed mixed results. Interestingly, 
the degree of killing that each strain exacted on either Δtup1 or wildtype C. albicans were 
similar, suggesting that there is no difference in the targeting of A. baumannii to either the fungal 
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form or wildtype during co-incubation (Figure 6a). Additionally there was no statistically 
relevant difference in killing between ATCC19606, AB030 and AB031 in either Δtup1 or 
wildtype. There were some interesting trends that could be observed, AB030 exposed to 
wildtype strain survived more than when incubated with AB031 and ATCC19606 respectively, 
however these results were not observed to be statistically significant. In an effort to visualize 
interactions between bacteria and yeast strains, Gram stains were prepared for each of the co-
incubations in the wildtype and filamentous form and photographed at 40X magnification 24 
hours post incubation (Figure 5b). The images show that the wildtype yeast (Figure 5b, lower 
panel) group around the wildtype yeast. The Δtup1 mutant and bacterial interactions (Figure 5b, 
top panel) are visually different compared to the wildtype. It seems that there may be some 
interaction between ATCC19606, AB030 and AB031 with the Δtup1 filamentous yeast. 
Additionally there seem to be gaps in the filaments that could be caused by some interaction 
with the bacterial strains; interestingly this is not at all seen in AB031 gram-stained co-
incubations (Figure 5b, top panel, right). It is currently unclear if the gaps observed in A. 
baumannii - Δtup1co-incubated strains are due to bacterial degradation of yeast filaments or if 





















Figure 6 - Survival of wildtype (Wt) and constitutively filamentous (Δtup1) C. albicans 
following co-incubation with A. baumannii strains. (A) Quantification of C. albicans 
survival following 24 hours co-incubation. Data are representative of three biological 
replicates. Error bars represent ±SD. (B) Gram stain of A. baumannii infected wildtype (Wt) 







                                                       





































In a previous report, electron microscopy images revealed that ATCC19606 strain does indeed 
adhere to Δtup1 filaments and induces apoptosis (Gaddy et al., 2009), while another report has 
shown that A. baumannii inhibits filamentation of C. albicans (Peleg et al., 2008), but a 
comparison between wildtype and filamentous forms has not been clearly done. According to 
the survival data, it seems that there is no variation between Δtup1 and wildtype which suggests 
that the bacterial strains kill both yeast forms equally. This would then suggest an alternative to 
the adhesion and degradation of Δtup1 filaments in previous reports and not observed in A. 
baumannii – yeast co-cultures through gram stain. No clear differences could be observed when 
comparing survival of filamentous yeast after co-culture with ATCC19606, AB030 and AB031 











3.2.3 Caenorhabditis elegans as a model organism to test virulence in AB030 and 
AB031 reveal differences in virulence, enhanced in presence of ethanol. 
Bacterial infection of C. elegans is easily carried out by replacing the usual E. coli OP50 food 
source with the pathogen of choice and then observing survival over time. The virulence of 
AB030, AB031 and ATCC17978 was assessed using this method. The ATCC17978 type strain 
was chosen because of its use in previous studies as a benchmark to measure virulence in A. 
baumannii using C. elegans (Smith et al., 2007; Vallejo et al., 2015)  and the insect G. 
mellonella (Iwashkiw et al., 2012; Peleg et al., 2009). Survival of C. elegans in standard 
nematode growth media (NGM) was carried out by spotting with relevant A. baumannii strain 
and growing for 24 hours at 37°C. This was followed by transferring on average 25-30 C. 
elegans from OP50 plates to each A. baumannii plate. In Figure 7, the mortality of C. elegans 
infected with AB030, AB031 and ATCC17978 show the assay does indeed cause death. 
Comparison of AB030 with ATCC17978 reveals that AB030 does not kill significantly faster 
or slower than ATCC17978 in three biological replicates (Figure 7a). Comparison of  AB031 
with ATCC17978 suggest a similar survival trend in the first 200 hours (Figure 7b); C. elegans 
survival after this point shows that ATCC17978 has a greater effect on mortality than AB031, 
however no statistically significant difference between AB031 and ATCC17978 was observed 
in three biological replicates. Interestingly the median survival or LT50 of C. elegans is 190 and 
237 hours respectively for AB030 and AB031. Although survival between strains was not 
statistically different, comparison of AB030 and AB031 show that AB030 may be killing at a 




















Figure 7 – Nematode infection assays measuring survival differences between AB031, 
AB030 and ATCC17978. Comparison of C. elegans infected with (A) ATCC17978 or AB030. 
(B) ATCC17978 or AB031 (C) AB030 or AB031 or (D) C. elegans infected with AB030 or 
AB031 grown on modified NGM containing 1.1% ethanol. Tick marks indicate when counting 





















Figure 8 – Nematode killing following infection with A. baumannii clinical isolates. 
Arrows indicate areas where nematodes seemed to burst when dying. Images AD 











Efforts to examine co-infection of the C. elegans host have focused on the role of yeast co-
culture with A. baumannii. It was shown that enhanced virulence was observed due to the 
presence of ethanol produced by the fermenting yeast (Smith et al., 2004). Therefore another 
experiment was performed using AB030 and AB031 grown on NGM containing 1.1% ethanol. 
This result showed a statistically significant difference between AB030 which killed at a faster 
rate compared to AB031 (p<0.0001, Mandel-Cox test and Gehan-Breslow-Wilcoxon test). The 
LT50 for C. elegans with ethanol and AB030 were 167 hours compared to AB031 at 216 hours, 
Figure 7D. The role of ethanol in enhancing the virulence in AB030 C. elegans infection 
suggests that ethanol triggers virulence factors such as those reported in yeast co-culture (Smith 
et al., 2004) and could be acting in this virulence model. 
 
An interesting visual phenotype was observed when C. elegans were killed by A. baumannii 
infection and was recorded for qualitative purposes, using observations from a dissecting 
microscope. The nematodes appeared to burst consistently from the mid-section when found 







3.2.4 Galleria mellonella as a model organism to test virulence in AB030 and 
AB031 reveal statistically significant differences between each strain. 
The results indicate that AB030 had a greater effect on mortality that was statistically significant 
compared to AB031 (Mandel-Cox test, p-value < 0.0001 Gehan-Breslow-Wilcoxon Test, p-
value <0.0001) and ATCC17978 (Mandel-Cox test, p-value < 0.0001 Gehan-Breslow-
Wilcoxon Test, p-value 0.0002) (Figure 9). Both ATCC17978 and AB030 had a median 
survival time of 8 hours while AB031 was 16 hours. It was also observed that post-injection, 
pigmentation changes were much faster in AB030 infected larvae compared to AB031 and 
ATCC17978 infected larvae. Overall the results using this infection model suggest that AB030 
































Figure 9 – Galleria mellonella larvae infection assay measuring survival after infection 
with AB030, AB031 or ATCC17978 at 1.5x108 CFU/mL. AB030 infected larvae show 
greater mortality than AB031 or ATCC17978. Inset photograph shows selection criteria to 
show live (yellow) versus dead (black) G. mellonella. Data is combined to show 3 biological 




























Comparison of this outcome to the C. elegans model shows similarity in that AB030 seems to 
be more virulent in the host compared to AB031. Overall it would seem that the host infection 
models chosen to assess the virulence of two blood infection isolates of A. baumannii, AB030 
(XDR) and AB031, were consistent in their findings. This shows that hyper-resistance and 
hyper-virulence can co-exist in same isolate (Table 3). 
 
3.2.5 Comparison of AB030 and AB031 Genome Sequence Indicate Additional 
Virulence Genes in AB030. 
In order to examine possible causes for the contrasting virulence between AB030 and AB031, 
the genomes of these two isolates were examined. Genome analysis revealed AB030 contains 
4,335,793 b.p. with a GC content of 39% and 4,258 putative genes (Loewen et al., 2014). The 
results from AB031 sequencing show 3,803,317 b.p. with a GC content of 39.2% and 3,564 
putative genes (Loewen et al., 2014). The results from our C. elegans and G. mellonella 
infection models show that the AB030 strain may present more virulence than AB031. 
Interestingly, variations in the genes from AB030 and AB031 can be seen that may play a role 
in virulence.  
 
Using the program CGView (Stothard & Wishart, 2005) a comparison of the two genome open 
reading frames was made using AB030 as the reference strain (Figure 10) (Al Saadi, 2014). The 
comparison showed gapped areas not found in the ATCC17978 (red) or AB031 (blue) genomes. 
The areas of the genome where large stretches of DNA were missing represent >20 protein 
encoding regions, totalling 287 annotated open reading frames (IX87_19875 - IX87_20250, 





















Figure 10 – Comparison of genomes ATCC17978 (blue), AB030 (green), AB031 (red) in 
CGView. Intensity of colour indicates overlapping blast alignments and height, percent 
identity. Annotated reading frames are shown by arrows. Gaps represent genes missing in 



































- IX87_18820, 3658785-3699400 b.p.; IX87_21240-21495, 4189007-4227845 b.p.; 
IX87_07695- IX87_07915, 1465597-1495812 b.p.; IX87_20430-IX87_20655, 4030710-
4071717 b.p.; IX87_08175-IX87_8375, 1550718-1578935 b.p.). The region ranging from 
IX87_19875 - IX87_20250 encodes a majority of hypothetical proteins as well as genes 
involved in choline dehydrogenase. Interestingly this region also encodes four RND efflux 
pump components; two outer membrane proteins, a transporter protein and a membrane fusion 
protein and downstream of these genes is a two component response regulator, which ranges 
from 3973088 – 3980853 in AB030. The IX87_18535 - IX87_18820 encoded either 
hypothetical proteins or genes involved in phage packing and phage tail synthesis. The regions 
IX87_21240-21495, IX87_07695- IX87_07915 and IX87_08175-IX87_08375 are similarly 
categorized encoding many phage and hypothetical proteins. IX87_20430-IX87_20655 encodes 
multiple enzymes for aromatics degradation and pyruvate metabolism.  
 
Genes that were found in AB030 and not AB031 with published roles in virulence were assessed 
and presented in Table 5; these genes may likely generate the AB030 enhanced virulence 
observed in the G. mellonella and C. elegans infection assays. Many of the genes are involved 




























Table 5 – Annotated ORF’s found in AB030 but absent from AB031 and ATCC17978 
that have a reported role in virulence. ORF’s are organized by subsystem, function and 




Subsystem Name Function Accession Location 









Cell wall and 
capsule 






















Cell wall and 
capsule 




















ImpA Type VI pilus IX87_03915 731,402..732,496 
Membrane 
Transport 
IcmF Type VI pilus IX87_03940 737,468..741,292 
Membrane 
Transport 
ImpH/VasB Type VI pilus IX87_03950 742,732..743,730 
Membrane 
Transport 
ImpG Type VI pilus IX87_03955 743,694..745,505 
Membrane 
Transport 
ImpF Type VI pilus IX87_03960 745,522..745,998 
Membrane 
Transport 
ImpC Type VI pilus IX87_03970 746,631..748,112 
Stress 
Response 
















There are a significant number of additional proteins in AB030 that are proposed to function in 
phages or phage associated functions (IX87_00085 – IX87_21455, Table 5). A recent report 
suggested that the homing endonuclease motif (HNH, IX87_01465) is commonly found in 
tailed phages adjacent to terminase genes indicating that they may have a role in phage 
packaging and phage head morphogenesis (Kala et al., 2014). The role of these unique genes in 
















Comparing the three virulence models shows that the insect and nematode models may be the 
most beneficial to studying virulence in A. baumannii. The nematode infection model was 
carried out over a two week period while the G. mellonella assay killing time was much shorter. 
This is likely due to the mode of infection where C. elegans ingest the bacteria whereas G. 
mellonella are injected with a specific CFU (1.5x108). An immune response was also 
immediately observed in the insects through pigmentation change, becoming darker indicating 
encapsulation of the invading pathogen (Thomaz et al., 2013). This was in contrast to the C. 
elegans model, an observation that could be due to a number of factors. The method with which 
C. elegans are infected with bacteria is through the mouth and pharynx and on their surface, 
since they are infected passively by supplementing the food source. This indicates that the bulk 
of the bacterial load will affect the digestive and intestinal tracts leading to distension, infection 
of the intestinal tract (Marsh & May, 2012b) or avoidance (Nandi et al., 2015). The model has 
been shown to some differences compared to mammalian models; for example the type III 
secretion system in enteropathogenic E. coli, was not required for infection in nematodes 
contrary to mammalian studies (Mellies et al., 2006). The observed phenotype for C. elegans 
that had succumbed to the infection seemed to show the nematode burst from the mid-section 
where vulva, uterus and eggs are located in the animal. Despite this being observed in many 
replicates across strains tested, it is unclear if this is and indirect consequence of eggs hatching 
inside the nematode and bursting out (Reinhart et al., 2000) or if the A. baumannii pathogen 




The more definitive result came from infection of G. mellonella where lethality was observed 
in less than 24 hours by increased pigmentation and no response to touch. In this model the time 
was significantly shorter compared to C. elegans. There are several reasons why this could be. 
The method of delivery was through injection and therefore the dose may be more directly 
disseminated into the larvae in a much shorter time. Final factors to consider are the isolates 
themselves, both blood isolates could be better diversified for low iron environments. Although 
not possessing blood the G. mellonella larvae contain hemolymph which is a iron containing 
circulatory equivalent in insects (Kim et al., 2001). In addition A. baumannii strains with 
defective iron scavenging genes were shown to have an attenuated virulence phenotype (Gaddy 
et al., 2012). Taken together it suggests that AB030 may possess additional virulence factors 
that facilitate its ability to cause faster killing of G. mellonella.  
 
The A. baumannii genome contains a large number of potential virulence factors that have yet 
to be characterized such as the role of type VI secretion system (Weber et al., 2015), iron 
acquisition associated genes (Penwell et al., 2012) and the cross functionality of stress response 
genes as virulence factors  (Zimbler et al., 2012). These include the role of phage genes. 
Comparing the AB030 to AB031 genome revealed a majority of extra genes in AB030, 
encoding phage molecules. RAST analysis of the genomes showed an additional 38 phage 
protein-encoding genes in AB030. Phages have been reported as the causative agent of many 
virulence phenotypes including toxin secretion (Mudrak & Kuehn, 2010) , cell lysis (Wagner et 
al., 2002) and transduction of phage genes encoding virulence factors (Chen & Novick, 2009). 
The proteins encoded by the 38 additional phage genes could be playing a role in the observed 




COG analysis using RAST identified putative group functions for 48% of the AB030 genome 
while the remaining 52% were of unknown or hypothetical function. A subset of annotated 
ORF’s was novel to AB030 and was not found in AB031 (Table 5) suggesting a likely role in 
virulence. IX87_14890 (NeuC) is conserved in A. baumannii but also has homologues in 
Haemophilus parasuis and Alysiella crassa. A functionally related protein IX87_13170, was 
not found exclusively in A. baumannii but as a multispecies protein. Both enzymes function in 
polysialic acid capsule synthesis, which aids in the pathogen evading immune responses. Since 
mammalian cells also produce surface polysaccharide in similar structures (ɑ-2,8 configuration) 
that can be found on neurons, glial cells and natural killer cells, bacteria synthesizing similar 
surface polysaccharides could survive undetected in the host. IX87_14885 (FnlB), which is 
mostly found in A. baumannii also has homologues in Haemophilus parasuis and Alysiella 
crassa. The IX87_14885 (FnlB) is an epimerase that converts GlcNAc (product of the NeuC 
enzyme) to UDP-N-acetyl-L-fucosamine (UDP-L-FucNAc), homologues in P. aeruginosa 
utilize UDP-L-FucNAc for a specific type of O antigen in LPS production (Mulrooney, Poon, 
McNally, Brisson, & Lam, 2005). Also part of LPS O antigen synthesis is IX87_14860, acting 
as a flippase in the translocation of FucNAc-ManNAcA-GlcNAc trisaccharide-lipid across the 
inner membrane (Burrows & Lam, 1999). 
 
Protein encoding gene IX87_21990 shows identity to a chitinase domain as well as a 
peptidoglycan binding domain. Chitin is a polymer composed of N-acetylglucosamine found 
ubiquitously in insects, fungi and crustaceans. They are also found in plants and defend from 
fungal and insect invasion (Kasprzewska, 2003). The chitinase class I enzymes are involved in 
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breaking down chitin by catalyzing the hydrolysis of the 1,4-beta-linkages in chitin. In terms of 
pathogenicity, Vibrio cholerae chitinases may play a role in facilitating binding to the epithelial 
layer of the intestine, allowing colonization. In early stages of cystic fibrosis infection by P. 
aeruginosa, chitinases were more expressed compared to later chronic stages suggesting this as 
a method of establishing infection (Tran et al., 2011). Interestingly, chitin monomers are 
composed of GlcNAc, the primary precursor of LPS (Mulrooney et al., 2005) and considering 
that IX87_21990 also has homology to the peptidoglycan binding domain there may be a cross 
functionality where the enzyme acts as a bifunctional chitinase/lysozyme (Frederiksen et al., 
2013) working to first establish infection and then later stabilize the bacterial membrane by 
maintaining LPS structures. Another player involved in chitinase/lysozyme associated 
breakdown was IX87_02085, encoding a holin enzyme. A report examining the chitinolytic 
protein secretion system in Serratia marcescens identified a holin-like inner membrane protein 
which was proposed to remodel the peptidoglycan layer of the pathogen to allow movement of 
the chitinolytic system through the periplasm and to the final outer membrane secretion step 
(Hamilton et al., 2014). Holins also act as regulators of the lysogenic cycle and in this way could 
also control cell lysis (Young, 2014). 
 
AB030 also contains three additional oxidative stress enzymes relative to AB031. One of the 
key innate mechanisms of host resistance to bacterial proliferation is through nutrient starvation. 
A key step in this process is the sequestration of iron in the blood by hemoglobin. Bacteria are 
able to counteract this by utilizing heme oxygenases that breakdown dissociated hemoglobin 
products, into biliverdin, CO and iron (Skaar, 2010). The IX87_00955 protein is a heme 
oxygenase, a major virulence determinant in many pathogenic organisms. Adjacent to 
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IX87_00955 is a protein classified as an energy transducer TonB (IX87_00960) and an outer 
membrane receptor protein (IX87_00975). Among strains of pathogenic A. baumannii, 
conservation of heme oxygenase was found in strains 4190, ACICU and AB0057 along with an 
outer membrane protein and TonB (Di Nocera, Rocco, Giannouli, Triassi, & Zarrilli, 2011). 
The process of heme acquisition and iron extraction requires the role of first capturing heme, a 
process facilitated by periplasmic TonB and the TonB dependant outer membrane transporter. 
The heme is eventually passed to the cytoplasm by ABC transporters where the heme oxygenase 
can breakdown heme and liberate iron (Contreras et al., 2014). The role of iron scavenging may 
also be fundamental for B. cereus virulence in insects, and parallels our findings for enhanced 
AB030 virulence (Harvie, 2005). 
 
Also unique to AB030 is the catalase protein (KatE), (IX87_20560). It seems that host 
intracellular replicating pathogens may utilize catalase more to evade host defenses such as 
hydrogen peroxide and superoxide anion generating reactive oxygen species (ROS) (Eshghi et 
al., 2012; Hébrard et al., 2009). However in intercellular replicating pathogens such as P. 
aeruginosa PA14 the KatE enzyme may not play a major role in virulence by reduction of 
hydrogen peroxide, (Lee et al., 2005) perhaps due to the redundancies present in bacteria 
responding to peroxide stress (Hébrard et al., 2009) such as the KatG (IX87_03325) gene 
present in both AB030 and AB031. Therefore the presence of an extra catalase gene in AB030 
may produce a greater protective effect against host production of ROS. 
 
Interestingly it seems that AB031 does not have a SoxR (IX87_03850) protein encoding gene. 
The SoxRS two component system is a redox sensor kinase that is able to detect changes in 
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oxidative stress. It does this when oxidation of the SoxR iron-sulphur clusters [2Fe-2S] in 
response to redox-active compounds (Gu & Imlay, 2011) triggers a de-repression of the soxS 
gene that is then overexpressed and upregulates multiple pathways in DNA-repair, efflux 
pumps, oxidation-resistant enzymes and superoxide dismutase (Blanchard et al., 2007). The 
activation of the SoxR in A. baumannii is yet to be characterized but it may be that the role of 
SoxR would be in response to oxidative and nitrosative stress brought on by redox active 
compounds such as antibiotics and host antimicrobial molecules that then cause activation of 
SoxS (Ding & Demple, 2000; Gaudu & Weiss, 1996). The loss of this sensor kinase could 
indicate why AB031 presented attenuated virulence when compared to AB030.  
 
A significant number of genes were found in AB030 encoding assembly and synthesis functions 
that were not found in AB031 (IX87_03910 – IX87_03970, Table 5) encoding type VI secretion 
system components. Typically the type VI secretion system in A. baumannii has not been 
implicated in virulence in host infection but recent evidence has uncovered that in absence of 
antibiotic pressure, expression of the typeVI genes occurs in a heterogeneous population 
through loss of an endogenous plasmid. The expression of the typeVI genes was found to act as 
a virulence mechanism, killing other species of bacteria obtained from a co-infected patient and 
those in the heterogeneous A. baumannii population, that retained the plasmid (Weber et al., 
2015). This may not directly suggest a role for typeVI genes in host virulence but perhaps these 
gene products could act upon endogenous flora present in the insect or in an infected patient 




Finally, study of specific genes in A. baumannii induced by ethanol exposure has seen the 
expression of genes involved in ethanol metabolism (Camarena et al., 2010) indicating that it 
can be used as a carbon source. The addition of ethanol to the C. elegans media enhanced 
virulence of both AB030 and AB031 indicating that virulence genes could be active in both 
strains. Genes coding for siderophore associated iron sequestration were found to be 
upregulated after ethanol exposure (Camarena et al., 2010) which could be occurring in the C. 
elegans virulence assay. Considering additional genes encoding iron scavenging are present in 
AB030 this could be induced to generate a faster kill rate since AB030 is better able to obtain 
iron from the host and survive.  
 
Overall the examination of these three virulence models allowed for the examination of 
robustness of A. baumannii virulence in non-mammalian models. Despite coming from the same 
site of infection these two strains share very distinct phenotypic and genotypic characteristics. 
They possess different drug resistance profiles, AB030 is XDR while AB031 is only resistant 
to two drugs and in a G. mellonella model shows virulence that is significantly less compared 
to AB030. In C. elegans studies, AB030 did show faster killing compared to AB031, and in the 
presence of ethanol the LC50 was decreased in both strains. The infections caused by A. 




3.3 Regulation of Resistance Nodulation Division Efflux Pumps in Acinetobacter 
baumannii.  
Parts of section 3.3 have been published elsewhere:  
Fernando, D., & Kumar, A. (2012). The Journal of Antimicrobial  
Chemotherapy, 67(3), 569-72. 
3.3.1 Growth Phase Dependent Expression of Efflux Pumps 
Efflux pumps have been associated with enhancing antimicrobial resistance by pumping drugs 
or possibly the derivatives or toxic by-products of antibiotics into the extracellular space. They 
likely also function to aid cells in maintaining a metabolic equilibrium and also may act as 
means to establish growth and promote proliferation (Piddock, 2006; Poole 2008). Although 
they effectively pump out antibiotics, their expression is not regulated by antibiotics (Poole 
2008) which suggests a more complex regulatory network. The predominant studies of efflux 
pumps focus on their role in resistance in clinical isolates by screening for their ability to work 
on antibiotics. In addition, mutations in their local regulators will often be linked to their 
overexpression and so it is difficult to ascertain what their natural function may be. Considering 
they are capable of extruding a range of structurally unique substrates but also have considerable 
substrate overlap between pumps and make up roughly 10% of the genome (Paulsen, 2003), 
their role must be more integral. More direct evidence is seen from a study by Alonso and 
colleagues who showed that despite being collected from the environment, strains of P. 
aeruginosa were capable of extruding the synthetic antibiotic quinolone, a drug not expected to 
be in the environment (Alonso, Rojo, & Martínez, 1999). Conversely strains of Burkholderia 
cepacia isolated from the lungs of a cystic fibrosis patient were shown to have greater efflux 
activity by interaction with natural plant hormone salicylate, with its local regulator (Nair et al., 
2004). There may be a more physiological role that efflux pumps play as a mechanism to remove 
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metabolic, oxidative and nitrosative stress, as well as membrane stress responses and virulence 
determinants (Poole 2008).  
 
The basic understanding of efflux as a mechanism to maintain homeostasis has been examined 
in the context of oxidative and nitrosative stress. As with all aerobic organisms by-products in 
the form of reactive oxygen (ROS) and reactive nitrogen species (RNS) species are formed over 
time and there is evidence to show that efflux is activated in the presence of ROS and RNS 
(Chang et al., 2005; Chen et al., 2008; Fetar et al., 2011; Fraud & Poole, 2011) perhaps involved 
in the extrusion of damaged (or damaging) products from the cell as well as increased antibiotic 
resistance (Poole 2014). 
 
The natural functions of RND efflux pumps in Acinetobacter baumannii species has not been 
studied before. Efforts to understand the natural functions of RND efflux pumps were examined 
by characterizing the expression of the three known pumps, adeB, adeG, adeJ and the 
uncharacterized efflux pumps AciBau_2436 and AciBau_2746 over various growth phases of 
ATCC19606 corresponding to early, mid, late log and stationary phases of growth. The rationale 
of this experiment was to help explain what happens to RND genes involved in antibiotic 
resistance in A. baumannii through increasing cell density. The expression of genes was 
measured over a total of 16 hours and 1mL aliquots were taken at 2, 4, 8 and 16 hours post 
inoculation (Figure 11). The average of two biological replicates was taken over the time course 
and the 2 hour time point was taken as the control with Ct values (Figure 12, inset) from this 
time point used as comparator to Ct values of other time points (Figure 12). Using 16S rRNA 
125 
 
as the reference gene, the expression of the adeB gene is highest at mid log phase and then 

































Figure 11 – Growth curve of ATCC19606 showing O.D.600 values over 16 hour time 
course. Values indicate O.D.600 at 2, 4, 8, 16 hour time points. Arrows indicate points of 
sample collection and O.D.600. Data is representative of three biological replicates. Error 


























The expression of AciBau_2436 follows a similar trend as adeB at, mid-log, late log and 
stationary phase, respectively (Figure 12). The expression of adeJ follows an inverse cell 
density dependant relationship where expression values decrease with increasing cell density. 
The expression of adeG at 2 hours shows a relatively low abundance compared to the other two 
characterized pumps (Figure 12, inset) but its expression stays relatively constant throughout 
the time course (Figure 12). This shows that the expression of adeG is very low compared to 
other efflux pumps but is relatively constant throughout all phases of growth. The expression 
of AciBau_2746 at 2 hours was above Ct 35 and remained at a Ct above 30 (below detection 
limit) during all phases of growth similar to the no reverse transcription control sample (used 
as a control for genomic DNA contamination). This suggested that AciBau_2746 was not 






















Figure 12 – Relative expression of RND efflux pumps in A. baumannii ATCC19606 
with increasing cell density over 16 hour time course. Expression of adeB, adeJ, adeG 
and putative efflux gene AciBau_2436. Ct values at 2 hour time point (inset) indicate control 
strain Ct. Gene AciBau_2746 was detected at Ct≥30 for all time points, therefore its 
expression was considered absent. Data is representative of two biological replicates. Error 






















3.4 Characterization of AdeFGH natural function as a response to antibiotic and 
nitrosative stress 
3.4.1 Characterization of the AdeFGH efflux pump and the related improved 
tolerance of A. baumannii strains in presence of nitrosative stress. 
As mentioned earlier, the role of RND efflux pumps is likely more physiologically important 
for survival. The number of efflux pumps encoded in a bacterial genome and their broad 
spectrum resistance profiles suggest a more substantial role than simply antibiotic efflux. 
Antibiotic treatments in a medical context have only been around for close to 100 years, so 
efflux pumps likely have physiologically relevant roles in bacterial cell survival. Out of the 
three known RND efflux pumps in A. baumannii, AdeG has the highest amino acid homology 
(80%) to the MexF RND pump in P. aeruginosa (Figure 13) with a region unique to AdeG and 
MexF ranging from position 500-520 in the alignment. It is not likely this region serves as a 
determinant of substrate specificity but could be part of the pump cytoplasmic loop region 
(Tikhonova, Wang, & Zgurskaya, 2002). Substrates of the MexEF-OprN efflux pump were 
identified as chloramphenicol, trimethoprim, ciprofloxacin through knockout studies (Maseda, 



























Figure 13 – Multiple amino acid alignment of RND efflux pump components from P. 
aeruginosa (MexB, MexD, MexY, MexF), E. coli (AcrB) and A. baumannii (AdeG) 
show greatest homology between AdeG and MexF. Alignments were made using 
Multiple Sequence Comparison by Log-Expectation (MUSCLE), regions with black boxes 





















Studies of the AdeFGH efflux pump in clinical isolates of A. baumannii have shown a similar 
substrate profile and also include clindamycin and fluoroquinolones (Cortez-Cordova & Kumar, 
2011). Considering this homology and that expression of adeG was constitutive with increasing 
cell density (Figure 12) in addition to its ubiquitous expression in the collection of Canadian 
clinical isolates (Figure 4), AdeFGH may have a prominent physiological role in A. baumannii. 
To examine if AdeFGH` has a physiological role, the type strains ATCC19606 and ATCC17978 
as well as two drug resistant isolates AB030 and AB031 were examined for their ability to 
respond to sub-MIC concentrations of drugs containing nitro groups. Initially only 
ATCC19606, AB030 and AB031 were used in the study and later ATCC17978 was introduced 
to provide a strain for knockout of the adeFGH local regulator AdeL. The rationale was to test 
the effect of adding an antibiotic that contained a nitro group, with the hypothesis that generating 
nitrosative stress in the cell would induce expression of AdeFGH. The induction of the MexF 
pump by nitrosative stress has been shown before (Fetar et al., 2011) and it was thought that 
upregulation of the AdeFGH efflux pump would then in turn improve strain relative tolerance 
in presence of non-nitrosative stress inducing antibiotic, trimethoprim. Strains were exposed to 
sub-MIC concentrations of trimethoprim, chloramphenicol or both in combination for 24 hours 
to test their tolerance. Both trimethoprim and chloramphenicol are antibiotics used to treat 
various bacterial infections. Trimethoprim works only on gram-negative bacteria by inhibiting 
the bacterial dihydrofolate reductase enzyme, a precursor of thymidine synthesis (Brogden et 
al.,, 1982). Chloramphenicol has activity against both gram-positive and negative bacteria by 
inhibiting the peptidyl transferase reaction on the bacterial 50S ribosomal subunit preventing 
peptide bond formation (Jardetzky, 1963). The MIC’s of each drug were first determined in 
biological replicates to confirm values (Table 6a). The assay was designed to test if the tolerance 
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of strains exposed to a sub-lethal MIC of trimethoprim could be improved by addition of a sub-
lethal concentration of chloramphenicol. The chemical structure of chloramphenicol contains a 
nitro group that once inside the cell could generate nitrosative stress due to mimicking a nitrated 
moiety or causing generation of RNS (Fetar et al., 2011). Trimethoprim contains amine groups 
instead of nitro groups and hence should not induce expression of adeFGH. Controls for this 
experiment included using a non-antibiotic compound, S-nitrosoglutathione (GSNO) capable of 
generating RNS (Bowman et al., 2011; Firoved et al., 2004) and the antibiotic florfenicol (FLO) 
with a similar structure to chloramphenicol, but lacking the nitro group in its structure (Table 
































Table 6 – Antibiotic drug structures and MIC’s against ATCC17978, ATCC17978, 
AB030 and AB031. (A) Trimethoprim, chloramphenicol and florfenicol MIC’s were 
determined using two-fold serial dilution method. (B) Structures of trimethoprim, 
chloramphenicol, florfenicol and s-nitrosoglutathione (GSNO) show nitro groups in 































ATCC17978 64 64 32 
N.D. 
ATCC19606 64 64 128 
AB030 64 32 8 
AB031 64 64 32 
  
                                                                                  
 
 













3.4.1 Sub-lethal combinations of TMP and CHL improve tolerance compared to 
TMP alone. 
Following MIC determination of the four isolates the tolerance of strains were assessed in sub-
lethal combinations of the two drugs, trimethoprim (TMP) and chloramphenicol (CHL). 
Combining 1/2 TMP with 1/4 CHL did show equal tolerance to 1/2 CHL alone and using these 
findings further studies were done maintaining the concentration of TMP at 1/2 MIC, and 
reducing the concentration of CHL. This was done to optimize the concentration of 
chloramphenicol that could elicit a significantly detectable improvement in tolerance. Values at 
1/10th and 1/100th CHL MIC in combination with 1/2 TMP showed improvements in tolerance 
in comparison to bacteria grown in 1/2 TMP alone (Figure 14). In total 3 strains were tested, 
ATCC19606, AB030 and AB031 since these strains represented a type strain and two clinical 
isolates with contrasting drug resistance profiles. All strains were tested with 1/2 TMP, and 1/2 
TMP in combination with 1/10 CHL or 1/100 CHL and 1/5 TMP alone as a positive control for 
tolerance. Strain ATCC19606 when grown with 1/2 TMP and 1/10 CHL or 1/100 CHL showed 
significant increase in O.D.600, compared to ATCC17978 with 1/2 TMP alone (Figure 14a). 
Markers filled in black indicate statistically significant difference from 1/2 TMP for the 
particular time point (Figure 14, p≤0.05). The ATCC19606 strain with 1/2 TMP and 1/10 CHL 
showed improved tolerance 2 hours earlier (hour 15) than 1/2 TMP and 1/100 CHL (hour 17). 
Interestingly after hour 15, the 1/2 TMP O.D.600 decreased while co-incubations with 1/10 CHL 
and 1/100 CHL went up significantly for specific time points (Figure 14a). The clinical isolate 
AB031 also showed improved tolerance in presence of 1/10 CHL compared to 1/2 TMP alone 






















Figure 14 – Improved tolerance of (A) ATCC17978, (C) AB031 compared to (B) AB030 
exposed to 1/2 MIC TMP with 1/10 or 1/100 MIC CHL compared to 1/2 TMP alone over 
24 hours. Significant difference between 1/2 TMP and combinations of CHL are shown by 
markers filled in black. The ATCC17978 strain has improved tolerance in combination with 
1/10 CHL and 1/100 CHL. Similarly addition of 1/10 CHL to AB031 growing with 1/2 TMP 
improves tolerance compared to TMP alone. The effect was seen but not significantly in 
AB030. Data are representative of 3 biological replicates, error bars represent ± SD. Symbols 






























The AB031 strain grew equally well in 1/2 TMP + 1/10 CHL compared to 1/5 TMP and better 
than 1/2 TMP by itself. The AB030 strain did not show any change in tolerance in combination 
however the addition of 1/10 and 1/100 CHL did not decrease the tolerance of AB030 and 
instead maintained tolerance similar to the effect of 1/2 TMP alone (Figure 14b). It could be 
that AB030 responds to sub-lethal additions of CHL in other concentrations not tested for, based 
on MIC’s (Table 6a). Findings showing that ATCC17978 and AB031 both respond to sub-lethal 
CHL with 1/2 TMP by improved tolerance, suggested that these strains responded the same way 
as strains harbouring the nitrosative stress-dependant efflux pump MexEF-OprN (Fetar et al., 
2011) and that the A. baumannii strains may express AdeFGH capable of responding to 
nitrosative stress. To test this hypothesis, the chemical florfenicol, an antibiotic that lacks nitro 
groups and therefore not likely to generate nitrosative stress, was substituted for CHL and 
conversely GSNO was substituted for CHL to act as a positive control for nitrosative stress. The 
MIC of FLO was determined for all four strains (Table 6a) and concentrations of GSNO were 
taken at 10 mM, based on studies showing the response of MexF (AdeG homologue) to GSNO 
(Fetar et al., 2011). When ATCC19606 was incubated with 1/2 TMP, O.D.600 did not exceed 
0.5 and showed minimal increase from 0-10 hours while growth in 1/2 TMP with either 10mM 
GSNO or 1/10 FLO improved tolerance to O.D.600 between 0.6-0.8 after 24 hours and increased 




















Figure 15 – Tolerance of both (A) ATCC19606 and (B) AB031 grown in 1/2 TMP is 
improved with addition of 1/10 FLO or 10 mM GSNO. Comparing (A) ATCC19606 
exposed to 1/2 TMP shows improved tolerance when CHL, FLO or GSNO are added. 
Concentrations of FLO or GSNO without TMP show improved tolerance compared to 
combinations with 1/2 TMP. The (B) AB031 strain grown in 1/2 TMP shows tolerance 





























The data from tolerance studies of ATCC19606 grown in sub-lethal concentrations of TMP in 
combination with GSNO do suggest that nitrosative stress may regulate genes that improve 
tolerance to promote growth (Figure 15a). However, tolerance is also improved with addition 
of the antibiotic florfenicol, an agent that does not generate nitrosative stress. This suggests that 
other mechanisms may respond to florfenicol and chloramphenicol, revealing that nitrosative 
stress may not be the only factor that is able to improve tolerance in ATCC19606. Somewhat 
in contrast to this finding are AB031 data showing that in the presence of 1/2 TMP, tolerance 
improves in 10 mM GSNO, but this effect is not observed when AB031 was incubated with 
1/10 FLO (Figure 15b). In addition both strains exhibited greater tolerance when incubated with 
either 10 mM GSNO or 1/10 FLO alone, without 1/2 TMP (Figures 13a and b). The contrasting 
results obtained when ATCC19606 and AB031 were exposed to nitrosative stress in the form 
of GSNO, and antibiotic in the form of florfenicol, suggest a more complex regulatory pattern 
may be at play.  
 
3.4.2 Gene expression analysis shows adeG responds to nitrosative stress in AB031 
and ATCC17978. 
The AdeG homologue MexF has been shown to overexpress in response to nitrosative stress 
caused by GSNO and was proposed as the reason for MexF overexpression in presence of CHL, 
an antibiotic that contains a nitro group. Chloramphenicol may resemble an endogenous nitrated 
nitrosative stress product that is pumped out of the cell to prevent cell damage caused by these 
high energy molecules (Fetar et al., 2011). These findings indicate what the natural function of 
this particular efflux pump could be since nitrosative stress occurs in the environment and often 
occurs through metabolism under anaerobic conditions (Bowman et al., 2011). The combination 
of chloramphenicol with trimethoprim improves tolerance of cells when 1/2 TMP MIC is 
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combined with 1/10 MIC of CHL. The role of efflux pumps as responders to nitrosative stress 
was measured using qRT-PCR after exposure for 15 minutes to combinations for TMP and/or 
CHL. Expression of adeG increases ~2-fold (Figure 16) upon addition of 1/10 CHL in 
ATCC19606 cells compared to ~1.65-fold for cells exposed to 1/2 TMP. The overexpression of 
adeG upon addition of chloramphenicol is suggestive that the nitro groups on the 
chloramphenicol compound (Table 6b) may be generating DNA or protein nitrosylated moieties 
acting as activators of efflux. To rule out the possibility of a synergistic effect caused by 
combination of TMP and CHL instead of nitrosative stress, AB031 cells were exposed to each 
antibiotic at 1/5 MIC and 10mM GSNO. The effect of single compound exposure on expression 
levels is shown in Figure 17. The expression of adeG increases in response to TMP, then CHL 
followed by 10mM GSNO which is proposed to generate nitrosative stress. The GSNO 
compound was used as a non-antibiotic nitrosative stress since it contains nitro groups that 
readily dissociate and nitrosylate biomolecules in the cell generating nitrosative stress (J. N. 
Smith & Dasgupta, 2000). The addition of 10mM GSNO caused a tremendous increase in adeG 
expression of 20.8-fold, significantly higher than CHL, TMP or LB control exposures (Figure 
17). The expression of adeJ stayed constant after TMP and CHL exposure but went up 
significantly, in the presence of GSNO. Expression of adeB went down with exposure to TMP, 

























Figure 16 – Expression of adeG increases after exposure to TMP and CHL. (A) 
Expression of ATCC19606, adeG after 1/2 TMP exposure is 1.65±0.16 and 1/2 TMP + 1/10 
CHL is 3.53±0.65. (B) AB031 expression of adeG is 3.6-fold±0.39 in response to 1/2 TMP 

























































Figure 17 – Expression of adeG in AB031 increases sequentially when exposed to 1/5 
TMP, CHL and 10mM GSNO, respectively. The addition of antibiotic increases expression 
of adeG, TMP 2.08±.10, CHL 3.97±0.46, 10mM GSNO 20.8±1.67. The expression of adeB 
decreases 0.002±0.0004, 0.04 ±0.003, and 0.03±0.004 for each compound, respectively. 
Expression of adeJ remains relatively constant for each antibiotic, 0.93±0.09, 1.17±0.04 and 





























The role of stress responses like the nitrosative stress response has been to remove or neutralize 
the buildup of toxic metabolites and damaged macromolecules returning the cell to equilibrium, 
possibly involving RND efflux pumps (Fetar et al., 2011; Poole 2008). Links between 
nitrosative stress and RND efflux induction have been demonstrated in E. coli  and P. 
aeruginosa (Fetar et al., 2011; Zhang et al., 2011). Interestingly in both of these studies the role 
of gene regulation was explicit in the activation of both MdtEF and MexEF-OprN. The MexEF-
OprN pump is a homologue of the AdeFGH pump and therefore it was thought if nitrosative 
stress was inducing MexEF-OprN through its activating regulator MexT, then perhaps AdeFGH 
expression was also modulated by its local regulator, AdeL (also a lysR regulator). Attempts 
were made to create a markerless knockout of adeL in AB031 and ATCC19606 but repeated 
attempts proved to be unsuccessful. Previous work using ATCC17978 to knockout genes using 
the recombineering approach were successful and therefore this strain was used for knockout 
studies of the adeL gene.  
 
3.4.3 Characterization of nitrosative stress effect on tolerance and RND pump 
expression in ATCC17978 and isogenic knockout of gene encoding adeFGH 
regulator, AdeL. 
To first show the phenotype of interest was present in ATCC17978, growth curves were carried 
out in a similar way to ATCC19606 and AB031 using sub-lethal drug concentrations of 
trimethoprim, chloramphenicol, florfenicol and GSNO. Despite ATCC17978 having a TMP 
MIC of 16mg/L (Table 6a) at this concentration the growth of the type strain was unhindered 
when compared to the LB only control (Figure 17a). The reasons for this could be due to 
differences in media used for MIC and growth curves; also aeration was used in growth curves 
which may have generated differences in results. When 1/10 CHL or 5mM GSNO was added 
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to 1/2 TMP tolerance improves compared to addition of 1/10 FLO (Figure 18a). The tolerance 
of the ΔadeL strains grown in presence of any antibiotic combination with TMP show tolerance 
defects (Figure 18b). Addition of CHL, FLO or GSNO causes a major loss of tolerance as 
compared to the wt strain (Figure 18a, b).   
 
The expression of all three efflux pumps, adeB, adeG and adeJ were measured in the ΔadeL 
strain and compared to wt for baseline characterization of efflux pump expression. Expression 
of the adeG goes up ~2-fold in agreement with previous findings that AdeL is a repressor of 
adeFGH. Unexpectedly, the expression of adeB also increased ~2-fold in the ΔadeL knockout 
strain (Figure 19). The MIC’s of TMP, CHL, FLO and GSNO were determined in the ΔadeL 
strain and were identical to those of ATCC17978 meaning sub-lethal concentrations were 
identical to the wt strain. Next the expression of pumps was determined by sub-lethal exposure 
of ATCC17978 and ΔadeL to TMP, CHL, FLO and GSNO. Efflux pump expression was 
measured by exposing each strain to 1/5 MIC of TMP, CHL or 5mM GSNO and performing 
qRT-PCR. Compared to 1/5 TMP exposed cells, 1/5 CHL exposed cells caused increased 
expression of adeB (2.6 to 4.5-fold), adeJ (1.3 to 2.3-fold) and adeG (1.9 to 7.0-fold) in the wt 



















Figure 18 – Sub-lethal TMP, CHL, GSNO, FLO effect tolerance in ATCC17978 and 
ΔadeL, reveal an adeL dependent tolerance. (A) The type strain ATCC17978 exposed to its 
MIC for TMP grows without any tolerance defects compared to LB control. With addition of 
1/10 CHL or 5mM GSNO tolerance improves compared to addition of 1/10 FLO. (B) 
Knockout of adeL in ATCC17978 shows no change in tolerance in LB. With addition of 1/10 
CHL, 5mM GSNO or 1/10 FLO there is no difference in tolerance. The adeL knockout strain 













































Figure 19 – Expression of RND pumps in ATCC17978 in adeL knockout strains 
indicate overexpression of adeG and adeB. The expression of efflux pumps and the local 
adeFGH regulator, adeL was measured in ATCC17978 and compared to expression in an 
adeL knockout strain. The expression of adeG and adeB increase after adeL knockout to 
2.19±0.22 and 2.59±0.29, respectively. Expression of adeJ remains relatively unchanged at 
1.19±0.12. Expression of adeL was detected at Ct 35, above the detection cutoff. Data are 








































Figure 20 – Expression of RND efflux pumps in ATCC17978 and ΔadeL after sub-lethal 
exposure to drugs reveal expression of adeB and adeG is independent of adeL. All 
expression is calculated relative to ATCC17978 LB control. The expression of adeB and adeJ 
in wt cells increase with exposure to 1/5 CHL or 1/5 FLO but not 5mM GSNO or ethanol only 
control. The expression of adeG increased after exposure to 1/5 CHL or 1/5 FLO but not GSNO 
or ethanol control. In ΔadeL knockout strain, expression of adeG showed same expression 
profile as wt. Expression of adeB increased after exposure to GSNO and adeJ showed no 
significant changes under any condition. Data is representative of two biological replicates and 
expression is calculated relative to ATCC17978 in LB. Error bars represent ±SD. Significance 






The overexpression of three efflux pumps in ATCC17978 after 1/5 CHL exposure suggests that 
perhaps an alternative global mechanism of regulation exists in ATCC17978 that is not present 
in ATCC17978 or AB031. The increased expression of adeG and adeB in response to CHL 
exposure is a phenotype not observed in AB031, where only adeG was induced by CHL (Figure 
17). The tolerance of ATCC17978 grown in TMP with CHL did not show improved tolerance 
compared to FLO (Figure 18a) and expression of efflux pumps was significantly higher in the 
CHL condition compared to the TMP condition, suggesting that there may be no link between 
tolerance and RND efflux pump expression (Figure 20). Unlike CHL the tolerance of 
ATCC17978 in inhibitory concentrations of TMP and FLO did not improve tolerance (Figure 
18a) but FLO did induce significant expression of any pumps (Figure 20). Despite the lack of 
clear tolerance phenotype or specific pump expression in presence of nitrosative stress, the 
expression of adeG was still higher than other pumps when induced with CHL.  
 
Considering the initial hypothesis that molecules from nitrosative stress could act as effector 
molecules binding to AdeL and modulating expression of adeFGH, the adeL gene was knocked 
out using recombineering and the flip recombinase system to create a markerless knockout in 
ATCC17978. The expression of RND pumps after knockout of adeL suggest that adeG as well 
as adeB efflux pump expression is regulated by adeL (Figure 19). These observations were 
confirmed with two biological replicates and confirmed AdeL acts as a repressor of adeFGH 
expression, but also suggest a possible novel regulatory mechanism of adeABC efflux gene 




The role of gene regulation with respect to nitrosative stress has not been examined in A. 
baumannii. The local regulator of adeFGH is the lysR-type regulator AdeL, located downstream 
and adjacently transcribed; it is proposed to act as a repressor of adeFGH expression (Coyne, 
Rosenfeld, et al., 2010). Growth curves were carried out on ATCC17978 in an identical assay 
(Figure 15), with sub-lethal concentrations of drug and showed a similar tolerance to 
ATCC19606 and AB031. The tolerance of ΔadeL strains in presence of no drug was unchanged 
compared to ATCC17978 (Figure 18b). However, addition of CHL to TMP containing cultures 
showed a major reduced tolerance compared to ATCC17978 (Figure 18b). Similarly, addition 
of GSNO to TMP cultures showed an even greater decrease in tolerance compared to 
ATCC17978 growing in the same condition (Figure 18b). The tolerance of cells with FLO 
addition to TMP cultures also showed a decrease in tolerance compared to CHL or GSNO 
(Figure 18b).  
 
The expression trend of efflux pumps showed no major differences between ΔadeL compared 
to wt (Figure 20). Expression of adeB increased in both strains when comparing TMP and CHL, 
2.63 and 4.53-fold (ATCC17978), 0.98 and 6.10-fold (ΔadeL) respectively. Expression of adeJ 
did not change as drastically, 1.26 and 2.26-fold, 1.45 and 1.79-fold respectively. The 
expression of adeG showed the greatest change where ATCC17978 was 1.90-fold before and 
6.98-fold after CHL exposure and ΔadeL 1.63-fold and 11.02-fold respectively. Comparing 
TMP to GSNO exposure, a decrease in adeB expression level was observed in ATCC17978 
(2.63 and 0.65-fold) and an increase in ΔadeL (0.98 and 2.32). Expression of adeJ did not 
change significantly comparing TMP and GSNO, ATCC17978 1.26 and 1.05, ΔadeL 1.45 and 
1.22. Expression of adeG did not significantly change comparing TMP and GSNO, 
160 
 
ATCC17978 1.90 and 2.24-fold, ΔadeL 1.63 and 2.61, respectively. Interestingly FLO exposed 
cells showed an increase in adeB expression relative to TMP (2.63 to 6.48-fold) also in adeJ 
(1.26 to 2.20-fold) and tremendously in adeG (1.90 to 21.71-fold) (Figure 20). Similar results 
were observed in the ΔadeL strain for adeB (0.98 to 3.85), adeG (1.63 to 10.27) but not adeJ 
(1.45 to 1.53). Finally to compensate for any changes caused by the chloramphenicol diluent, 
ethanol, expression under ethanol exposure was measured; no major changes were observed in 
pump expression in the ATCC17978 wildtype or the ΔadeL knockout strain. Overexpression of 
adeG was expected because studies with no drug show upregulation of the pump in adeL 
deletion strains (Figure 19) and previous studies have shown mutations in adeL associated with 
adeG overexpression (Coyne, Rosenfeld, et al., 2010) however this was not observed with 
ATCC17978 vs ΔadeL exposed to GSNO (2.2 vs 2.6-fold) or TMP (1.9 vs 1.6-fold). Overall 
the data indicate that in ATCC17978 the regulation of adeFGH is not only controlled by its 
local repressor AdeL but also by another protein. This is likely a global regulatory mechanism 
that is able to control other pumps such as AdeB. The expression of adeB correlates with 
expression of adeG under CHL and FLO conditions (Figure 20) and therefore could be 
controlled by similar regulatory mechanisms that differs from adeL.  
 
The deletion of adeL caused the upregulation of the cognate operon adeFGH but also the 
unexpected upregulation of adeB suggesting a more intimate regulation between the two RND 
pumps. The deletion of adeL caused a major defect in tolerance of cells grown in TMP combined 
with either CHL, GSNO and FLO while no effect was seen in LB and in rich media, compared 
to the parent strain (Figure 18). The tolerance of cells did not correlate with expression of 
pumps. The expression of adeG and adeB went up with CHL or FLO but expression was 
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relatively unchanged with exposure to GSNO or TMP (Figure 20). This is in contrast to 
observations in ATCC17978 where addition of CHL or GSNO to TMP was able to improve 
tolerance of cells compared to FLO combinations (Figure 18a). A major loss of tolerance was 
observed in ΔadeL cells exposed to CHL and TMP or GSNO and TMP compared to the cells 
exposed to TMP alone, suggesting that AdeL may play a more global role apart from local 
regulation of adeFGH expression. The deletion of adeL comes at a significant cost when 
exposed to nitrosative stress (GSNO, CHL) suggesting it may play a role as activator or positive 
effector molecule for another set of genes in ATCC17978 that allow the cell to survive. 
Conversely the tremendous increase in expression of adeG after CHL or FLO exposure suggests 
that another regulator is activated by the presence of these molecules or their by-products. This 
activation is likely AdeL independent since a knockout of the regulator did not translate to 
increased adeG expression.  
 
The presence of nitrogroups on both GSNO and chloramphenicol and the role of the AdeFGH 
homologue, MexEF-OprN, suggested that these compounds or their nitrosative stress 
derivatives could activate expression of adeFGH. The role of AdeFGH does not seem to be 
directly involved in efflux of nitrosative stress products in ATCC17978 as was proposed since 
pump expression could not be used to explain nitrosative stress exposure or tolerance 
phenotypes. Interestingly the role of the adeFGH regulator AdeL may be more significant in 
response to nitrosative stress independent of adeFGH regulation in ATCC17978 since 
knockouts of this gene proved detrimental to tolerance. Also the role of adeL may be more 
global than once thought considering expression of not only adeG but also adeB increased in 




As mentioned earlier the similar expression profiles of adeB and adeG also suggest these genes 
in ATCC17978 may be controlled by a global regulator. Both CHL and TMP have been 
identified as substrates of the AdeABC and AdeFGH pumps however pump expression was 
much higher in CHL exposed cells compared to TMP. It was thought that ethanol used as the 
diluent for CHL may be effecting gene expression. To rule out this effect gene expression was 
carried out in strains exposed to ethanol alone, a 3 and 2-fold overexpression of adeG was 
observed in ethanol exposed ATCC17978, ΔadeL cells, respectively (Figure 20).  
 
To characterize why differences were observed between AB031 and ATCC19606 compared to 
ATCC17978, analysis of the adeFGH promoter region and AdeL was carried out. No major 
differences in nucleotide sequence was found when comparing the intergenic region from these 
three strains except for a single base pair change in AB031 from guanine to adenine at 165b.p. 
Amino acid sequence of AdeL amino acids from each strain was compared and a single amino 


























Figure 21– Alignments of AdeL amino acid sequence and intergenic region from 
ATCC17978, ATCC19606 and AB031. Mutations were found if different from other two 
strains. (A) The intergenic region was identical in ATCC17978 and ATCC19606 with a 
single nucleotide change 165GA found in AB031. (B) A single amino acid change was 

















ATCC17978  GAGGTGCTCCTAGTTATTTGGATACCTGTT 30 
ATCC19606  GAGGTGCTCCTAGTTATTTGGATACCTGTT 30 
AB031      GAGGTGCTCCTAGTTATTTGGATACCTGTT 30 
           ****************************** 
 
ATCC17978  TTCAGACTTTTAGTTATGGTCCGTATGGGA 60 
ATCC19606  TTCAGACTTTTAGTTATGGTCCGTATGGGA 60 
AB031      TTCAGACTTTTAGTTATGGTCCGTATGGGA 60 
           ****************************** 
 
ATCC17978  GAAACAGGGTTTATGGAATGGACGGAGCAT 90 
ATCC19606  GAAACAGGGTTTATGGAATGGACGGAGCAT 90 
AB031      GAAACAGGGTTTATGGAATGGACGGAGCAT 90 
           ****************************** 
 
ATCC17978  AAAAGTTTGTCAATCACGAATAAATATATT 120 
ATCC19606  AAAAGTTTGTCAATCACGAATAAATATATT 120 
AB031      AAAAGTTTGTCAATCACGAATAAATATATT 120 
           ****************************** 
 
ATCC17978  AAATTTGATAACACTATTCGTATTTTTATA 150 
ATCC19606  AAATTTGATAACACTATTCGTATTTTTATA 150 
AB031      AAATTTGATAACACTATTCGTATTTTTATA 150 
           ****************************** 
ATCC17978  ACAATTGATGTGTTTGCACTAGAAAATGCA 180 
ATCC19606  ACAATTGATGTGTTTGCACTAGAAAATGCA 180 
AB031      ACAATTGATGTGTTTACACTAGAAAATGCA 180 
           *************** ************** 
 
 











ATCC17978 MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDA 80 
ATCC19606 MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDA 80 
AB031     MRVFNKVVETNSFSLAADSLGLPRASVTTTIQALEKHLQVRLLNRTTRKISLTPDGAVYYDRTARILADVADIESSFHDA 80 
 
ATCC17978 ERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATA 160 
ATCC19606 ERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATA 160 
AB031     ERGPRGQLRIDVPVSIGRLILIPRLRDFHARYPDIDLVIGLNDRPVDLVGEAVDCAIRVGELKDSSLIARRIGTFQCATA 160 
 
ATCC17978 ASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYM 240 
ATCC19606 ASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYM 240 
AB031     ASPIYLEKYGEPTSIEDLQKNHKAIHFFSSRTGRNFDWDFVVDDLIKSVSVRGRVSVNDGDAYIDLALQGFGIIQGPRYM 240 
 
ATCC17978 LTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTI 320 
ATCC19606 LTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTI 320 
AB031     LTNHLESGLLKEVLPQWTPAPMPISAVYLQNRHLSLKVKVFVDWVAELFAGCPLLGGTALPFDQKCEFACDKETGHEYTI 320 
 
ATCC17978 RTLVEQHNIAEAYTLKT 337 
ATCC19606 RTLVEQHNIAEAYTLKT 337 
AB031     RTLVEQHNIAEARVLKT 337 
 





The AdeFGH pump seems to have a more prominent role in the growth and maintenance of A. 
baumannii. Growth phase analysis of efflux pumps revealed that AdeFGH may have a 
metabolic function in A. baumannii since its expression did not significantly change through a 
growth curve. This result also suggests that the pump is genetically regulated by a mechanism 
that is different from the other pumps, adeB, adeJ and the putative efflux pump AciBau_2436. 
The expression of adeB, adeJ and AciBau_2436 seem to follow a similar expression pattern, 
where the genes are downregulated with increasing cell density. This may suggest that adeB, 
adeJ and AciBau_2436 expression are controlled by the same global regulatory pathway. It is 
interesting to note that expression of adeB and AciBau_2436 genes is highest at 2 and 4 hours 
and then significantly decreases after that, suggesting a possible link to metabolic functions in 
the cell since there was no selective pressure during growth. In a study examining the expression 
of 20 efflux pumps in E. coli, acrD was similar in expression pattern to adeB and AciBau_2436 
over growth phase. Expression analysis revealed that relative to early log phase (O.D.600 0.4), 
expression of acrD went up in mid-log phase and then down during stationary phase (Kobayashi 
et al., 2006). Considering that the acrD efflux pump has been directly linked to drug efflux 
(Elkins & Nikaido, 2002; Nishino & Yamaguchi, 2001), it may be that under non-drug induced 
stress conditions, these efflux pumps play a more prominent role during logarithmic growth. 
Even though its purpose during logarithmic growth is not clearly understood, expression data 
from acrD studies suggest that the pumps may play a role in enterobactin expression during 




The expression of adeJ is more tightly linked to the growth phase of cells. As cell density 
increases the expression of adeJ goes down (Figure 12) which could indicate an alternative 
function that is more prominent under drug-stress conditions. It has been shown that adeJ had 
a much higher expression in the AB030 XDR Canadian isolate compared to less resistant strains 
of A. baumannii in a collection of Canadian isolates (Figure 2). The expression of adeG was 
very low but consistent during the growth phase of ATCC19606 (Figure 12). It is interesting 
that expression of adeG was most ubiquitously expressed in the Canadian collection of clinical 
isolates suggesting a possible role in drug resistance (Table 4). In addition it does possess the 
broadest substrate profile of the three characterized pumps (Coyne et al., 2011). The levels of 
adeG remain upregulated compared to initial expression which suggests a possible 
physiological importance. A recent study showed a correlation between strains expressing adeG 
and propensity to form biofilms where efflux of antibiotics and acyl-homoserine lactones 
(AHL’s) were suggested to induce expression of biofilms (He et al., 2015). Expression of 
mexAB-oprM from P. aeruginosa was found to be low during the lag stages of growth and 
increase in expression with cell density to a maximal expression in stationary phase (Evans & 
Poole, 1999). This particular pump was also linked to quorum sensing a phenotypic 
characteristic of biofilm formation, showing that strains hyperexpressing mexAB-oprM were 
unable to accumulate AHL to express virulence factors (Evans et al., 1998) while knockout of 
pump expression was linked to repression of the AHL response in P. aeruginosa (Minagawa et 
al., 2012). Expression of the A1S_2746 RND efflux pump was not seen in this study since its 
abundance levels at two hours were detected well above 30 cycles and remained above 30 for 
the duration of the time course. The study shows the importance of RND efflux pumps in a cell 
density dependent manner. The diversity in expression levels over time strongly suggest that 
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efflux pumps in A. baumannii may have diverse roles in the cell and also that regulation may 
be controlled by an as yet unknown global regulatory protein. Studying the functional role under 
non-antibiotic or host induced stress response reveal metabolic roles for efflux pumps in A. 
baumannii. As cell density increases there is a reduction in available nutrients and there is 
evidence that efflux pumps play a role in supporting cell maintenance during higher cell 
densities. Efflux pumps such as MexAB-OprM from P. aeruginosa show increased activity 
during higher cell densities linked to the activity of acyl-homoserine lactone secretion molecules 
for quorum sensing (Maseda et al., 2004). The efflux pump AaeAB was shown to activate in 
response to 4-hydroxybenzoic acid a phenolic compound that is an intermediate of ubiquinone 
biosynthesis. The accumulation of this compound in the cell triggers activation of the AaeAB 
pump acting as mechanism to reduce accumulation of 4-hyddroxybenzoic acid (Van Dyk et al., 
2004). The A. baumannii pump AdeFGH could have a role in metabolism and efflux of an as 
yet unknown metabolic compound. This has implications for basic cell maintenance and 
survival in a system where A. baumannii culture dominate and without any external stressor. 
This analysis helps uncover the natural functions of RND efflux pumps in A. baumannii in rich 
media where external factors do not influence the outcome of growth or gene expression.  
 
Because A. baumannii is a major nosocomial pathogen that primarily infects 
immunocompromised individuals, its intrinsic drug resistance properties are important to 
characterize in order to understand how drug resistance may develop in a host and what function 
the RND efflux pumps play in generating the intrinsic drug response. Studying the organism’s 
physiological response to antibiotic mimics, and using sub-lethal concentrations of drugs, help 
establish a link between how non antibiotic stressors encountered in the natural environment or 
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the host could trigger the initiation of intrinsic drug resistance mechanisms, namely the RND 
efflux pumps. 
 
The expression of AdeFGH seems to play a dynamic role in response to nitrosative stress. This 
particular phenotype was observed in the presence of the nitrosative stress generating compound 
GSNO and the nitro group containing antibiotic, chloramphenicol. The generation of nitrated 
moieties by GSNO dissociation (Firoved et al., 2004) and subsequent nitrification of various 
macromolecules could cause damage to the cell triggering inducible stress responses (Bowman 
et al., 2011; Fetar et al., 2011; McCollister et al., 2011). In the case of MdtEF the anaerobic 
global regulator, ArcA was confirmed as an activator of mdtEF through gene deletion and pump 
transcript expression analysis while the mexEF-oprN pump was only induced under nitrosative 
stress in presence of the positive regulator MexT, a lysR type regulator. 
 
The homologue of AdeFGH in P. aeruginosa MexEF-OprN was shown to have a role in 
nitrosative stress response (Fetar et al., 2011) that this study also revealed was possible. The 
current study showed expression of the AdeFGH significantly increases in the presence of 
similar concentrations of GSNO that trigger MexEF-OprN expression. This was also observed 
using the nitrosated antibiotic chloramphenicol but not trimethoprim, also a substrate of the 
pump but containing amine groups instead of nitro groups. The purpose of this upregulation is 
directly linked to a possible role in detoxification of the cell, removing damaged nitrated 
macromolecules produced by exposure to nitrosative stress. Previous studies have shown 
stationary phase ATCC17978 cells exposed to nitrosative stress had enhanced survival 
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compared to cells from exponential phase. This was also accompanied by increased survival 
when exposed to three different classes of antibiotics (Soares et al., 2010). The exact mechanism 
of this survival may be linked to production of catalase and other enzymes expressed during 
oxidative stress but the exact mechanism is yet to be determined. However, AdeFGH may be 
playing a role in these observations which would correlate with the studies in this report. The 
expression of the mexEF-oprN and mdtEF efflux pumps were also associated with activation 
and expression of respective regulators MexT and ArcA. In the absence of these regulators the 
expression of pumps was not observed (Fetar et al., 2011; Zhang et al., 2011). A homologue of 
the adeFGH regulator AdeL, in Burkholderia cepacia was also shown to act as a positive 
regulator of its efflux pump, similar to the mexEF-oprN and mdtEF regulators. In the study, 
chloramphenicol and the siderophore salicylate was shown to induce expression of the LTTR 
ceoR and its adjacent efflux pump ceoAB-opcM indicating a positive regulation phenotype (Nair 
et al., 2004), however since deletion studies were not carried out it is not possible to rule out 
CeoR independent overexpression of the ceoAB-opcM operon. The role of AdeL was examined 
by creating a markerless knockout in ATCC17978 and then performing tolerance assays and 
gene expression of the three pumps to assess the role of gene regulation in expression of RND 
pumps. The expression of AdeFGH in LB grown cells increases modestly in adeL deletion 
strains compared to ATCC17978 (Figure 19). The results of the drug induction study suggest 
that adeFGH may be expressing with very little regulation by AdeL. The adeL knockout strains 
after CHL exposure show significant increase in adeFGH expression (6.98-fold) compared to 
no drug induction. The expression of this pump does not change as drastically when exposed to 
trimethoprim or GSNO. Moreover exposure to florfenicol, a negative control for nitrosative 
stress, generated a significant increase in adeG expression (Figure 20). This suggests that 
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nitrosative stress was not triggering expression of adeG. The expression profile of adeB had a 
similar trend to adeG across all compounds tested in both strains. The adeB pump expressed 
highly in CHL and FLO exposed cells but did not change significantly between adeL knockout 
strains and ATCC17978. To rule out the presence of ethanol (the CHL diluent) as an effector 
of AdeFGH and AdeABC overexpression, its effect was measured separately and no major 
changes in gene expression could be observed between TMP exposed cells and ethanol exposed 
cells in ATCC17978 or ΔadeL (Figure 20).  These observations provide more evidence that 
nitrosative stress is not the inducing factor involved in adeG expression and further shows that 
expression of adeB and adeG may be more similarly regulated than thought in ATCC17978. 
 
RND pump activation is a highly regulated action and it is likely that effector molecules such 
as the drug molecules themselves or a downstream product of antibiotic action, trigger the 
activation of the pump to remove said effector molecules. The lysR transcriptional regulators 
or LTTR family typically form homotetramers consisting of an N-terminal DNA binding 
domain and a C-terminal effector binding domain in each monomer. The binding model of the 
AdeL LTTR remains to be fully elucidated; evidence from this study show that deletion of adeL 
does not cause a dramatic increase in AdeFGH expression but rather a small consistent increase 
(Figure 19). Taken together, AdeL may act as a repressor under native conditions. Effector 
molecule binding, which could be damaged peptides after chloramphenicol or florfenicol 
exposure, or perhaps the drugs themselves, cause conformational changes and activation of 
adeFGH transcription. However, since expression of adeG was high in both ATCC17978 and 
ΔadeL after CHL and FLO exposure, the AdeL regulator is likely not necessary to enhance 
expression of the pump. Its role could be to ensure finer regulation of gene expression whereby 
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reduction in the number of effector molecules will cause a return to the repressed state for the 
efflux pump and a conformational change to AdeL to prevent binding of the RNA polymerase 
complex. After analysis of the ATCC17978, ATCC19606 and AB031 intergenic region 
between adeL-adeFGH, a single point mutation in the AB031 intergenic (165 b.p. ga) region 
was identified. However promoter analysis using BProm for bacterial promoter analysis, 
revealed that this position may not likely have a role in LTTR or transcription factor binding 
which correlates with previously reported findings (Coyne, Rosenfeld, et al., 2010). 
Additionally a single mutation was also discovered in the C-terminal end of AdeL in AB031. 
Again the position of this amino acid was mapped using predictive software, in this instance, 
NCBI Conserved Domain Database (CDD) and revealed that the mutation is not in the predicted 
HTH domain or the dimerization domain of AdeL. It is currently unknown if the mutations 
observed have any effect on the tolerance and expression of adeG. Single point mutations in the 
promoter region of RND pumps have been responsible for generating pump overexpression, 
such as the TriABC-OpmH pump (Mima et al., 2007). Conversely mutations in regulator genes 
such as the mutation that characterized AdeL as a repressor of adeFGH (Coyne, Rosenfeld, et 
al., 2010) may also play a role in AB031 tolerance and gene expression findings.  
 
Overall the differences observed between ATCC17978 and ATCC19606 and AB031 suggest 
that other factors are involved in the expression of AdeFGH and cell tolerance. Closer 
examination of the genome of ATCC19606 revealed an MFS superfamily protein EmrB, with 
hits to the chloramphenicol/florfenicol efflux protein FexA found in Staphylococcus lentus. 
EmrB is known to efflux hydrophobic antibiotics such as nalidixic acid and this particular EmrB 
protein was not found in AB031 genome sequence, suggesting further that two different 
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mechanisms could be acting in ATCC19606 and AB031 that confer improved tolerance when 
CHL is added in sub-lethal concentrations. The specific induction of AdeFGH in all strains was 
achieved, but whether this is due to nitrosative stress or an antibiotic inducible effect may 
depend on the strain. Therefore there must be an alternative regulatory pathway that 
distinguishes the two major findings in this study, that AdeFGH induction and improved 
tolerance is controlled by nitrosative stress or independently of nitrosative stress, perhaps 














3.5 Study of Triclosan Resistant Acinetobacter baumannii ATCC17978 reveals a 
unique composition of phenotypes and RND efflux regulation.  
Parts of section 3.5 have been published elsewhere:  
Fernando, D. M., et al., (2014). Antimicrobial Agents and Chemotherapy. 
58(11):6424-31. 
 
Triclosan is a synthetic bisphenol compound that has specific activity against organisms that 
carry out type II fatty acid biosynthesis, targeting prokaryotes. Because of its high specificity 
against the bacterial pathway of fatty acid synthesis the use of triclosan as a common biocide 
has skyrocketed since its first use in 1972 to the point that 75% of soap brands contain triclosan, 
and across the United States 75% of adults and children are reported to excrete triclosan in their 
urine (Bergstrom, 2014) where it may accumulate in the environment. Many brands of personal 
hygiene products, cleaning products, clothing and office stationary contain triclosan and are 
available in Canada. This widespread use of triclosan has raised concern that bacterial pathogens 
could develop resistance to this biocide with cross resistance to other medically relevant 
antibiotics. Resistance to triclosan has been shown through in vitro studies and generation of 
resistant E. coli (McMurry et al., 1998b) and P. aeruginosa mutants (Hoang & Schweizer, 
1999). This study identified a single base pair change from GGT to GTT in the enoyl acyl-
carrier protein reductase-encoding fabI gene, an essential gene in the synthesis of fatty acids, 
and prevents triclosan binding to the FabI enzyme. In addition to this mechanism of resistance, 
P. aeruginosa PAO1 also contains the fabV gene that also acts as a enoyl acyl-carrier protein 
reductase; its deletion was shown to impart >2000-fold sensitivity to triclosan (Zhu et al., 2010). 
In addition to the mutation in the target protein-encoding gene, efflux  is also responsible for 
triclosan resistance in E. coli (McMurry et al., 1998a), P. aeruginosa and S. enterica serovar 
Typhimurium (Webber et al., 2008) as well as the efflux pump TriABC-OpmH that specifically 
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pumps triclosan and confers >1000-fold resistance to the biocide (Mima et al., 2007). Along 
with the significantly decreased susceptibility to triclosan, cross resistance to medically relevant 
antibiotics and efflux pump expression is a frequently associated phenotype that has been 
reported through surveillance studies (Curiao et al., 2015; Lavilla et al., 2015), direct 
experimental correlations (Braoudaki & Hilton, 2004; Braoudaki & Hilton, 2005; Karatzas et 
al., 2007) and through study of triclosan cross resistance and efflux pump activity (Chuanchuen 
et al., 2001; Gantzhorn et al., 2015; Pycke et al., 2010). 
 
3.5.1 Triclosan mutants are resistant to multiple antibiotics 
Considering A. baumannii’s notorious ability to generate resistance to a wide spectrum of 
antimicrobials and biocides the study sought to determine the effect of triclosan to select for 
mutants of A. baumannii. Triclosan resistant A. baumannii strains were derived from 
ATCC17978 and characterized based on high level resistance to triclosan (Table 7) and  cross 
resistance to antibiotics, the MIC of 21 medically relevant antibiotics were tested (Table 7) 
using the 2-fold broth dilution method against these two isolates compared to ATCC17978. Of 
the tested antibiotics 7/21, ceftriaxone, cefepime, ciprofloxacin, moxifloxacin, aztreonam, 
tigecycline, trimethoprim-sulfamethoxazole, (33%), Table 7, showed sequential decreased 
susceptibility from ATCC17978 to AB042 followed by AB043. 4/21, piperacillin/tazobactam, 
meropenem, doripenem, ertapenem, (19%) had no difference between AB042 and AB043. 2/21, 
imipenem and amoxicillin-clavulanic (10%) showed a lower MIC in AB043 compared to 
AB042 and ATCC17978 and 7/21, cefoxitin, cefazolin, ceftazidime, tobramycin, gentamycin, 























Table 7 – MIC of ATCC17978, AB042 and AB043 against a panel of twenty antibiotics 
show decrease susceptibility after exposure to triclosan. Sequential increases in resistance 
from AB042 to AB043 are observed for (TRI) triclosan, (CRO) ceftriaxone, (FEP) cefepime, 
(CIP) ciprofloxacin, (MXF) moxifloxacin, (AZT) Aztreonam, (TGC) tigecycline, (DOX) 
doxycycline, (SXT) trimethoprim-sulfamethoxazole while no difference in resistance was 
observed between the two strains for antibiotics (PTZ) piperacillin/tazobactam, (MEM) 
meropenem, (DOR) doripenem, (ETP) ertapenem. Resistance did not change against the 
antibiotics (FOX) cefoxitin, (CFZ) cefazolin, (CAZ) ceftazidime, (TOB) tobramycin, (GEN) 
gentamicin, (AMK) amikacin and (CLI) colistin. Interestingly a lower MIC was recorded for 
(AMC) amoxicillin-clavulanic acid and (IPM) imipenem where the MIC value for AB043 was 












TRI PTZ FOX CFZ CRO FEP CAZ IPM MEM DOR ETP CIP MXF TOB GEN AMK AMC AZT TGC DOX CLI SXT 
AB042 
256 32 >32 >128 32 8 (S) 8 0.25 (S) 1 (S) 0.5 16 0.5 (S) 0.25 (S) ≤0.5 ≤0.5 (S) ≤1 (S) 32 32 0.5 (S) 0.5 2 (S) 4 (R) 
AB043 
512 32 >32 >128 64 16 (I) 8 0.12 (S) 1 (S) 0.5 16 1 (S) 0.5 (S) ≤0.5 ≤0.5 (S) ≤1 (S) 16 64 1 (S) 1 2 (S) >8 (R) 
ATCC 




susceptibility to carbapenems, fluoroquinolones and glycylcyclines. The isolation of triclosan 
resistant strains revealed a cross resistance to multiple antibiotics of at least three different 
classes by MIC. The next part of the study was to characterize how this phenotype may be 
generated in AB042 and AB043. The generation of triclosan resistant mutants in S. enterica 
serovar Typhimurium, E. coli and P. aeruginosa have been characterized by mutations in their 
fabI genes (Gantzhorn et al., 2015; Hoang & Schweizer, 1999; McMurry et al., 1998b; Webber 
et al., 2008), the target of triclosan. The fabI gene (A1S_0534) and promoter in A. baumannii 
AB042 and AB043 were PCR amplified and sequenced to identify any mutations that may 
confer resistance to triclosan. Sequencing of the fabI gene and promoter revealed a single 
basepair mutation converting guanine to thymine causing an amino acid change from glycine 
to valine (116G V) in both AB042 and AB043 (Figure 22a). To confirm that the AB042 and 
AB043 mutation in fabI confers triclosan resistance the mutant gene and the wildtype (wt) gene 
were individually cloned into the pUCA30 (p) vector and expressed under carbenicilin selection 
in ATCC17978. The MIC of ATCC17978 overexpressing mutant fabI showed a 32-fold and 8-
fold decrease in triclosan susceptibility compared to the vector only control and wt fabI 
(overexpression) control, respectively (Figure 22c).  To determine if the expression levels of 
fabI changed relative to ATCC17978, qRT-PCR was performed on mid-log phase cells and 
expression of fabI measured revealing a significant 3.7-fold ±0.16 overexpression compared to 
the parent strain, while AB042 showed a 1.1-fold overexpression (Figure 22b). Another 
reported triclosan resistance mechanism has been shown by the MATE family pump, AbeM 
(Su et al., 2005a) and was tested for activity by qRT-PCR. No change in expression was 




The second finding from MIC results showed a cross-resistance effect toward multiple classes 
of antibiotics (Table 7). The resistance mechanisms inherent to ATCC17978 must be 
employed by AB042 and AB043 in order to achieve the decreased susceptibility that was 
observed, since these were not isolated from nosocomial environments or directly from 
patients. To identify which intrinsic mechanisms may be active in the triclosan mutants qRT-








Figure 22 – Sequencing and gene expression profile of fabI in AB043, AB042 and 
ATCC17978. (A) The fabI gene in AB042 and AB043 reveal a single base pair mutation, 
guanine to thymine causing an amino acid change from glycine to valine 116G V. (B) 
Expression of fabI in AB043 is 3.7-fold, AB042, 1.1-fold. Data is representative of two 
biological replicates. Error bars represent ±SD, Asterisk indicate statistical significance, 
p≤0.05. (C) Triclosan MIC (μg/mL) of ATCC17978 overexpressing either ATCC17978 fabI 













AB042         MTQGLLAGKRFLIAGVASKLSIAYGIAQAL 30 
AB043         MTQGLLAGKRFLIAGVASKLSIAYGIAQAL 30 
ATCC17978     MTQGLLAGKRFLIAGVASKLSIAYGIAQAL 30 
              *****************************       
AB042     HREGAELAFTYPNEKLKKRVDEFAEQFGSK 60 
AB043     HREGAELAFTYPNEKLKKRVDEFAEQFGSK 60 
ATCC17978     HREGAELAFTYPNEKLKKRVDEFAEQFGSK 60 
          ****************************** 
AB042         LVFPCDVAVDAEIDNAFAELAKHWDGVDGV 90 
AB043         LVFPCDVAVDAEIDNAFAELAKHWDGVDGV 90 
ATCC17978     LVFPCDVAVDAEIDNAFAELAKHWDGVDGV 90 
              ****************************** 
AB042      VVHSIVFAPAHTLDGDFTEVTDRDGFKIAH 120 
AB043         VVHSIVFAPAHTLDGDFTEVTDRDGFKIAH 120 
ATCC17978     VVHSIGFAPAHTLDGDFTEVTDRDGFKIAH 120 
              ***** ************************  
AB042         DISAYSFVAMARAAKPLLQARQGCLLTLTY 150 
AB043         DISAYSFVAMARAAKPLLQARQGCLLTLTY 150 
ATCC17978     DISAYSFVAMARAAKPLLQARQGCLLTLTY 150 
              ****************************** 
AB042         QGSERVMPNYNVMGMAKASLEAGVRYLASS 180 
AB043         QGSERVMPNYNVMGMAKASLEAGVRYLASS 180 
ATCC17978     QGSERVMPNYNVMGMAKASLEAGVRYLASS 180 
              ****************************** 
AB042         LGVDGIRVNAISAGPIRTLAASGIKSFRKM 210 
AB043         LGVDGIRVNAISAGPIRTLAASGIKSFRKM 210 
ATCC17978     LGVDGIRVNAISAGPIRTLAASGIKSFRKM 210 
              ****************************** 
AB042         LDANEKVAPLKRNVTIEEVGNAALFLCSPWA 240 
AB043         LDANEKVAPLKRNVTIEEVGNAALFLCSPWA 240 
ATCC17978     LDANEKVAPLKRNVTIEEVGNAALFLCSPWA 240 










































Figure 23 – Expression analysis of RND and MATE family pumps reveal 
overexpression of adeJ in AB042 and AB043. RND efflux pumps adeB, adeG and 
putative efflux pumps AciBau_2818 and AciBau_3219 do not show increased expression 
in AB042 or AB043. The adeJ pump shows significant overexpression sequentially in 
AB042 (2.33-fold) and AB043 (6.63-fold). The MATE family pump abeM, reported to 
efflux triclosan does not significantly change in expression. Data is representative of two 


























3.5.2 Triclosan mutants have repressor dependent and independent mutations 
controlling adeJ expression. 
The three characterized efflux pumps adeB, adeG and adeJ were analyzed for expression in 
AB042 and AB043 relative to control strain ATCC17978 and using reference gene 16S. 
Quantification of adeB transcript levels reveals no significant change in AB042 or AB043 
relative to control strain (Figure 23). The AdeB substrate range is limited to antibiotics and has 
not been shown to target biocides or heavy metals (Coyne et al., 2011). The expression of adeG 
was also measured and significant change in expression was not observed in AB042 or AB043. 
This particular efflux pump is proposed to have no intrinsic role in MDR since it is not found 
constitutively expressed in wildtype strains. However it should be noted that expression analysis 
of Canadian A. baumannii isolates have shown otherwise, where adeG was observed in the 
entire collection at levels ≥ 2-fold compared to the reference strain (Figure 2). The expression 
of adeJ was observed to increase in AB042 and higher in AB043. This finding was in-line with 
previous findings identifying AdeIJK as having the broadest substrate profile of the three pumps 
including another biocide chlorhexidine (Damier-Piolle et al., 2008; Rajamohan et al.,  2010b). 
The putative efflux pumps AciBau_2818, which has an unknown substrate profile, and 
AciBau_3219, which is proposed to be involved in cobalt-zinc-cadmium efflux by homology, 
were not overexpressed but showed a significant decreased expression compared to 
ATCC17978 (Figure 23). In AB042 expression of both AciBau_2818 and AciBau_3219 was 
downregulated while in AB043, only AciBau_3219 was shown to be downregulated (Figure 
23). These pumps have yet to be characterized and their substrate profile remains unknown. 
Finally the MATE family pump abeM was also measured because it was identified as having 
triclosan efflux activity in an E. coli surrogate study (Su et al., 2005a). Results show that 




To determine if AdeIJK plays a role in triclosan resistance directly the ATCC17978 operon was 
expressed in single copy in an efflux pump deficient strain of P. aeruginosa lacking 7 known 
efflux pumps. A consistent 2-fold decrease in susceptibility was observed in the AdeIJK 
expressing strain suggesting that although not a major substrate of AdeIJK, the triclosan 
molecule can be extruded from the cell by AdeIJK efflux. Therefore the proposed reason for 
overexpression of adeIJK in AB042 and AB043 was thought to be probable mutations in the 
adeIJK repressor, AdeN or the adeIJK promoter or adeIJK operon. Sequencing of the promoter 
and genes in the adeIJK operon revealed no mutations. Sequencing of the adeN gene located 
8.78 kbp from adeIJK revealed a 73 b.p. deletion in the adeN sequence from AB042, but not 
AB043 (Figure 24). This deletion caused a shifted reading frame and a premature stop codon in 
the amino acid sequence generating a 47 amino acid truncation (Figure 24). The AdeN protein 
is part of the TetR family of gene regulators that has been shown to repress the expression of 
adeIJK. When truncated the adeIJK efflux pump is deregulated and expression has been shown 
to increase 5-fold in a clinical isolate of A. baumannii (Rosenfeld et al., 2012). Using this 
previously reported information it was hypothesized that the AdeN truncation was causing the 
increased expression of adeIJK, and complementing with native adeN from ATCC17978, 
would repress the adeIJK overexpression phenotype in AB042. The repressor was cloned from 
ATCC17978 into the p vector and electroporated into AB042, followed by harvesting log phase 
cells from the adeN compliment and the empty vector control for RNA extraction and 
subsequent qRT-PCR. Analysis of qRT-PCR data show the overexpression of adeIJK in 
AB042, 2.36±0.10 and the empty vector control, 2.05±0.16 while the complimented adeN strain 
shows a decrease in expression close to ATCC17978 levels, (1.11±0.03), Figure 25. This data 
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reveal that AB042, adeIJK overexpression is due to the mutation found in the adeN gene of 
AB042 and complementation of this mutation restores repression of the adeIJK operon (Figure 
25a). Phenotypic evidence of this was shown through MIC assays using moxifloxacin and 
ciprofloxacin. The AB042 and vector only control show a ~2.0-fold reduced susceptibility to 
moxifloxacin and ciprofloxacin while the adeN compliment restored MIC values back to 



























Figure 24 – adeN gene alignment from ATCC17978, AB042, AB043 show a 73 b.p. deletion 
in the adeN gene from AB042 leading to a premature stop codon and truncated protein. 
The 73 b.p. deletion occurs in the middle of the open reading frame creating a modified reading 













adeN DNA Sequence Alignment 
ATCC17978  TTATTTACTGCAATCTGCGATTATCGCCGTGAAATGTTTTTTAAAGATATCTGCATTGCATTTCAACCAGAGCAAACTTCTTTAA 300 
AB043       TTATTTACTGCAATCTGCGATTATCGCCGTGAAATGTTTTTTAAAGATATCTGCATTGCATTTCAACCAGAGCAAACTTCTTTAA 300  
AB042       TTATTTA-------------------------------------------------------------------------TTTAA 227 
            ******                                                                          *****                                                                                                                                                              
 
AdeN Amino Acid Alignment 
 
ATCC17978    MHDPVLESHHLVCEKPQTRRGIERRLALLLSATELFLEKGYDAVSLDDIVNHAGGSKTSIYKYFGNKDGLFTAICDYRREMFFKD 
AB042         MHDPVLESHHLVCEKPQTRRGIERRLALLLSATELFLEKGYDAVSLDDIVNHAGGSKTSIYKYFGNKDGLFI*------------ 
               ***********************************************************************  
  
ATCC17978    ICIAFQPEQTSLKDYLIQTLIRFYKHIIQPEHIAF 120 




















Figure 25 – Overexpression of adeN in AB042 restores (A) adeJ expression levels to 
ATCC17978 levels by qRT-PCR, and (B) MIC of moxifloxacin and ciprofloxacin. The 
overexpression of adeJ is ~2.0-fold in AB042 and AB042-p, overexpression of p-adeN 
represses adeIJK to wildtype levels, ~1.0-fold. MIC values were shown to decrease, 
moxifloxacin (2-fold) and ciprofloxacin (2.0-fold), indicating that overexpression of 
















Strain adeN Expression MXF CIP 
AB042 p 0.125 0.5 
AB042 p-adeN 0.06 0.25 










Changes in adeN from AB043 were not found and sequencing confirmed that no mutations, 
insertions or deletions were found in this gene or the adeIJK promoter and operon. To confirm 
that adeIJK overexpression in AB043 was occurring independent of AdeN the same p-adeN 
construct was electroporated into AB043 and harvested at log phase followed by RNA 
extraction for subsequent qRT-PCR. The data reveal that overexpression of the AdeN repressor 
in AB043 does not reduce expression of adeIJK efflux pump transcript levels. The expression 
of adeJ in AB043 was 6.57±0.411 and expression of adeJ in AB043-p-adeN was 8.57±0.96. In 
the vector only control pump expression was 14.56±4.03. The lack of repression observed for 
adeJ was coupled with expression of the repressor, adeN. Fold change values were 2.52±0.19, 
4.83±0.38, and 2.37±0.68, respectively. Despite overexpression of the repressor levels of adeJ 
did not reduce, thus confirming the AdeN independent expression of this pump (Figure 26). 
This also suggests that an alternative regulatory mechanism is involved in adeIJK expression 
that has yet to be identified. The increasing use of the biocide triclosan has raised concerns due 
to increasing development of triclosan resistance. Exposure of the type strain ATCC17978 to 
increasing concentrations of triclosan identified two triclosan mutants that possess identical 
triclosan resistance mutations but have sequential decreasing susceptibilities to triclosan and 
antibiotics (Table 7). Through quantitative PCR a single efflux pump, AdeIJK was shown to 
exhibit a sequentially increasing expression in AB042 and AB043, respectively (Figure 23). 
Sequencing of its cognate regulator, a 47-amino acid truncation was found in AdeN from 
AB042 and its complementation showed a decrease in adeIJK expression, and an MIC of 
moxifloxacin and ciprofloxacin (Figure 25). Considering that no mutations were found in these 

















Figure 26 – Overexpression of adeN in AB043 does not restore adeIJK expression 
levels to ATCC17978 level. Expression of adeIJK is significantly higher (denoted by 
asterisk) in AB043, AB043-p and AB043-p-adeN compared to ATCC17978. Despite 
significant overexpression of adeN relative to AB043 (denoted by asterisk), expression of 
adeIJK remains significantly higher in AB043 compared to ATCC17978. Expression of 
AB043 pUCA30 was 2.37 ± 0.68. Data is representative of at least two biological 
replicates, error bars represent ±SD. Asterisk indicates significant difference between 
ATCC 17978 control and test in adeJ measurement. In adeN measurement asterisk 
























AB043 genome the proposed hypothesis was that regulation of pump expression may be 
controlled by an as yet unidentified adeIJK regulator. In order to identify this regulator as well 
as other strain wide differences a multi-omics approach was taken the results of which will be 
presented and discussed in the last part of chapter 4. 
 
3.5.3 Triclosan resistant strains contain modified fatty acid composition and 
osmotic stress tolerance. 
Triclosan exposure to ATCC17978 generated decreased susceptibility to multiple antibiotics 
and a point mutation in the gene involved in fatty acid chain elongation (fabI), causing a 
decreased susceptibility to triclosan. The role of fatty acid (FA) biosynthesis and its effect on 
bacterial tolerance was tested since we proposed that changes in the makeup of fatty acids may 
have an adverse effect on membrane integrity and osmotic stress compensation. Bacteria such 
as P. aeruginosa often encounter changes in osmolarity when encountering a new environment 
or when infecting a new site in the host, and must adapt by modulating gene expression to 
compensate for osmotic shock and grow under sustained osmotic pressure (Aspedon et al., 
2006). Opportunistic bacteria that infect the cystic fibrosis lungs must often contend with high 
viscosity mucus and use intrinsic mechanisms to survive this osmotically stressful infection site 
(Folkesson et al., 2012). To assay the ability for strains to survive osmotic stress, growth curves 
were carried out in a 96-well format in the presence the non-ionic stressor, sucrose. Growth in 
LB showed no tolerance defects while increasing concentrations of sucrose showed a visible 



















Figure 27 – Tolerance defect in AB042 and AB043 with increasing sucrose 
concentration. Triclosan resistant strains grow similarly to ATCC17978 in LB growth 
media (A). Supplemented with a range of sucrose, 0.3M (B), 0.5M (C) 1.0M (D) reveal 
tolerance defects at all concentrations. AB043 consistently shows weaker tolerance 
compared to AB042 while ATCC17978 grows with least perturbation. Data is 






























ATCC17978 (Figure 27). Strains showed a relatively equal tolerance distribution in each 
molarity of sucrose tested. FA’s are a primary component of bacterial lipid membranes and 
changes in fatty acid composition maintain optimum solubility and fluidity depending on the 
environment. Sucrose as a non-ionic source of osmotic stress has shown to have an effect on 
growth and cause changes in FA composition (McGarrity & Armstrong, 1981; Tsatskis et al., 
2005). The effect on growth was observed when comparing ATCC17978 tolerance when grown 
in LB and then when supplemented with sucrose (Figure 27). To understand exactly how FA 
composition in the membrane is changed due to triclosan exposure and possibly the mutation in 
fabI, quantification of total membrane FA’s in AB042, AB043 and ATCC17978 was carried 
out using FAME. The results of carrying out quantification of fatty acids in the triclosan 
resistant strains and parent strain ATCC17978 show differences in fatty acid composition. The 
two major changes in composition are seen in the 2.5-fold increase in C16:1 and the 3-fold 
decrease in C18:1 between ATCC17978 and the two triclosan mutants (Figure 28). Interestingly 
no other changes in FA composition comparable to C16:1 and C18:1 were observed, except for 
a small ~1.5-fold increase in C12 in AB042 and AB043 (Figure 28).  Both C16:1 and C18:1 
contains a single double bond in the respective chains but this does not clearly identify where 
the double bond is located. The specific changes in fatty acid composition after triclosan 
exposure have not been documented in literature. However studies on the drug diazaoborine 
(drug with similar binding to FabI) (Levy et al., 2001) have shown that mutations in the fabI 
homologue, envM confer changes in the composition of fatty acids in S. typhimurium; 
specifically the accumulation of C16 and smaller chain length FA’s. In addition the amount of 

















Figure 28 – Fatty acid analysis of triclosan resistant mutants show major changes in 
C16:1 and C18:1. Triclosan resistant strains show a similar FA composition that has a higher 
composition of C16:1, 29.64% in AB042 and 39.95% in AB043 compared to 11.29% in 
ATCC17978. Conversely amounts of C18:1 are reduced in AB042 10.84% and AB043 
11.05% compared to ATCC17978, 35.14%. Values of other even numbered carbon chain 
length FA’s show increases in AB042 and AB043 except for C10, C14, C18 and C18:1 n7c. 



















to native expression levels (Turnowsky et al., 1989). What this suggests is that the effects on 
structure and function of the membrane occur as an effect of triclosan inhibition of the fabI gene 
and the primary target of triclosan is fabI and fatty acid biosynthesis (Heath 1998). The 
reduction of 18:1 in AB042 and AB043 also correlates with findings of diazaoborine exposure 
showing a reduction in C18 overall. The modification of the fatty acid composition in A. 
baumannii was shown through FAME analysis and has been linked to the fabI homologue in S. 
typhimurium.  
 
3.5.4 Triclosan resistant strain shows attenuated virulence, motility and 
temperature dependent biofilm formation. 
We next wanted to examine the effect of triclosan exposure on pathogenesis in an infection 
model. This was carried out by using a G. mellonella model where larvae are injected with 108 
cfu/mL and observed for pigmentation change and response to touch over time. Among the 
strains tested the parent strain ATCC17978 had the smallest LC50 of 8 hours while AB042 was 
18 hours. AB043 infected populations had a 60% survival at the end of the study, while 
ATCC17978 and AB042 ended at 10-15% survival (Figure 29). Interestingly the loss of the fabI 
homologue in S. typhimurium showed a loss of LPS which could lead to attenuated virulence 
phenotypes (Turnowsky et al., 1989) and in other studies disruption or deletion of enzymes in 
the FASII pathway show attenuated virulence phenotypes (Brown & Gulig, 2008; Fozo et al., 
2007). To test other aspects of virulence such as the ability to form biofilm and motility these 
assays were examined at different temperatures and conditions for optimisation. Motility is a 
virulence characteristic, and is the ability of the pathogen to migrate when colonizing the host 





















Figure 29 – A G. mellonella infection model reveal attenuated virulence in AB043, 
compared to AB042 and ATCC17978. The AB043 strain virulence is attenuated 
compared to AB042 and parent strain ATCC17978. The ATCC17978 LC50 14 hours, 
AB042 LC50 18 hours and AB043 was not able to kill more than 50% of the population 
when tested. Strains show statistically significant difference by log-rank test and Kaplan-

























genes were identified encoding type IV secretion system proteins used in twitching motility and 
inactivation or mutation of genes within the type IV secretion apparatus have shown loss of 
motility and virulence (Clemmer et al., 2011; Eijkelkamp et al., 2011; Harding et al., 2013). 
Biofilm formation on biotic and abiotic surfaces does not correlate with motility from previous 
studies examining collections of A. baumannii isolates (Eijkelkamp et al., 2011). However, loss 
of motility has been attributed to disruption of the bfmS gene in addition to other genes involved 
in virulence, such as LPS production and quorum sensing in A. baumannii (Clemmer et al., 
2011). Motility was measured by spotting log phase cells on semi-solid agar media and 
incubating for 12-18 hours at 37°C or 30°C. The AB043 strain has a visual difference in motility 
compared to AB042 and the parent strain ATCC17978 (Figure 30b). There also appears to be a 
translucent component running in front of the bacterial cells that is not present in the other two 
strains. Biofilm formation was also assayed and it was found that significantly more biofilms 
were generated in AB043 compared to the other strains, but only when incubated at 30°C and 
not at 37°C (Figure 30a). These two observations suggest that the strain may be more 
opportunistic when incubated at lower temperatures and on abiotic surfaces. Since motility was 
not observed to be temperature dependant it may be that the motile AB043 is able to form 
biofilms on abiotic surfaces that are close to but not equal to that of the host internal temperature. 
Examples of this scenario could be expected when using equipment that comes into close 
























Figure 30 – Triclosan strain AB043 shows biofilm formation at 30°C but not 37°C and 
is motile on semi-solid agar. (A) The AB043 strain showed significant biofilm formation 
compared to ATCC17978 and AB042 when incubated at 30°C. Strains at 37°C did not show 
any differences in biofilm. Data is the average of three biological replicates, error bars 
represent ± SD (B) The AB043 strain shows motility on semi-solid agar and was not 
temperature specific. Data is representative of at least three biological replicates and error 


































3.5.5 Identification and characterization of mutant global regulator HNS 
Efforts to characterize genes that have a link between these observed phenotypes, virulence and 
fatty acid synthesis revealed a gene (A1S_0268) encoding the histone-like nucleoid structuring 
protein or HNS. The HNS protein is highly abundant across species of bacteria and is 
consistently expressed throughout all phases of growth acting as a global repressor of genes 
(Dillon & Dorman, 2010). Interestingly the gene was found to be disrupted in Mycobacterium 
smegmatis (Arora et al., 2008) and a species of ATCC17978 (Eijkelkamp et al., 2013) 
generating a similar motility phenotype with no changes in biofilm formation at 37°C although 
activity at 30°C was not tested (Eijkelkamp et al., 2013). While sequencing from our 
ATCC17978 and AB042 strains showed no mutations in this gene, AB043 revealed an insertion 
element in the hns gene corresponding to an 88 b.p. DNA fragment with inverted repeats flanked 






























Figure 31 – The HNS gene in AB043 contains an 88 b.p. insertion element with inverted 
repeats flanking its ends. The insertion element has inserted into a region of the hns gene 
that has been duplicated (ATTGCAAGC) causing a non-functional peptide to be synthesized. 
Insertion element is bolded and underlined regions indicate inverted repeats. Dashed line 


























Blast search of the 88 b.p. insertion element showed a limited number of hits. The first hit was 
in the ATCC17978 genome as was expected. The region where the insertion element is from is 
flanked by two genes encoding hypothetical proteins.  
 
To determine if the HNS regulator was responsible for the phenotypes that were observed the 
hns gene from ATCC17978 was cloned into the pUCA30 (p) overexpression vector and 
electroporated into AB043. In addition, a markerless knockout of hns in ATCC17978 was made 
generating an isogenic mutant. Complementation of the hns mutant in AB043 revealed a loss 
of motility revealing that the hns disruption generated the motility phenotype (Figure 32b). 
However, a reduction in biofilm formation was not observed in the complimented AB043. 
Conversely, the Δhns ATCC17978 did form more biofilms than the ATCC17978 strain but did 
not have a motility phenotype (Figure 32a). Finally expression analysis was carried out in the 
AB043 strain and the isogenic knockout in ATCC17978, to determine if expression of adeIJK 
was modulated by the HNS regulator. Data revealed that the overexpression of adeIJK was 
independent of the hns gene in AB043 and that adeIJK expression levels do not significantly 






















Figure 32 – Motility in AB043 is repressed by the HNS regulator but has no role in 
regulation of biofilm. (A) The formation of biofilms is independent of wildtype hns but an 
isogenic knockout of the gene does cause an increase in biofilm formation. (B) Motility 
phenotype was observed to be dependent on wildtype hns expression in AB043 but in the 
isogenic knockout, motility was not observed. Data is representative of two biological 










































Figure 33 – Expression analysis of adeJ reveal an hns independent expression in both 
ATCC17978 and AB043. Knockout of the hns gene or its complementation do not induce 
expression of adeJ pump. Similarly complimenting AB043 with wildtype hns does not 
change high expression of adeJ in AB043. Expression of adeJ remains high compared to 
ATCC17978 (denoted by *, p≤0.05). The vector only control also induced expression of adeJ 



























The HNS protein has a high affinity for DNA containing AT rich nucleotides with the motif 
(TCGATAAATT) (Dillon & Dorman, 2010). Considering that the HNS gene is expressed at all 
stages of growth (Dillon & Dorman, 2010) the phenotypes observed to be under regulation of 
HNS, such as biofilm formation in ATCC17978 and motility in AB043, were not thought to be 
growth phase dependant. However, the lack of regulation imparted on biofilm formation and 
the lack of motility in isogenic knockouts suggested that more genetic differences were present 
between AB043 and ATCC17978. In addition the osmotic stress growth phase defect (Figure 
26) and the independent adeIJK overexpression phenotype (Figure 27) remained to be 
explained.  
 
In order to characterize these unexplained observations and provide possible targets for the 
novel regulation of adeIJK a multi-omics approach was utilized for AB043, AB042 and 
ATCC17978. The results of RNA-sequencing (RNA-seq), proteomics and genomics of both 








3.6 Transcriptomics and Proteomic Analysis of AB042 and AB043 
3.6.1 Genome sequencing of strains show large deletions in AB043 
The assembled AB042, AB043 and ATCC17978 genomes were annotation on the Rapid 
Annotation Using Subsystem Technology pipeline (RAST) (Overbeek et al., 2014). Regions of 
AB042 and AB043 with missing genes compared to ATCC17978 were identified and are shown 
in Table 8. In total 34 genes are absent in both AB042 and AB043, the majority of which were 
of hypothetical function. There are a total of 5 genes absent in AB042 that were conserved in 
AB043 and 33 genes absent in AB043 that were conserved in AB042. A group of 12 genes, 
2169 – 2181 encoding hypothetical function as well as 2603 – 2607 and 2610, 2611 followed 
by 2610 – 2618, all of hypothetical function are absent in both strains. Interestingly 2611 
corresponds to the periplasmic component of a phosphonate ABC transporter and 2181 is a 
RelE replicon stabilization toxin. In another region gene 1101 encodes an alkyl hydroperoxide 
reductase protein. It is unclear why these genes were excised from the genome of AB042 and 
AB043 and analysis of the 2169-2181 groupings of genes reveals no immediate connection 
between them. The 2169 gene codes for a membrane protein of unknown function, 2170 
encodes a component of a toxin-antitoxin system and 2171 encodes an outer membrane protein 
receptor for iron transport. Gene 2172 encodes for a member of a protease family, 2173 is 
unknown, 2174 contains a Flid (flagellar capping protein) domain while 2175 also like 2173 
did not present any conserved domains. Gene 2176 codes for the Rep_3 superfamily which is 
involved in initiation of plasmid replication, 2177 contains a HTH domain and codes for a 
putative DNA replication protein, 2178 is unknown. Finally gene 2179 is unknown, 2180/81 
codes for the RelB/RelE antitoxin/toxin system which encodes the antitoxin RelB and the RelE 
mRNA-degrading endonuclease. The next downstream gene is conserved in AB042 and AB043 
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and codes for a secretory lipase. This region of the genome encodes many proteins that have 
roles in virulence; such as toxin production, iron acquisition and flagella encoding genes 
(Contreras et al., 2014; Wang & Wood, 2011).  In AB042 of the 5 genes that have been deleted 
(Table 10), gene 122 corresponds to a nitrate/nitrite transporter while the remaining 4 are 
hypothetical proteins. The AB043 genome has 33 deleted genes with a large stretch of 
sequential genes, AB043_1140 – 1158 deleted (Table 9). This region encodes hypothetical and 
unknown function proteins but also contains a FAD/FMN-containing dehydrogenase (1140) 
and a bacteriophage protein STY1048 (1158) (Table 9). Genes 1141-1151, 1153 – 1155 are 
unknown, 1142 contains a flagellar export protein domain and is often found in type III secretion 
systems. 1143 contains a zinc ribbon domain often found in transcriptional control. Gene 1152 
contains a phage capsid domain; gene 1156 contains a domain for ribonuclease H that cleaves 
RNA, while 1157 codes for a viral head morphogenesis protein found in bacteriophages (Table 
9).  
 
The annotation of genomes revealed that ~1% of common genes were missing in AB042 and 
AB043 after exposure to triclosan. In addition AB042 had five unique genes missing compared 
to ATCC17978 and AB043 that were mostly of hypothetical function while AB043 had a larger 
number of deletions, approximately 33 unique genes, mostly adjacent in their location (Table 
9). These genes were also hypothetical with unknown function except for approximately nine 














Table 8 – Genes deleted from the AB042 and AB043 genome compared to the parent 
strain ATCC17978. Annotation and comparison using the RAST server reveals 34 
common genes deleted in the AB042 and AB043 genomes. *Intergenic region, §Promoter 



















ACCESSION NO.  
hypothetical 
protein 
38 445 3213--3214 3189--31090 A1S_2056 
hypothetical 
protein 




protein F (EC 
1.6.4.-) 
50 1101 3536--3538 3513--3515 A1S_1200 
hypothetical 
protein 
127 1203 676--677 671--672 A1S_2927,2928* 
hypothetical 
protein 
65 1677 380--381 376--377 A1S_3523,3524* 
hypothetical 
protein 
38 1746 1039--1040 1037--1038 A1S_0088,0087* 
hypothetical 
protein 




96 2169 1163--3494 1161--3470 A1S_3474,3475* 
hypothetical 
protein 
105 2170 1163--3494 1161--3470 A1S_3475§# 
unknown 233 2172 1163--3494 1161--3470 A1S_3476# 
hypothetical 
protein 
66 2173 1163--3494 1161--3470 A1S_3476, 3477*# 
hypothetical 
protein 
124 2174 1163--3494 1161--3470 A1S_3476, 3477*# 
hypothetical 
protein 




317 2176 1163--3494 1161--3470 A1S_3472# 
putative 
protein 
192 2177 1163--3494 1161--3470 A1S_3472, 3473*# 
hypothetical 
protein 
48 2178 1163--3494 1161--3470 A1S_3472, 3743*# 
hypothetical 
protein 











98 2181 973--972 971--970 A1S_3472, 3473*  
hypothetical 
protein 
41 230 2620-2619 2560-2559 A1S_0489 - 0490* 
hypothetical 
protein 




119 2603 228--243 224-239 A1S_3469Ɨ 
Cro-like 
protein 
101 2604 228--243 224-239 A1S_3468Ɨ 
hypothetical 
protein 





377 2606 228--243 224-239 A1S_3467 
hypothetical 
protein 
238 2607 387--3229 383--3205 A1S_3466-3467* 
hypothetical 
protein 









197 2611 1944--1929 1884--1869 A1S_3464 
hypothetical 
protein 
48 2615 1944--1929 1884--1869 A1S_3461-3462* 
putative 
protein 




319 2617 1944--1929 1884--1869 A1S_3471 
hypothetical 
protein 
123 2618 2078--2079 2018--2019 A1S_3470 
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57 2769 2199--2200 2138--2139 A1S_3690, 3691* 
hypothetical 
protein 








Table 9 – Genes missing from AB042 (5 genes) genome compared to the parent strain 
ATCC17978. Annotation and comparison using the RAST server reveals 5 genes deleted 




































114 122 2557--2558 2496 A1S_3752 
hypothetical 
protein 
39 1032 3179--3180 3155 A1S_3819 
hypothetical 
protein 
39 1431 3309--3308 3285 A1S_2714, 2715 
hypothetical 
protein 
41 1605 3092--3093 3068 A1S_2499 
hypothetical 
protein 














Table 10 – Genes missing from the AB043 (33 genes) genome compared to the parent 
strain ATCC17978. Annotation and comparison using the RAST server reveals 33 genes 
deleted in AB043 genome. AB042 comparison to ATCC17978 shows five genes deleted. 






















118 1018 3141--3142 3166 A1S_3817, 2569* 
Phage protein 328 1128 3494--659 1628 A1S_3622 
hypothetical 
protein 






















218 1141 2046--2041 1614 A1S_3619 
hypothetical 
protein 
167 1143 2041--2541 1612 A1S_1163 
hypothetical 
protein 
76 1144 2041--2541 1611 A1S_1163 
hypothetical 
protein 




256 1146 2041--2541 1609 A1S_1162 
hypothetical 
protein 
128 1147 2041--2541 1608 A1S_1161 
hypothetical 
protein 



























401 1154 2041--2541 1601 A1S_1155 
hypothetical 
protein 
100 1155 2041--2541 1600 A1S_3616 
hypothetical 
protein 
184 1156 2041--2541 1599 A1S_3615 
plasmid-related 
protein 




445 1158 2041--2541 1597 A1S_1153 
hypothetical 
protein 




256 2151 2567--2565 1576 A1S_3606 
putative Cro 
protein 




167 2156 2561--2558 1581 A1S_3607 
hypothetical 
protein 













245 2161 2553--2555 1591 A1S_3614 
hypothetical 
protein 




54 3594 1861--1862 1921 A1S_1353 
















phage proteins, and a cell-wall  associated hydrolase, FAD/FMN containing dehydrogenases, 
signal peptides, a plasmid-related protein, bacteriophage protein, Cro protein and a DNA-
cytosine methyltransferase. 
 
The cell-wall associated hydrolase is responsible for cleavage of the bacterial cell wall during 
growth and cell wall remodelling. The bacteriophage protein STY1048 has an unknown 
function while the Cro repressor protein controls the expression of phage genes during lytic 
growth (Folkmanis et al., 1977).  Putative signal peptides are used as leader sequences to direct 
protein synthesis and subcellular localization (Payne et al., 2012) and DNA cytosine 
methyltransferases are highly ubiquitous across all eukaryotes and prokaryotes and methylate 
DNA. The loss of these genes in AB043 could indicate the observed attenuated virulence in the 
G. mellonella infection assay (Figure 29).  
 
To address the role that these gene losses as well as mutations in the genome could be having 
on gene expression RNA-sequencing was carried out and the results were analysed using the 
UNITY software developed at the University of Manitoba Physics Department. The assembled 
reads from the MiSeq assembly pipeline were aligned with the ATCC17978 transcriptome used 
for reference gene values and annotation from IMG/ER. The expression of AB042 and AB043 





3.6.2 RNA-sequencing data reveal uncharacterized transcriptional regulation in 
AB042 is modulated and SOS transcriptional repressors in AB043 
downregulated. 
The COG categorized genes, involved in lipid metabolism and transport show upregulation of 
genes involved in malonate conversion and utilization for energy production and fatty acid 
biosynthesis. Common genes (found in both AB042, AB043) in the malonate decarboxylase 
gene cluster (mdc) are, alpha subunit (ABA_01480), beta subunit (ABA_01483) and the 
triphosphoribosyl-dephospho-CoA synthase or mdcB (ABA_01481). In addition AB043 also 
overexpresses the mdcH or epsilon subunit (ABA_01486) of the malonate decarboxylase 
pathway (Table 12). 
 
Several transcriptional regulators were downregulated in AB042 ~ 2-fold which was not 
observed in AB043 (Table 11). The ABA_01206 gene encodes a putative HxlR family regulator 
that is downregulated (~2-fold) and ABA_00969 and ABA_01755 both encode TetR regulators. 
ABA_01755 is downstream of the glnLG two component system which responds to nitrogen 
limitation and triggers glutamate production (Shimizu, 2013) while ABA_00969 is adjacent to 
hypothetical proteins. The last two genes involved in regulation in AB042, ABA_03260 and 
ABA_03579, both downregulated, are tetR family regulators (Table 11). These genes are both 
adjacent to C4 antisense RNA, transcribed in the same orientation and upstream. The C4 
antisense RNA can act as a repressor of downstream genes by way of stem loop structures that 
inhibit promoter sites (Citron & Schuster 1992). The downregulation of ABA_03260 and 
ABA_0357 could be related to the activity of these antisense RNA products however expression 
of either was not detected by RNA-seq.  
229 
 
The AB043 transcriptome contains greater changes in fewer genes a large number of which are 
downregulated and of unknown function. DNA repair and recombination genes were 
downregulated including an integrase (ABA_02800, -4.9-fold) encoding a gene characterized 
by its function of integrating phage DNA that is usually part of pathogenicity islands. In addition 
DNA polymerase was downregulated (ABA_02804, -4.4-fold) as well as SOS response 
transcriptional repressors (ABA_02803, -5.2-fold and ABA_03524, -6.9-fold). Interestingly 
many genes coding for unknown secreted proteins were also observed to be upregulated and 
will be discussed in their relation to the csu operon (Tomaras et al., 2003). Considering their 
proximity to the pili assembly protein encoding genes (ABA_02266-02267) they are likely part 
of the csu operon in A. baumannii (Di Nocera et al., 2011). Finally many genes of unknown 
function were also downregulated in AB043 and their function remains to be characterized.  
 
Overall the major changes in gene expression belong to general functional prediction, amino 
acid transport and metabolism and of unknown function. Some of the genes of unknown 
function may have characterized roles that will be discussed. Many genes with a role in 
transcription are moderately downregulated (~2-fold) and their function relates to the novel Hxlr 
family of regulators whose function has yet to be characterized. The AB043 transcriptome 
revealed fewer genes with modulated. However, fold change was greater overall, ~5-fold 
(ABA_03281) a tetR transcriptional regulator and -5.4-fold (ABA_02803) an SOS 
transcriptional repressor. Some genes downregulated more than ABA_02803, upon further 
analysis were not found in AB043 by BLAST analysis. This suggests that these genes may be 
missing in the AB043 genome. Also identified in both AB042 and AB043 was the upregulation 
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of the malonate decarboxylase gene cluster utilized for metabolism of malonate (J H Koo, Cho, 





































Figure 34 – Transcriptome of AB042 and AB043 grouped according to clusters of 
orthologous group (COG) show differences relative to ATCC17978. Accession 
numbers indicate at least 2-fold change in expression relative to ATCC17978. The AB042 
transcriptome show broader changes across subsystem categories and AB043 shows genes 
with greater changes in gene expression across a smaller number of subsystem categories. 












































Table 11 - Genes in AB042 showing at least 2-fold change by RNA-seq, in at least one 
biological replicate. Highest expressed gene unique to AB042, from COG “Function 
unknown” ABA_00142 ~4.7-fold (uncharacterized conserved protein). The lowest 
expressed gene unique to AB042 from COG “Amino acid transport and metabolism”, 
ABA_02623 ~ -3.2-fold (arginine N-succinyltransferase). Genes in grey shaded boxes have 


















Amino acid transport and 
metabolism 
Aspartate ammonia-lyase  2.1 1.05 ABA_00881 A1S_1726 2248 




4.65 0.56 ABA_01414 A1S_1361 1827 
Amino acid transport and 
metabolism 
FAD dependent oxidoreductase 
TIGR03364  
2.81 0.33 ABA_01416 A1S_1363 1829 
Amino acid transport and 
metabolism 
Putative threonine efflux protein  2.17 1.9 ABA_02278 A1S_2224 2821 
Amino acid transport and 
metabolism 
amine acid ABC transporter, 
permease protein 
4 0.11 ABA_02359 A1S_2300 2898 
Amino acid transport and 
metabolism 
amine acid ABC transporter, 
permease protein 
2.44 0.94 ABA_02360 A1S_2301 2899 
Amino acid transport and 
metabolism 
arginine N-succinyltransferase  -3.6 -2.83 ABA_02623 A1S_1093 1521 
Carbohydrate transport and 
metabolism 
Sugar phosphate permease  2.05 0.37 ABA_00459 A1S_0968 1388 
Carbohydrate transport and 
metabolism 
trehalose-phosphatase  2.51 2.35 ABA_01032 A1S_0804 1229 
Carbohydrate transport and 
metabolism 
Arabinose efflux permease  2.23 0.81 ABA_01329 A1S_3146 3742 
Carbohydrate transport and 
metabolism 
Arabinose efflux permease  2.42 0.73 ABA_02645 A1S_1112 1543 
Cell motility 
Chemotaxis signal transduction 
protein  













2.4 1.06 ABA_03000 A1S_2489 3082 
Coenzyme transport and 
metabolism 
Methylase involved in 
ubiquinone/menaquinone  
2.09 1.02 ABA_00833 A1S_1681 2200 
Coenzyme transport and 
metabolism 
hypothetical protein  2.09 2.82 ABA_00903 A1S_1748 2270 
Coenzyme transport and 
metabolism 
dethiobiotin synthase  2.14 0.57 ABA_01037 A1S_0809 1234 
Coenzyme transport and 
metabolism 
triphosphoribosyl-dephospho-
CoA synthase MdcB  
3.67 3.52 ABA_01481 A1S_1428 1893 
Defense mechanisms multidrug efflux pump, adeJ 2.1 1.64 ABA_00247 A1S_2736 3339 
Defense mechanisms 
type I secretion system ATPase, 
LssB family  
2.87 1.65 ABA_03298 A1S_1242 1705 




2.33 2.24 ABA_00572 A1S_1467 1935 
Energy production and 
conversion 
L-proline dehydrogenase -4.47 -5.97 ABA_00641 A1S_1528 2006 




2.01 1.7 ABA_01083 A1S_3280 1273 








4.47 2.6 ABA_00142 A1S_2839 3442 
Function unknown Predicted membrane protein  -2.24 -0.72 ABA_00860 A1S_1706 2227 
Function unknown TIGR01244 family protein  -2.15 -2.26 ABA_00863 A1S_1709 2230 
Function unknown hypothetical protein  -2.23 -1.17 ABA_01532 A1S_1077 1503 
Function unknown 
Uncharacterized protein 
conserved in bacteria  






3.28 3.69 ABA_02143 A1S_2091 2688 
Function unknown 
Uncharacterized protein 
conserved in bacteria  




-6.4 -6.28 ABA_02328 A1S_2271 2867 
Function unknown Predicted membrane protein  2.72 2.52 ABA_02380 A1S_2886 2919 




2.31 1.66 ABA_00111 A1S_2872 3474 
General function prediction 
only 
Ferredoxin subunits of nitrite 
reductase 
4.46 2.52 ABA_00435 A1S_0945 1363 
General function prediction 
only 
phage prohead protease, HK97 
family  
2.81 5.09 ABA_00725 A1S_1590 2090 
General function prediction 
only 
Zn-dependent hydrolases, 
including glyoxylases  
-2.26 -1.91 ABA_00862 A1S_1708 2229 
General function prediction 
only 
Dehydrogenases with different 
specificities  
2.42 2.42 ABA_00902 A1S_1747 2269 
General function prediction 
only 
NADH-FMN oxidoreductase RutF, 
flavin reductase (DIM6/NTAB) 
family 
2.42 1.68 ABA_00904 A1S_1749 2271 
General function prediction 
only 
NADP-dependent 3-hydroxy acid 
dehydrogenase YdfG 
3.72 1.47 ABA_00919 A1S_1764 2286 
General function prediction 
only 
Acetyltransferases  -3.45 -0.48 ABA_00955 A1S_1800 2321 
General function prediction 
only 
Phenylpropionate dioxygenase, 
large terminal subunit 
2.79 1.55 ABA_01082 A1S_0852 1272 
General function prediction 
only 
glutathione-regulated 
potassium-efflux system ancillary 
protein KefF 
-3.12 -0.31 ABA_03253 A1S_1287 1747 
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General function prediction 
only 
3-oxoadipate enol-lactonase  2.5 1.28 ABA_03672 A1S_1889 2430 
General function prediction 
only 
Phenylpropionate dioxygenase, 
large terminal subunit 
2.24 1.53 ABA_03698 A1S_1860 2403 
Inorganic ion transport and 
metabolism 
Sulfate permease and related 
transporters (MFS) 
2.54 3.78 ABA_01248 A1S_3225 78 




2.09 0.27 ABA_01299 A1S_3174 31 




2.72 2.16 ABA_01466 A1S_1413 1878 
Inorganic ion transport and 
metabolism 
Chromate transport protein ChrA  2.1 2.16 ABA_01514 A1S_1457 1927 
Intracellular trafficking, 
secretion, and vesicular 
transport 
efflux transporter, outer 
membrane factor (OMF), adeK 
2.1 1.61 ABA_00246 A1S_2737 3316 
Intracellular trafficking, 
secretion, and vesicular 
transport 
Tfp pilus assembly protein PilN  3.08 1.75 ABA_01283 A1S_3194 47 
Intracellular trafficking, 
secretion, and vesicular 
transport 
Tfp pilus assembly protein PilO  2.31 1.41 ABA_01284 A1S_3193 46 
Intracellular trafficking, 




-2.63 -0.41 ABA_01311 A1S_3165 19 
Intracellular trafficking, 
secretion, and vesicular 
transport 
Outer membrane protein  3.92 1.95 ABA_03299 A1S_1241 1704 
Lipid transport and 
metabolism 
Membrane-associated 
phospholipid phosphatase  
2.42 1.82 ABA_00249 A1S_2734 3337 
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Lipid transport and 
metabolism 
acetyl-CoA acetyltransferases  2.56 3.55 ABA_00886 A1S_1731 2253 
Lipid transport and 
metabolism 
Acyl carrier protein 
phosphodiesterase  
-3.09 -2.32 ABA_01408 A1S_1354 1821 
Lipid transport and 
metabolism 
malonate decarboxylase, alpha 
subunit  
4.1 3.12 ABA_01480 A1S_1427 1892 
Lipid transport and 
metabolism 
biotin-independent malonate 
decarboxylase, beta  
3 2.5 ABA_01483 A1S_1430 1895 
Lipid transport and 
metabolism 




maleylacetoacetate isomerase  -3.08 -3.32 ABA_02553 A1S_3415 556 
RNA processing and 
modification 
RNA 3'-phosphate cyclase  -2.95 -4 ABA_02331 A1S_2273 2870 
Secondary metabolites 




2.26 0.49 ABA_02441 A1S_2381 2975 
Secondary metabolites 
biosynthesis, transport and 
catabolism 
fumarylacetoacetate hydrolase -2.42 -3.27 ABA_02554 A1S_3414 557 
Secondary metabolites 




2.67 1.45 ABA_03181 A1S_0109 360 
Transcription 
transcriptional regulator, TetR 
family  
-2.17 -0.92 ABA_00969 A1S_0744 1166 
Transcription 
transcriptional regulator, HxlR 
family  
-2.05 -0.74 ABA_01206 A1S_3262 118 
Transcription 
transcriptional regulator, TetR 
family  




transcriptional regulator, HxlR 
family  
-2.17 -1.25 ABA_03252 A1S_1288 1748 
Transcription 
transcriptional regulator, TetR 
family  
-2.63 -0.38 ABA_03260 A1S_1272 1741 
Translation, ribosomal 
structure and biogenesis 
Asp-tRNAAsn/Glu-tRNAGln 
amidotransferase A  
























Table 12 - Genes in AB043 showing at least 2-fold change by RNA-seq, in at least one 
biological replicate. Highest expressed gene, from COG “Transcription” was ABA_03281 
~5.06-fold, (tetR transcriptional regulator). Gene with greatest downregulation was from 
COG “Transcription”, ABA_02803 ~ -5.4-fold, (SOS transcriptional repressor). Genes in 
grey shaded boxes have similar expression in AB042. Genes that did not have any hits in 
AB043 genome but mapped to ATCC17978 genome were are labelled “no hits”. Table 






















2.78 1.32 ABA_01414 A1S_1361 1769 
Amino acid transport and 
metabolism 
Putative threonine efflux 
protein  
2.02 2.4 ABA_01419 A1S_1366 1774 
Amino acid transport and 
metabolism 
amine acid ABC transporter, 
permease protein 
3.11 0.01 ABA_02359 A1S_2300 2872 




3.5 3.74 ABA_01031 A1S_0803 1226 
Carbohydrate transport and 
metabolism 
trehalose-phosphatase  4.7 5.62 ABA_01032 A1S_0804 1227 
Cell wall/membrane/envelope 
biogenesis 
alanine racemase  2.75 3.67 ABA_01411 A1S_1357 1766 





3.56 3.89 ABA_01481 A1S_1428 350 
Energy production and 
conversion 
succinate dehydrogenase 
and fumarate reductase  
-2.1 -0.93 ABA_00276 A1S_2714 3286 
Energy production and 
conversion 
L-lactate transport  -2.31 -0.12 ABA_00340 A1S_0067 396 




-2.1 -0.28 ABA_00342 A1S_0069 393 
Energy production and 
conversion 
L-proline dehydrogenase -3.34 -4.98 ABA_00641 A1S_1528 1946 












2.35 2.6 ABA_00855 A1S_1700 2161 




2.09 2.08 ABA_00856 A1S_1701 2162 




2.18 2.55 ABA_00857 A1S_1702 2163 





2.88 2.46 ABA_01495 A1S_1486 1849 
Function unknown 
Predicted integral 
membrane protein  
-2.36 -2.02 ABA_00093 A1S_2889 3467 
Function unknown 
phage portal protein, HK97 
family  
2.17 1.31 ABA_00724 A1S_1589 2029 
Function unknown 
type VI secretion protein, 
VC_A0107 family  
3.68 4.03 ABA_01346 A1S_1294 1703 
Function unknown 
type VI secretion protein, 
EvpB/VC_A0108 family  
















5.66 6.4 ABA_02270 A1S_2218 2752 
Function unknown 
Uncharacterized protein 
conserved in bacteria  









associated protein  
-7.2 -7.72 ABA_02802 A1S_2963 no hits 
Function unknown 
Uncharacterized protein 
conserved in bacteria  
-5.39 -5.6 ABA_02825 A1S_1157 no hits 
Function unknown 
Uncharacterized protein 
conserved in bacteria  
-4.6 -5.23 ABA_02827 A1S_1155 no hits 
Function unknown 
phage-related protein, 
HI1409 family  
-4.24 -5.27 ABA_02832 A1S_1153 no hits 
Function unknown 
phage uncharacterized 
protein (putative large  




-2.66 -2.44 ABA_02834 A1S_1151 no hits 
Function unknown 
Uncharacterized protein 
conserved in bacteria 
-2.51 -2.17 ABA_03525 A1S_1145 no hits 
Function unknown 
Uncharacterized protein 
conserved in bacteria  
-4.2 -4.4 ABA_03534 A1S_1148 no hits 
General function prediction only 
Ferredoxin subunits of 
nitrite reductase  
2.61 2.1 ABA_00435 A1S_0945 1362 
General function prediction only 
Phage terminase-like 
protein, large subunit  
2.49 1.97 ABA_00723 A1S_1588 2028 
General function prediction only 
phage prohead protease, 
HK97 family  
4.06 4.21 ABA_00725 A1S_1590 2030 
General function prediction only 
phage head-tail adaptor, 
putative, SPP1 family  
3.3 1.84 ABA_00729 A1S_1592 2034 
General function prediction only 
Phage-related lysozyme 
(muraminidase)  
2.39 2.99 ABA_00744 A1S_1600 2049 
General function prediction only 
Phage-related lysozyme 
(muraminidase)  
2.16 1.03 ABA_01799 A1S_2016 2511 
Inorganic ion transport and 
metabolism 
Catalase  3.16 4.83 ABA_01444 A1S_1386 1797 
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2.52 3.11 ABA_01466 A1S_1413 1819 
Intracellular trafficking, 
secretion, and vesicular 
transport 
P pilus assembly protein, 
porin PapC  
3.8 4.66 ABA_02266 A1S_2214 2748 
Intracellular trafficking, 
secretion, and vesicular 
transport 
P pilus assembly protein, 
chaperone PapD  
4.94 3.85 ABA_02267 A1S_2215 2749 
Intracellular trafficking, 
secretion, and vesicular 
transport 
Tfp pilus assembly protein, 
pilus retraction  
-2.62 -0.18 ABA_03108 A1S_0643 646 
Lipid transport and metabolism 
malonate decarboxylase, 
alpha subunit  
3.48 3.58 ABA_01480 A1S_1427 1833 




2.87 2.43 ABA_01483 A1S_1430 1836 
Lipid transport and metabolism 
malonate decarboxylase, 
epsilon subunit  
3.04 1.83 ABA_01486 A1S_1427 1839 
Lipid transport and metabolism Acyl-CoA dehydrogenases  2.95 1.12 ABA_03185 A1S_0113 352 
Replication, recombination and 
repair 
Integrase  -4.85 -5.44 ABA_02800 A1S_1175 655 
Replication, recombination and 
repair 
Nucleotidyltransferase/DNA 
polymerase involved  
-4.43 -4.69 ABA_02804 A1S_1173 657 
Secondary metabolites 




3.52 0.88 ABA_03184 A1S_0112 353 
Secondary metabolites 
biosynthesis, transport and 
catabolism 
amino acid adenylation 
domain  





TetR family  
2.25 1.62 ABA_02271 A1S_3796 2753 
Transcription 
SOS-response 
transcriptional repressors  
-5.24 -5.55 ABA_02803 A1S_1174 658 
Transcription 
transcriptional regulator, 
TetR family  
5.06 6.3 ABA_03281 A1S_1256 1664 
Transcription 
SOS-response 
transcriptional repressors  
-6.92 -7.95 ABA_03524 A1S_1144 no hits 
Translation, ribosomal structure 
and biogenesis 
ribosomal protein L33, 
bacterial type  
-2.02 -0.12 ABA_01933 A1S_0447 927 
Translation, ribosomal structure 
and biogenesis 
Asp-tRNAAsn/Glu-tRNAGln 
amidotransferase A  







3.6.3 Global proteome of AB042 and AB043 show trend with RNA-seq data and 
overall show fewer changes in expression compared to wildtype  
The triclosan resistant strains AB042 and AB043 were also assessed for total protein expression 
profile to confirm transcriptomic data and provide greater context for observed phenotypic 
observations.  
 
The overexpression of pili assembly and type VI secretion genes was confirmed by proteomics 
(Table 14) and further suggests a role of these genes in possible biofilm formation and motility. 
Overexpression of mRNA coding for enzymes in carbohydrate transport and metabolism, and 
cell wall biogenesis were statistically overexpressed in AB043 at the protein level (Table 14) 
compared to the parent strain. The role of HNS was assessed by harvesting proteome from 
AB043 and AB043 complimented strains to identify HNS dependant protein expression and 
determine its role in motility. The analysis of protein show that the type VI genes do not respond 
to the overexpression of the HNS regulator while the csu genes encoding pili assembly proteins 
do decrease, but not to wildtype levels (Table 15). This may provide confirmation of the HNS 
independent biofilm phenotype that was observed for AB043, as it was shown complementation 


























Figure 35 – The proteome of (A) AB042 and (B) AB043 reveal clusters of genes that 
have modulated expression relative to ATCC17978. Accession numbers located in the 
same box are part of the same COG. (A) The AB042 strain: ABA_00208 Unknown function; 
ABA_00248,00247 defense mechanisms; ABA_01034,01035 coenzyme transport and 
metabolism; ABA_01480, 02199 lipid transport and metabolism; ABA_02253 function 
unknown; ABA_02488 translation, ribosomal structure and biogenesis; ABA_03265 lipid 
transport, metabolism. (B) The AB043 strain: ABA_00247, 00269 defense mechanisms; 
ABA_00606, 00829 unknown function; ABA_01301, 01302 transcription; ABA_01248 
inorganic ion transport and metabolism; ABA_01348, 01346 intracellular trafficking; 
secretion and vesicular transport; ABA_01408 energy production and conversion; 
ABA_02270 function unknown; ABA_02726, 02816, ABA_03111, 03307 function 





















































Table 13 – Similar trends between transcriptomics and proteomic data for AB042. 
Upregulation of the adeJ efflux pump (ABA_00247) and the outer membrane component 
adeK (ABA_00246) trends with RNA-seq. The sulfate permease transporter (ABA_01248) 
has the highest expression in RNA-seq and protein expression. The expression of malonate 
decarboxylase (ABA_01480) is also highly expressed in both RNA-seq and proteomics. 
Boxes in grey indicate genes expressed in both AB042 and AB043. Proteomics fold change 
and standard deviation is representative of two biological replicates. Table organized by 








































2.1 1.335 0.172 ABA_00881 A1S_1726 2248 


















2.54 10.059 0.897 ABA_01248 A1S_3225 78 




alpha subunit  




in bacteria  
2.44 1.076 0.245 ABA_01998 A1S_0385 867 


























Table 14 – Similar trends between transcriptomic and proteomic data for AB043. The 
overexpression of the csu genes (ABA_02266-67) and type VI genes (ABA_01346-47) 
were confirmed by protein expression. Also confirmed was overexpression of alanine 
racemase (ABA_01411) and trehalose-6-phosphate synthase (ABA_01031) and trehalose 
phosphate (ABA_01032). Also confirmed was the overexpression of the uncharacterized 
secreted proteins (ABA_02268, 02270, 02286) likely part of the csu operon. 
Overexpression of catalase and the downregulation of SOS transcriptional repressors are 
also observed at both the mRNA and protein levels. Proteomics fold change and standard 






























phosphate synthase  










alanine racemase  2.75 10.62 2.66 ABA_01411 A1S_1357 1766 




fumarate reductase  
-2.1 0.7 0.16 ABA_00276 A1S_2714 3286 
Energy production and 
conversion 
L-lactate transport  -2.31 0.64 0.2 ABA_00340 A1S_0067 396 





-2.1 0.79 0.14 ABA_00342 A1S_0069 393 




-3.34 0.79 0.16 ABA_00641 A1S_1528 1946 
Function unknown 
type VI secretion 
protein, VC_A0107 
family  









2.56 6.56 1.28 ABA_01347 A1S_1295 1704 
Function unknown 
Uncharacterized 
secreted protein  
5.39 8.03 1.43 ABA_02268 A1S_2216 2750 
Function unknown 
Uncharacterized 
secreted protein  




in bacteria  
2.83 6.32 2.02 ABA_02286 A1S_2230 2768 
Inorganic ion transport 
and metabolism 




P pilus assembly 
protein, porin PapC  




P pilus assembly 
protein, chaperone 
PapD  




























Table 15 – Global protein expression of AB043 before and after HNS compliment show 
an HNS independent expression of type VI proteins. A total of 49 proteins showed 
differential expression when the HNS compliment was compared to the AB043. Protein 
expression observed by vector alone expression are excluded. The difference between 
columns “43+hns / 17978” and “43/17978” labelled “Change in expression”, show change 
with HNS complementation. Greatest change in expression due to HNS complementation 
was 4.28, aspartate racemase (ABA_02251), decreasing in expression. Rows italicised are 
products from the csu and typeVI operons and indicate no change in expression after HNS 
complementation. Protein data is representative of two biological replicates. Table 























phosphate synthase L 
chain, N-terminal 
domain/Carbamoyl-
phosphate synthase L 




0.282 0.496 1.288 1.57 ABA_03265 A1S_1270 
Isocitrate lyase 0.715 0.688 1.071 1.786 ABA_00497 A1S_1008 
transaldolase 1.184 1.029 0.673 1.857 ABA_02109 A1S_2065 









1.472 0.912 0.437 1.909 ABA_02130 A1S_2079 
Uncharacterized 
proteins, homologs of 
lactam utilization 
protein B 
0.408 0.59 1.536 1.944 ABA_03268 A1S_1267 
sulfate/thiosulfate-
binding protein 
0.605 0.742 1.34 1.945 ABA_03043 A1S_2531 
tRNA (guanine-N(7)-)-
methyltransferase 
1.266 1.138 0.693 1.959 ABA_02778 A1S_1196 




1.224 0.948 0.742 1.966 ABA_00060 A1S_2914 
Rhodanese-related 
sulfurtransferase 
1.361 1.185 0.64 2.001 ABA_00050 A1S_2924 
betaine-aldehyde 
dehydrogenase 




Superfamily II DNA 
and RNA helicases 
1.304 1.318 0.804 2.108 ABA_02316 A1S_2260" 
Uncharacterized 
protein conserved in 
bacteria 




1.372 1.067 0.797 2.169 ABA_00120 A1S_2862 
transcriptional 
regulator, IclR family 
1.35 1.387 0.835 2.185 ABA_02064 A1S_0316" 
TonB-dependent 
copper receptor 
1.75 0.787 0.47 2.22 ABA_03239 "A1S_0170" 
Uncharacterized 
protein conserved in 
bacteria 
1.567 1.67 0.72 2.287 ABA_02422 A1S_2361 
Nitroreductase 1.524 1.255 0.818 2.342 ABA_02770 A1S_2644 
indole-3-glycerol 
phosphate synthase 






0.295 0.9 2.187 2.482 ABA_00226 A1S_2757 
phosphoribosylamine-
-glycine ligase 
1.619 1.245 0.942 2.561 ABA_02239 A1S_2189 
Acyl-CoA synthetases 
(AMP-forming)/AMP-
acid ligases II 
0.595 1.672 2.918 3.513 ABA_03413 A1S_0591 
type VI secretion 
protein IcmF 
2.261 1.198 1.69 3.951 ABA_01353 A1S_1302 
aspartate racemase 3.87 1.495 0.41 4.28 ABA_02251 A1S_2202 
P pilus assembly 
protein, chaperone 
PapD 
6.713 3.536 3.676 10.389 ABA_02267 A1S_2215 
Uncharacterized 
secreted protein 
8.025 3.696 4.264 12.289 ABA_02268 A1S_2216 
P pilus assembly 
protein, porin PapC 
7.371 3.851 5.412 12.783 ABA_02266 "A1S_2214 




6.564 2.589 6.539 13.103 ABA_01347 A1S_1295 
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type VI secretion 
protein, VC_A0107 
family 
5.35 3.249 13.434 18.784 ABA_01346 A1S_1294 
DNA-binding protein 
H-NS 
0.414 0.723 19.058 19.472 ABA_02886 A1S_0268 
type VI secretion 
system effector, Hcp1 
family 
10.011 5.568 10.421 20.432 ABA_01348 A1S_1296 
Uncharacterized 
secreted protein 
36.584 24.491 33.364 69.948 ABA_02270 "A1S_2218 
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3.6.4 The role of mutant HNS in AB043 and its role in motility 
HNS plays a role in overexpressing the proteins encoded by the following genes. The protein 
encoded by ABA_00226 contains an NfeD-like domain possibly involved in lipid metabolism 
(Green et al., 2009). ABA_00417 encodes a betaine aldehyde dehydrogenase enzyme expressed 
as an osmoprotectant during osmotic stress and ABA_03421 encodes a ribosomal protein L20, 
a molecule that facilitates the assembly of 23s rRNA to 50s rRNA. The ABA_03043 gene 
encodes a sulfate ABC transporter and ABA_03268 encodes a lactam utilization protein of 
unknown function. ABA_03265 is close to the ABA_03268 and encodes a biotin dependant 
acetyl-coA carboxylase converting propanoyl-CoA to succinyl-CoA. The ABA_00497 gene 
encodes isocitrate lyase, an enzyme whose orthologue is malate synthase which is utilized in 
glyoxylate cycle.  
 
The gene ABA_02251 encodes the aspartate racemase protein involved in conversion of amino 
acids in both D and L enantiomers. The ABA_02239 gene encodes a purD protein is involved 
in the synthesis of purines and ABA_02421encodes an indole 3-glycerol phosphate synthase 
synthesising tryptophan from chorismate. The ABA_02770 encodes a nitroreductase possibly 
linked to the function of the TonB protein which is also downregulated in presence of HNS and 
possibly involved in detoxification of RNS. Gene ABA_02422 encodes the Smr domain of a 
DNA-nicking endonuclease that may have a role in mismatch repair or recombination. The 
ABA_03239 gene encodes the TonB dependant copper receptor which is associated with copper 
or iron acquisition and likely has a role associated with motility. A transcriptional regulator 
belonging to the IcIR family, ABA_02064 was observed to be downregulated by HNS and 
whose family members are involved in regulation of acetate and glycerol production (Galinier 
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et al., 1991). The ABA_00120 gene encodes the preprotein translocase subunit SecA, part of 
the general type II secretion pathway. ABA_02324 which has similarity to a cytoplasmic iron 
sensing protein YaaA has been shown to reduce hydrogen peroxide toxicity by reducing unused 
iron in the cytoplasm (Y. Liu, Bauer, & Imlay, 2011). Gene ABA_00060 encodes another 
member of the type II secretion system, SecD gene and ABA_00050 encodes a rhodanese-
related sulfurtransferase. The gene ABA_02778 encodes a guanine tRNA-methyltransferase but 
its function is unknown. ABA_02130 encodes the mechanosensitive ion channel (MscS) whose 
role may be to relieve osmotic pressure and ABA_02240 encodes a D-methionine transport 
substrate binding protein, part of the ABC transporters. Finally ABA_02109 was observed to 
decrease in expression in presence of HNS overexpression. The gene ABA_02109 encodes a 











There are 3979 annotated protein coding genes predicted by the IMG/ER pipeline and of those 
AB042 transcriptomic analysis showed 73 genes with expression ≥ log2 2-fold compared to 
ATCC17978 in at least one biological replicate. Of these 73 genes, 13 were common with 
AB043 resulting in 60 unique genes overexpressed in AB042. The AB043 transcriptome reveals 
46 unique genes with expression ≥ log2 2-fold compared to ATCC17978 in at least one 
biological replicate. The scope of data showing the global transcriptome of AB042 and AB043 
indicate that less than 25% of the transcriptome of each strain is common between the two which 
suggests that each strain may have had a divergent path of resistance. There are no instances 
where expression greater than two-fold in one strain was observed to be opposite in the other 
strain. The majority of genes in both strains were characterized as having a general function or 
of unknown function.  
 
Genes that were involved in transcription were generally down regulated in AB042. Many of 
these regulators had no clearly identified role. The HxlR regulator (ABA_01206) is adjacent to 
the AhpD enzyme, which catalyses the reduction of peroxides to alcohols via oxidation of 
cysteine residues in the enzyme and therefore reduces oxidative stress in the cell (Clarke et al., 
2011). The expression of these HxlR regulators could repress expression of these enzymes 
unless encountering antibiotic stress or growth related stresses, however other members of the 
family have been reported as activators of expression (Yurimoto et al., 2005). Acinetobacter 
baumannii contains two SOS response regulators identified to be downregulated in AB043. The 
activation of the SOS response involves DNA damage activating RecA mediated cleavage of 
LexA that causes de-repression of SOS genes (Little et al., 1980). The UmuD (ABA_02803) is 
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a LexA homologue as it was shown to cleave in the presence of mitomycin and required RecA 
for cleavage (Hare et al., 2012). The function of the second gene is currently unknown however 
it does contain a specialized HTH domain that may be involved in responding to xenobiotic 
stresses (Yao & Denison, 1992). Examining genes upregulated in AB043, trends were found 
with many phage genes in a microarray analysis of A. baumannii after DNA damage including 
a phage-related lysozyme were upregulated (Aranda et al., 2013). Also in AB043 multiple 
members of 2-oxoglutarate dehydrogenase complex (ABA_854-857) were upregulated which 
generate reducing equivalents to relieve oxidative stress in M. tuberculosis (Bryk et al., 2002). 
Interestingly catalase (ABA_01444) was also observed to be upregulated and this could be in 
response to the deregulation of the SOS response genes eliciting a “false alarm” response in the 
cell. The SOS response has also been linked to generation of drug  resistance in Vibrio 
(Baharoglu & Mazel, 2011) and E.coli (Petrosino et al., 2009) . Rifampicin resistant strains of 
A. baumannii have been identified after treatment with UV, alkyl damage or desiccation. The 
induction of SOS response genes was observed to be similar in rifampicin resistant and 
desiccated A. baumannii strains (Norton et al., 2013). Two other transcriptional regulators 
observed to be uniquely overexpressed in AB043 alone: ABA_2271 and ABA_3281. While 
expression of adeN (ABA_01755) in AB043 did not have a increased expression (≥2-fold) the 
expression of these uncharacterized regulators were 2.25 and 5.06-fold. The expression of 
adeIJK genes (ABA_00246,47,48) did not express greater than 2-fold but their values were 
1.05, 1.46,2-fold in AB043 and 2, 2.1, 1.96-fold in AB042, respectively.  
 
The upregulation of pili assembly genes (ABA_02266-67) have considerable implications for 
biofilm formation, motility and virulence. The homologues of the pili genes are found in A. 
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baumannii where they are part of the csuA/BABCDE operon, specifically PapC, encoded by the 
csuD gene and PapD, by the csuC gene. Further analysis of this operon revealed additional 
homologues upregulated in RNA-seq and proteomics data from AB043, (ABA_02265, csuE), 
(ABA_02268, csuB), (ABA_02270, csuA/B) (Table 14). These genes have been shown to 
facilitate biofilm formation on polystyrene which suggests reasons for their persistence on 
medical grade equipment and on abiotic surfaces in nosocomial settings (Eijkelkamp et al., 
2011; Tomaras et al., 2003). The concomitant increased expression of these proteins and biofilm 
formation noted in AB043 suggest that the csu operon is likely involved in the observed 
phenotype. The bfmRS two component system genes (ABA_00974, ABA_00975) and their role 
in csu regulation have shown loss of bfmR causes loss of csu expression and biofilm formation 
while the loss of bfmS caused partial loss of biofilm (Tomaras et al., 2008). The expression of 
the bfmRS genes in AB043 was opposite to published findings, (Tomaras et al., 2008), where 
expression of bfmR was downregulated at both the mRNA and protein level (-1.03-fold, 0.85-
fold) while bfmS was upregulated at the protein level (2.39-fold). Expression of bfmR at the 
mRNA level was not detected greater than 2-fold. The gacSA sensor kinase (ABA_03398) and 
response regulator (ABA_02855), recently shown to control biofilm formation via the csu 
operon as well as motility and virulence (Cerqueira et al., 2014) was not detected in proteome 
analysis (gacS) and had decreased expression in both mRNA and protein (gacA) of no more 
than 2-fold. While this would explain the attenuated virulence of AB043, the loss of gacS was 
linked to loss of motility and virulence as well as biofilm formation (Cerqueira et al., 2014) also 
shown through bfmR deletion (Tomaras et al., 2008). These findings suggest that an alternative 
regulatory mechanism that does not involve Gac or Bfm exists at least for biofilm formation but 
still involves the csu operon genes. The AB043 strain readily forms biofilms at 30°C and not 
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37°C which also suggest alternative mechanisms of regulation. Also overexpressed in AB043 
were the type VI secretion (TSS) genes (ABA_01346-47), known to play a role in bacterial 
killing in a mixed species population (Carruthers et al., 2013; Weber et al., 2013). While the 
expression of these genes has been shown to generate a mixed population that can outcompete 
strains not expressing TSS, they also cause a decrease in tolerance and susceptibility to 
antibiotic (Weber et al., 2015). The AB043 strain presented no loss of tolerance when compared 
to the parent strain in growth curves (Figure 27), and the resistance profile of AB043 shows 
decreased susceptibility to multiple classes of antibiotics (Table 7). It may be that only specific 
components of the TSS machinery are overexpressed in the AB043 strain and that it is missing 
the full TSS locus (Eijkelkamp et al., 2013; Wright et al., 2014). Genome analysis of the AB043 
strain identified 12 genes in a cluster encoding the various members of the type VI secretion 
system (ABA_00130-141) however only ABA_01346-47 had increased gene expression 
relative to ATCC17978 (Table 14).  
 
The trehalose phosphatase and trehalose-6-phosphate synthase are key stress response enzymes 
that facilitate cell survival during osmotic stress. The genes encoding these enzymes are 
activated by osmotic stress (Giaevere et al., 1988). Trehalose is a stress response metabolite that 
is synthesized from UDP-glucose and glucose-6-phosphate, accumulating in the cell acting as 
an osmoprotectant along with glutamate (Styrvold & Strøm, 1991). Finally, the decreased 
expression of energy production and conversion enzymes in the cell show the downregulation 
of enzymes that bring in lactate (ABA_00340) for conversion into pyruvate and 
ferrocytochrome C (ABA_00342) (Dehydrogenase, 1968). Interestingly pyruvate is utilized by 
the Pyruvate/2-oxoglutarate dehydrogenase complex (ABA_00854) and was shown to be 
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overexpressed in the AB043 mRNA profile and in M. tuberculosis strains responding to 
oxidative stress (Bryk et al., 2002). 
 
The exposure of A. baumannii type strain ATCC 17978 to increasing concentrations of triclosan 
allowed the selection of isolates with a resistance to triclosan and multiple medically relevant 
antibiotics. Upon further study a single mutation in the fabI gene of both strains was shown to 
confer resistance to triclosan. Interestingly AB043, the strain with a higher MIC also had a 
higher expression of fabI (Figure 22b) and was subsequently shown in proteomics analysis to 
be overexpressed in both AB042 (1.64-fold) and AB043 (1.41-fold). The reason for the 
observed reduction in FabI protein abundance compared to transcript abundance may be due to 
rapid mRNA turnover (Vogel et al., 2012) and subsequent loss of message at the translational 
step showing less FabI in proteomics analysis. In previous studies of A. baumannii clinical 
isolates the overexpression of fabI was associated with a higher MIC for triclosan, strains with 
a lower MIC among the collection correlated with mutation but without overexpression (Chen 
et al., 2009). The overexpression of fabI by in AB043 was not observed at the proteomics level 
suggesting a difference in gene expression and protein expression. Studies have shown that the 
major factor in generation of triclosan resistance has been through mutation of the fabI gene 
across multiple species (Curiao et al., 2015; Gantzhorn et al., 2015) but has also been linked to 
loss of virulence (Gantzhorn et al., 2015; Karatzas et al., 2007). Interestingly the loss of the fabI 
homologue in S. typhimurium showed a loss of LPS which could lead to attenuated virulence 
phenotypes (Turnowsky et al., 1989) and in other studies disruption or deletion of enzymes in 
the FASII pathway show attenuated virulence phenotypes (Brown & Gulig, 2008; Fozo et al., 
2007). These findings correlate with the generation of attenuated virulence in the AB043 strain 
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compared to AB042 and ATCC 17978 and suggest that its infectious potential is reduced after 
triclosan exposure. Whether this has a correlation with increased resistance to antibiotics or 
efflux pump expression is unknown. Efflux pump MexEF-OprN overexpression has shown to 
cause a reduction in virulence by extruding quorum sensing precursor molecules in P. 
aeruginosa causing a reduction in virulence (Lamarche et al., 2011).  
 
The second finding from this study was the cross resistance to multiple antibiotics that was 
observed to be sequential for AB042 and AB043 respectively. Multiple studies have also 
demonstrated that cross resistance to antibiotics is a common occurrence after triclosan 
adaptation, in vitro (Braoudaki & Hilton, 2004; Gantzhorn et al., 2015; Pycke et al., 2010) and 
in vivo (Lerma et al., 2015) exposure. In a surveillance study, isolates of mesophilic and 
psychotropic Pseudomonads were obtained from various areas along the chain of a meat 
processing plant that routinely used triclosan for disinfection and cleaning. Isolated strains were 
shown to have triclosan resistance that correlated with cross resistance to ampicillin, 
amoxicillin, erythromycin, imipenem and trimethoprim (Lerma et al., 2015). In a study 
examining the generation of cross resistance, the E. coli strain O157 was observed to generate 
triclosan resistance after two passages and consistently presented cross resistance to various 
antimicrobial agents including chloramphenicol, erythromycin, imipenem and tetracycline. 
Exposure to other biocides such as benzylkonium chloride did not achieve as great a decrease 
in susceptibility to as large a number of antibiotics as did triclosan (Braoudaki & Hilton, 2004). 
The point mutation generating triclosan resistance has unknown effects on the membrane 
structure and function in bacterial cells. This study revealed that a loss of larger fatty acid chains 
occurred in triclosan resistant strains with the majority loss of C18:1 and increase in C16:1. This 
266 
 
has also been observed in cells exposed to the triclosan homologue diazaoborine, also targeting 
fabI, revealing the accumulation of C16 and loss of C18 and larger fatty acids (Turnowsky et 
al., 1989). The gram-negative bacterium Rhodozpirillum rubrum S1H was shown to have 
decreased susceptibility to multiple drugs but increased susceptibility to membrane 
permeabilization drugs such as polymyxin B and colistin. Although in AB042 and AB043 
increase in susceptibility against colistin was not observed, no change in MIC was found 
compared to the parent strain. Changes in morphological attributes of E. coli cells with fatty 
acid defects were observed, zones of clearing in cells were observed with electron microscopy 
and that these areas had the inner membrane contracted, suggesting a defect in membrane 
synthesis (Turnowsky et al., 1989). Although no physical strain defects could be seen in the 
membrane from electron microscopy images (Appendix 6) the change in fatty acid size 
distribution is a cause of triclosan exposure. The changes in fatty acid size distribution may not 
be related to triclosan resistance but rather a secondary physiological effect of the exposure. 
Although no direct studies have examined the role of efflux pumps and fatty acid synthesis, the 
FA inhibitor thiolactomycin caused overexpression of MexAB-OprM (Schweizer 1998). In 
another study thiolactomycin inhibited P. aeruginosa growth, supplementation of both C16 and 
C18 was shown to suspend the observed growth defect (Hayashi et al., 1984). The increased 
expression of AdeIJK could be linked to this physiological response, removing a buildup of 
fatty acids or toxic by-products from the cell since modified fatty acids could be accumulating 
in the cell. In fatty acid synthesis the elongation of C16:1 (palmitoleate) to C18:1(cis-vaccenate) 
is carried out by the FabF enzyme (Fujita et al., 2007) which was found to be downregulated in 
both AB042 and AB043 (ABA_01857) by transcriptomic analysis. Therefore the direct action 
of triclosan on FabI and its subsequent mutation may not be the direct cause of modified fatty 
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acid distribution but rather a secondary effect involving mutations in FabF may be the cause of 
changes in fatty acid distribution. Strains showing higher MIC to triclosan have been associated 
with expression of multiple drug resistance mechanisms including efflux pumps (Pycke et al., 
2010) such as mexCD-oprJ (Chuanchuen et al., 2001), marA, soxS, acrAB (Lenahan et al., 2014; 
McMurry et al., 1998a) and the adeJ efflux pump in A. baumannii. The expression of smeDEF 
operon from Stenotrophomonas maltophilia was shown to be de-repressed through 
crystallographic studies of SmeT bound by triclosan revealing the biocide as a de-repressor of 
pump expression leading to improved tolerance in presence of antibiotic and triclosan compared 
to antibiotic alone (Hernández et al., 2011). The role of Sigma factors in Salmonella 
Typhimurium, rpoS, rpoD were recently shown to have a major effect on triclosan resistance, 
generating high triclosan resistant strains when mutated in combination with fabI, and low 
resistance strains when only the fabI gene was mutated (Gantzhorn et al., 2015). A disruption 
in the hns gene encoding the histone like nucleoid structuring protein, a global regulator, was 
identified in AB043 linked to the motility phenotype observed. In regard to the role of HNS in 
reducing the observed motility of AB043 (Figure 32b), the original hypothesis was that through 
type VI secretion factors pili were facilitating surface associated motility which was related to 
hns disruption in previous studies (Eijkelkamp et al., 2013). After analysis of proteomic data 
surprisingly the type VI genes (ABA_01346, ABA_01347, ABA_01348, ABA_01353), (Table 
16) were not observed to respond to hns wildtype overexpression. Analysis of genes that did 
change in response to HNS overexpression were found and 48 possible targets identified (Table 
15). Interestingly the GacSA response regulator is 2.5-fold overexpressed in AB043-p-hns in 
comparison to AB043 (0.69-fold) and AB043-p (0.75-fold), relative to expression in 
ATCC17978. This is contrary to reports showing that loss of gacS and its complementation by 
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gacR have roles in positive regulation of biofilm and motility (Cerqueira et al., 2014) and 
suggests that motility in AB043 and biofilm formation are occurring independent of the Gac 
system. Additional evidence of this comes from biofilm studies with overexpression of hns in 
AB043, where the results show no changes in biofilm compared to the AB043 strain (Figure 
32). In addition a recent study examining the role of HNS global transcriptome in Vibrio cholera 
identified a Gac homologue overexpressed upon complementation of Δhns mutants (Ayala et 
al., 2015).  
 
Of the genes downregulated by HNS the following were involved in membrane associated 
functions, ABA_03239, 00120, 00060, 02130, 02240 while the remainder, ABA_02324, 00050, 
02778 and 02109 were involved in various functions including iron regulation, transcription 
regulation and metabolic functions. One of the targets downregulated by overexpression of HNS 
relative to AB043 was the TonB dependant copper receptor (ABA_03239). The TonB 
dependant copper receptor in ATCC 19606 has been shown to have a role in adherence to 
fibronectin (Smani et al., 2012). Subsequent studies examining the role of its downstream in the 
interacting protein, TonB, demonstrated a loss of adherence to fibronectin in ΔtonB strains 
(Zimbler et al., 2013). In P. aeruginosa the Ton-B dependant copper receptor imports copper 
as a co-factor for nitroreductase activity (Lee et al., 1989), another protein downregulated in the 
AB043 complimented strain (ABA_02770) (Table 15). Also in P. aeruginosa, disruption of the 
tonB gene specifically caused a reduction in twitching motility (Huang et al., 2004) possibly 
suggesting a link to the observed motility phenotype in AB043. Other membrane associated 
genes were also downregulated in presence of HNS, including the periplasmic domains of an 
ABC-type amino acid/ signal transduction pump (ABA_01460) and an ABC-type metal ion 
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transport system (ABA_02240). The protein secretion system components SecDF (ABA_0060) 
and the ATPase component of the Sec translocation complex (Kostakioti et al., 2005) 
(ABA_00120) were also downregulated upon HNS complementation (Table 15). It is unlikely 
that the HNS gene has any role in fatty acid biosynthesis as it is commonly associated with 
regulation of pathogenicity associated genes and horizontally acquired DNA (Troxell et al., 
2011). Although HNS in A. baumannii has been implicated in repression of type VI genes by 
HNS disruption (Eijkelkamp et al., 2013), in AB043 complimented with HNS, repression of 
type VI genes or any genes with a putative role in biofilm formation was not observed. One 
enzyme that was definitively regulated by HNS was aspartate racemase, an enzyme that 
produces D and L forms of aspartate and is sparsely distributed in nature (Marin et al., 2007). 
A species of Pseudomonas was shown to convert D-aspartate to L-aspartate, and subsequent 
conversion to D- and L-alanine showing the interconversion of D-amino acids (Markovetz et 
al., 1966). Both forms of alanine are principal components of the peptidoglycan layer and 
therefore reinforce its structure. Although gram negative bacteria contain a much thinner layer 
of peptidoglycan the decrease in fatty acid chain length in AB043 may be linked to a global 
stress response that involves the HNS regulator. Increase in amino acid racemization and 
possibly incorporation into the peptidoglycan layer may be to compensate for membrane 
defects.  Complimentary evidence of osmotic stress and fatty acid synthesis assays show the 
strain has a modified composition of fatty acids that could affect membrane integrity  and result 
in defective growth during membrane stress. 
 
Strains resistant to triclosan may be able to circumvent perturbations in fatty acid membrane 
composition to survive since weaker tolerance in the presence of osmotic stress was observed. 
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Studies on the effect of diazaoborine on membrane integrity showed a decrease in the amount 
of C18 production and increase in C16 and decreases in LPS production (Turnowsky et al., 
1989). The study also found a substantial increase in the amount of OmpC protein expression 
at 30°C but not 42°C. The OmpC protein has been identified as a protein involved in initiation 
of biofilm on abiotic surfaces (Prigent-Combaret et al., 1999) however a homologue in A. 
baumannii could not be identified. This could perhaps be a factor involved in AB043 biofilm 
formation at 30°C. Overall disruption of genes in the FASII pathway show attenuated virulence 
phenotypes (Brown & Gulig, 2008; Fozo et al., 2007).  
 
The changes in the physiology of the triclosan mutants can be understood with findings from 
other studies. Microarray studies of E. coli strains showed an increase in many genes involved 
in the biosynthesis of membrane proteins, including transporters, reductases/dehydrogenases 
and stress response regulators (Kim, & Pan, 2010). The data from AB042 and AB043 suggest 
a similar expression profile with many membrane bound proteins encoded in high amounts as 
well as changes in ABC transporters and repressors of the SOS response and regulation 
(AB042).  
 
Another transcriptomic analysis of E.coli identified a significant upregulation of genes involved 
in D-malic acid utilization (Curiao et al., 2015) which may correlate with our findings of 
increased expression of malonate metabolising enzymes. These genes are transcriptionally 
controlled by the MdcY repressor protein (Koo et al., 2000) that is conserved in AB042 and 
AB043. Malonate can be used as a carbon source by Acinetobacter species for energy (Barbe 
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et al., 2004) by way of these genes (Koo & Kim, 1999). Malonate can also be used as a precursor 
molecule for fatty acid chain elongation during the conversion of malonyl-CoA to malonyl-
ACP by (ABA_01481). This conversion can also be carried out by the FabD enzyme followed 
by a condensation reaction of the product with acetyl-CoA via FabH to produce an acetoacetyl-
ACP product, for entry into fatty acid elongation. Subsequent elongation can also be made by 
addition of malonyl-ACP via FabB or FabF enzyme (Cronan & Thomas, 2009). The fabB gene 
responsible for a condensation reaction in fatty acid elongation was found to contain a point 
mutation 496GA converting 166DN in AB042 and AB043 but its effect on fatty acid 
synthesis is not known (Hoang & Schweizer, 1997). Analysis of fabD, fabH and fabF sequences 
did not show any mutations compared to the isogenic strain. Also related to fatty acid 
biosynthesis the fabE gene, which converts acyl-CoA to enoyl-CoA, is upregulated in AB043 
(ABA_03185) and was also found to be essential for motility in A. baumannii M2 strain 
(Clemmer et al., 2011). 
 
The mutations found in the fatty acid biosynthesis pathway modify lipids and membrane 
permeability, overexpression of the RND efflux pump adeIJK through a repressor independent 
pathway as well as modifications to metabolic pathways and mechanisms to enhanced stress 
response and persistence phenotypes. The use of the biocide triclosan and its derivatives and 
homologues should carefully be considered due to the additional findings in this study showing 























The overall work in this thesis was focused on identifying the role of RND efflux pumps in A. 
baumannii as a mechanism of antibiotic resistance but also as having a physiological role in the 
species. Of the three pumps screened against a collection of clinical isolates the most ubiquitous 
of these is was found to be the AdeFGH pump that has the least number of antibiotic substrates 
compared to AdeABC and AdeIJK. Considering that this pump is not most frequently identified 
as having a role in MDR this led to further study of the pump and its putative natural function.  
 
The natural functions of RND efflux pumps although diverse in their specific function seem to 
play key roles in survival through detoxification and removal of lethal substrates or their by-
products. The expression of AdeFGH was constant through different phases of growth contrary 
to the other pumps, indicating that AdeFGH may play a role in maintenance through increasing 
cell density. The AdeFGH was also revealed to respond significantly to nitrosative stress 
generated by the compound GSNO and the antibiotic chloramphenicol but not by florfenicol. It 
is thought that the nitro-groups present in GSNO and chloramphenicol nitrosylate molecules in 
the cell or mimic nitrosylated compounds that activate pump expression. Further testing of this 
revealed that this effect may not be universal and limited to specific strains for example ATCC 
19606. Attempts to characterize the role of the local adeFGH repressor AdeL in nitrosative 
stress uncovered that in ATCC17978 nitrosative stress does not induce AdeFGH expression. 
Examination of pump expression revealed that the AdeFGH pump is significantly upregulated 
in presence of chloramphenicol and florfenicol. These compounds both target bacterial 
ribosomes and therefore in ATCC17978, AdeFGH may respond to ribosomal stress in the cell. 
This effect was observed to occur independently of the AdeL regulator suggesting that induction 
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of AdeFGH by chloramphenicol or florfenicol may occur by another pathway. Nitrosative stress 
does not seem to play a major role in efflux pump expression in ATCC17978.  
 
Finally the role of biocides generating cross resistance to antibiotics and the role of RND pumps 
in this process was studied. The biocide triclosan was utilized to generate a FabI 116 GV 
mutation causing triclosan resistance in two strains AB042 and AB043. These strains also 
showed overexpression of the AdeIJK pump. In AB042 AdeIJK overexpression was caused by 
a 73 b.p. deletion in the adeIJK repressor AdeN. Subsequent complementation with AdeN 
restored adeIJK repression and drug susceptibility. Interestingly in AB043 we did not identify 
this mutation and therefore its regulation is likely to be controlled by an as yet unidentified 
regulatory mechanism. Along with this unknown regulation the AB043 strain showed specific 
biofilm formation at 30°C but not 37°C and presented a twitching motility not observed in the 
parent strain ATCC17978. Twitching motility was found to be linked to a disruption in the HNS 
gene and its complementation repressed the motility observed but did not repress adeIJK 
expression. The distribution of fatty acids was also observed to be changed with the major 
constituent being C16 in AB043 versus C18 in ATCC17978. Transcriptomics, proteomics and 
whole genome sequencing was carried out to build a knowledge base of targets, pathways and 
physical changes, to better understand the global changes in the AB042 and AB043 strains. 
Overall changes in regulation and secondary metabolism were observed in AB042 as well as 
changes in fatty acid metabolism and synthesis. In AB043 major upregulation of the csu gene 
cluster was observed as well as genes in type VI secretion system. Complementation with hns 
did not repress expression of csu or type VI gene clusters and is therefore likely involved in 




The list of probably targets that have altered expression relative to the parent strain, and those 
genes that have been deleted from the AB043 strain, will make up a source from which to 
identify the putative regulator of AdeIJK. In addition this list will help identify the players 
































The expression of efflux pumps in Acinetobacter baumannii among the collection of clinical 
isolates from Canada reveal a novel expression profile that suggests adeFGH may play a more 
prominent physiological role in A. baumannii that has yet to be discovered. Further evidence of 
this comes from examination of AB030 and AB031. Despite having contrasting drug resistance 
mechanisms they both highly express adeG. Analysis of growth phase dependant expression 
also shows that this pump may be regulated by unique regulatory pathways independent of the 
other characterized efflux pumps. The role of this pump may have some purpose in removing 
aberrant peptides as its expression was shown to be highly upregulated in presence of 
chloramphenicol and florfenicol, but not trimethoprim or GSNO, a nitrosative stress generating 
molecule. This is contrary to the AdeFGH homologue in P. aeruginosa MexEF-OprN that is 
positively regulated by MexT and required for its observed nitrosative stress response (Fetar et 
al., 2011). It is possible that a positive regulator activating expression of the adeFGH pump is 
acting in this regard but a MexT homologue has not been identified in A. baumannii and overall 
the gene is highly conserved in Pseudomonas species. It may be that a totally new regulator 
may be controlling the expression of AdeFGH operon in response to chloramphenicol and 
metabolic stress. Interestingly the homologue of AdeL in Burkholderia species CeoR, has been 
shown to respond to chloramphenicol and salicylate inducing its cognate efflux pump 
expression (Nair et al., 2004). Future studies should examine the range of substrates that are 
able to induce expression of AdeFGH including chemicals that inhibit protein synthesis like 
aminoglycosides and also confirm the absence of a DNA damage inducible expression by using 
florfenicol drugs and testing for AdeFGH operon expression. To identify putative regulators, 
this approach could be expanded performing RNA-sequencing before and after exposure to 
ascertain a putative novel regulator controlling AdeFGH expression in ATCC17978. A clear 
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change in MIC against chloramphenicol was not observed (Appendix 3), therefore it is unclear 
if a detectable change is present due to overexpression of the AdeFGH pump. However, growth 
in ATCC19606 was shown to improve in the presence of chloramphenicol (Appendix 4) along 
with AdeFGH operon expression. This suggests that in some strains this nitrosative stress 
dependence maybe tightly regulated. Knockouts of this regulator in ATCC19606 could 
therefore also provide valuable insight into regulation by physiological means of the AdeFGH 
pump.  
 
The generation of triclosan resistant mutants in ATCC17978 was found to be cross resistant to 
multiple antibiotics. The role AdeIJK was shown to be integral to resistance in AB042 through 
an adeN mutation. Although it was shown that triclosan is likely a poor substrate of AdeFGH 
through surrogate studies in P. aeruginosa, a logical study would be to analyze the MIC of 
triclosan in A. baumannii strains with an adeN knockout. Using the parent strain ATCC17978, 
knockout of this repressor would provide a similar background with which to compare MIC. In 
addition since the global role of AdeN is currently unknown, an excellent study would be to 
compare the transcriptome and proteome (data not shown) of the AB042 strain and 
complimented strains to the ΔadeN clean knockout in ATCC17978. 
 
The AB043 strain revealed an AdeN independent expression of AdeIJK suggesting that a novel 
regulatory protein is involved in controlling expression of AdeIJK. In addition the role of 
membrane stress triggering efflux pump expression could be a factor in identifying the novel 
regulator. Future studies will be directed towards identifying step wise mutants for AdeFGH 
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overexpression that are independent of adeN mutation to pinpoint the change and later sequence 
the genome to identify the regulator. 
 
The enhanced biofilm formation in AB043 at 30°C is possibly due to overexpression of the 
CSU and type VI secretion system that has been shown to play a role in biofilm formation on 
abiotic surfaces in A. baumannii. These large operons were not found to be regulated by the 
HNS global regulator and therefore negate their role in motility but not biofilm formation. The 
temperature dependence is intriguing as 30°C is not the ideal internal body temperature. 
Therefore, considering that triclosan is an external chemical used as a biocide this may represent 
a response from A. baumannii that enhances survival on abiotic surfaces in close contact with a 
patient such as a catheter tube, intravenous lines and respiratory equipment. Future studies 
would be to perform biofilm assays on medical equipment and utilize different media in a 96-
well format in minimal media to identify factors influencing biofilm formation. Additionally 
knockout of the CSU and type VI operons would be useful to identify if these genes are indeed 
responsible for biofilm formation in AB043. Future studies examining the motility in AB043 
by using scanning electron microscopy, showing definitely what the motility factors look like 
could provide more clues as to its operon and regulon. Considering the relatively general 
information regarding motility that has been reported it may be a novel finding to show a type 
























I Appendix - Construction of A. baumannii Overexpression Vectors 
The pPLS114 (pSR1266TET) vector was generated by blunt-end cloning the ori1266 origin of 
replication into the pUCP26 plasmid that contained the tetA tetracycline resistance marker. This 
vector was used to generate a multi-copy plasmid with tetracycline selection, usable in E. coli, 
P. aeruginosa and A. baumannii with blue white selection. A neutral site in pUCP26 was chosen 
to clone in ori1266 adjacent to the tetA gene. The 1337b.p. ori1266 fragment was PCR amplified 
from the pWH1266 vector using ori1266 primers (Appendix 1 Table 1) and Taq DNA 
polymerase (NEB, Pickering, Canada). This was followed by gel extraction and polishing using 
T4 DNA polymerase (NEB, Pickering, Canada) following manufacturer’s protocol. The 
pUCP26 plasmid was digested with AatII (NEB, Pickering, Canada) and similarly gel extracted 
and polished. DNA ligations were set up in 5:1 and 8:1 ratios and incubated at 12°C overnight 
(Appendix 1 Figure 2). Next day half ligation mixture was used to transform DH5ɑ and selected 
on tetracycline 5μg/mL. Colonies growing on tetracycline plates were verified for ori1266 by 
PCR screening and replication in ATCC 17978.  
 
The pPLS092 (pSR1266TMP) plasmid was constructed using a mutagenesis method to 
introduce ori1266 origin of replication into the pUCP28T vector. This vector was used to 
generate a multi-copy plasmid with trimethoprim selection, usable in E. coli, P. aeruginosa and 
A. baumannii with blue white selection A neutral site in pUCP28T was chosen to clone ori1266, 
downstream of the dihydrofolate reductase (dhfr) gene. The ori1266 fragment was amplified 
using primers with flanking regions homologous to the pUCP28T plasmid site of insertion and 
3’ end of the primer homologous to the ori1266 fragment (Appendix 1 Table 1). The gel 
extracted ori1266 fragment with flanking sequences homologous to pUCP28T was used in the 
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mutagenesis reaction. Mutagenesis was performed as per manufacturer’s instructions using the 
QuickChange II Mutagenesis Kit (Agilent Technologies, Santa Clara, USA) with some 
modifications. The melting temperature for the hybrid ori1266 fragment was chosen as the 
melting temperature of the original primer set melting temperatures. Following parental strand 
degradation the DNA was immediately transformed into DH5ɑ cells and recovered for 1 hour 
at 37°C, shaking at 200rmp in LB media. Bacteria were plated on 50μg/mL trimethoprim and 
incubated at 37°C overnight. Colonies that grew on trimethoprim were confirmed by PCR of 
the ori1266 fragment and transformed into ATCC 17978 (Appendix 1 Figure 2).  
 









































































Appendix 2 Figure 1 – Cloning scheme for adeL and hns knockout cassettes into pMO130 
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Appendix 3 Figure 1 – Confirmation of 
clean knockout of adeL gene in 
ATCC17978 using flanking adeL full 
length primers. Gel shows excision of 
Gm marker from ATCC17978 leaving 
~600 b.p. and complementation with A. 
baumannii overexpression vector 
pSR1266TET –adeL. 
Appendix 3 Figure 2 – Confirmation of 
clean knockout of hns gene in ATCC17978 
compared to gDNA from strains carrying 





IVa Appendix - Table of ΔadeL Minimum Inhibitory Concentration of Antibiotics 
Table A3 – Antibiotic MIC’s (μg/mL) of trimethoprim (TMP), chloramphenicol (CHL), 
florfenicol (FLO), doxycycline (DOX),  trimethoprim-sulfamethoxazole (SXT), tazobactam-
piperacillin (TZP), amikacin-clavulanic acid (AMC),  ceftriaxone (CRO), cefepime (FEP), 















DRUG ATCC17978 ΔadeL 
TMP 16 32 
CHL 128 64 
FLO 128 64 
DOX 0.75 0.38 
SXT 32 R>32 
TZP 0.047 <0.016 
AMC 32 24 
CRO 0.5 0.19 
FEP 1.5 1.5 
MXF 0.064 0.064 
DOR 0.25 0.25 




V Appendix - CFU in Sublethal Concentrations of ½ TMP, ½ TMP+ 5mM GSNO 
and ½ TMP+ 1/10 CHL 
 
 Overnight cultures of respective strains were spotted (10μL) on media as described 
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